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ABSTRACT 
KIMBERLY MICHELLE STEWARD: Strategies for the Synthesis and Use of -Stereogenic 
-Keto Esters 
(Under the direction of Jeffrey S. Johnson) 
I. Extant Methods for the Preparation of -Keto Esters 
An overview of the synthetic methods to prepare -keto esters is presented, with a 
particular focus on strategies to incorporate a stereocenter at the -position. 
II. Catalytic Nucleophilic Glyoxylation of Aldehydes 
The synthesis of -silyloxy -keto esters via a cyanide catalyzed benzoin-type 
reaction with silyl glyoxylates and aldehydes is described. Critical to the success of the 
reaction was identifying Yb(O
i
Pr)3 and acetone cyanohydrin as a mild source of cyanide to 
prevent isomerization of the products to the corresponding -silyloxy -keto esters. Several 
secondary transformations add to the utility to the -keto ester products. Of the methods 
available to prepare -hydroxy -keto acid derivatives, this method provides the most direct 
route and displays the broadest substrate scope. 
 
iv 
 
III. Asymmetric Synthesis of -Keto Esters via Cu(II)-Catalyzed Aerobic 
Deacylation of Acetoacetate Alkylation Products 
A simple and efficient method for the preparation of -stereogenic -keto esters is 
described using a copper(II)-catalyzed aerobic deacylation of substituted acetoacetate esters. 
The substrates for the title process arise from catalytic, enantioselective conjugate addition 
and alkylation reactions of acetoacetate esters. The mild conditions do not induce 
racemization of the incipient enolizable -keto ester. The reaction is tolerant of a number 
esters, certain ketones, ketals and nitro groups and establishes synthetic equivalency between 
acetoacetate esters and the glyoxylate anion synthon. 
 
 
IV. Dynamic Kinetic Resolution of -Keto Esters via Asymmetric Transfer 
Hydrogenation 
The development of the first highly selective dynamic kinetic resolution of -
stereogenic -keto esters via asymmetric transfer hydrogenation using a newly designed 
(arene)Ru(monosulfonamide) catalyst is described. For substrates incorporating a diester at 
the -postion, spontaneous lactonization of the nascent -hydroxyl group onto the pendant 
ester occurs to provide trisubstituted -butyrolactones with complete diastereocontrol. 
v 
 
Extension of this method to -substituted -diketo esters results in chemoselective dynamic 
reduction of the -keto ester providing highly enriched -keto -hydroxy esters.  
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CHAPTER ONE 
EXTANT METHODS FOR THE PREPARATION OF -KETO ESTERS 
1.1 Introduction 
-Keto acids are of considerable importance in biological systems as they play 
integral roles in various metabolic and biosynthetic pathways.
1
 Pyruvic acid is the simplest 
derivative, which in its active form as phosphoenol pyruvate (PEP) 1.1, undergoes aldolase-
catalyzed CC bond formation to aldehydes in the biosynthesis of the sialic and ulosonic 
acids (Figure 1a).
2
 Important natural products including N-acetylneuraminic acid (NeuAc), 3-
deoxy-D-manno-2-octulosonic acid (KDO), and 3-deoxy-D-arabino-2-heptulosonic acid 7-
phosphate (DAHP) are produced in this manner. These are distinct classes of carbohydrates 
which exhibit a wide range of biological activity due to their participation in cell surface 
interactions. Accordingly, the -keto acid subunit has been incorporated into peptidic 
molecules to generate potent inhibitors of proteolytic enzymes such as -chymotrypsin and 
the cysteine proteinase calpain.
3
 The ability to prepare these and other synthetic analogues to 
evaluate structure-activity relationships hinges upon convenient synthetic methods for the 
direct incorporation of the -keto acid moiety. 
For the synthetic chemist, the -keto ester presents itself as a unique and versatile 
functional group.
4-5
 Due the inductive effects of the adjacent ester and opportunities for 
chelation, -keto esters display an enhanced electrophilicity relative to a normal ketone.6 As 
2 
 
a result, they react readily with nucleophiles, providing access to a number of useful organic 
building blocks including -hydroxy7 and -amino esters8 (Figure 1b). In addition, 
subsequent derivatization of the pendant ester permits additional opportunities to introduce 
molecular complexity; however, despite these useful attributes, the development of a general 
method for the de novo introduction of the -keto ester functionality has not been realized, 
particularly for those -keto esters bearing a -stereogenic center. The purpose of this initial 
chapter is to provide an overview of the synthetic methods available for the preparation of -
keto esters, with a particular focus on strategies to incorporate a stereocenter at the -
position. 
Figure 1-1. Synthetic Utility of -Keto Esters 
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1.2 Synthetic Strategies for the Preparation of Achiral -Keto Esters 
1.2.1 Oxalic Acid Derivatives 
The most direct and widely used method for the preparation of simple aryl and alkyl 
-keto esters is the addition of an organometallic to diethyl oxalate 1.2 (Scheme 1-1). This 
approach was first disclosed by Wieland
9
 using Grignard nucleophiles, but the reaction was 
reported to proceed in low yield.  A number of modified procedures have since been 
developed that deliver synthetically useful yields and the method that is commonly employed 
uses a slight excess of Grignard reagent (1.2 equivalents) at low temperatures.
10
 Notably, 
over-addition to the ester is not observed; this is attributed to the chelation-stabilized 
tetrahedral intermediate allowing the ketone to only be exposed after hydrolytic work-up. 
The isolated yields for alkyl -keto esters tend to be lower than aryl derivatives due to the 
volatility of the products. This methodology is not limited to diethyl oxalate and Grignards; 
dimethyl and dibenzyl oxalates and organolithium, –sodium, and –potassium nucleophiles 
are also commonly used. If the -keto acid is desired, tert-butyl oxalyl imidazole11 1.3 is 
used due to the facile acid-catalyzed cleavage of the tert-butyl ester.  
 
Scheme 1-1. -Keto Ester Synthesis Using Diethyl Oxalate 
 
 
4 
 
The Friedel-Crafts acylation with ethyl oxalyl chloride 1.4 has found widespread use 
in the preparation of a variety of -keto ester substrates (Scheme 1-2). In addition to aryl 
nucleophiles, activated 1-alkenes, including dithio acetals, vinyl sulfides, and N-vinylamides, 
readily react to provide ,-unsaturated -keto esters;12 enol ethers13 and enamines14 react 
analogously to give ,-dioxoesters and ,-enamino esters respectively. This methodology 
has been proven to be particularly useful for the acylation of diazoalkanes
15
 which gives 
access to pyruvate and its higher homologues and has been strategically used in the chain 
elongation of diazo sugar derivatives.
16 
 
Scheme 1-2. -Keto Ester Synthesis via Friedel-Crafts Acylations with Ethyl Oxalyl 
Chloride 
 
 
1.2.2 Acylation Reactions 
1.2.2.1 Umpolung Reagents 
The acylation of acyl anion equivalents with ethyl chloroformate is another common 
approach to -keto ester synthesis (Scheme 1-3). Meyers has shown that thioesters 1.5 
5 
 
display umpolung reactivity (polarity reversal of functional groups) following thiophilic 
addition of Grignard reagents to furnish magnesio dithio acetals 1.6 (Scheme 1-3a).
17 
These 
intermediates readily react with ethyl chloroformate to provide the corresponding -keto 
ester following deprotection. Corey and Seebach
18
 have demonstrated that lithiated dithianes 
1.7 derived from aldehydes react in a similar manner and the -keto acid can be obtained 
directly using carbon dioxide as the terminal electrophile (Scheme 1-3b). Comparable 
reactivity of lithiated dimethylamino nitriles 1.8 has been reported by Reutrakul
19
 (Scheme 1-
3c). Additionally, the “inverse” of these reactions has been reported by Eliel20 who 
demonstrated that 1,3-dithiane-2-sodium-2-carboxylates 1.9 (glyoxylate anion equivalents) 
undergo alkylation with various alkyl halides (Scheme 1-3d). 
 
Scheme 1-3. Acylation of Acyl Anion Equivalents with Ethylchloroformate 
 
 
 
6 
 
1.2.2.2 Pummerer Rearrangement 
Ogura has established (methylthio)methyl p-tolyl sulfones 1.10 as -keto ester 
surrogates following acylation with aromatic and aliphatic carboxylic esters (Scheme 1-4).
21
 
Oxidation of the methyl thiol to the sulfone 1.11 with hydrogen peroxide and acetic acid 
induces a Pummerer rearrangement with concomitant elimination of p-tolyl sulfinic acid 
yielding the corresponding -keto thiol ester 1.12. The methyl ester 1.13 is obtained 
following further oxidation of the thiol and subsequent treatment with hydrogen chloride in 
refluxing methanol. Alternatively, enamine 1.15, derived from the treatment of 
(methylthio)methyl sulfoxide 1.14 with sodium hydride and the appropriate nitrile, can be 
oxidatively transformed to the corresponding -keto ester upon treatment with copper(II) 
chloride and methanol via a similar reaction pathway (hydrolysis followed by a Pummerer 
rearrangement and subsequent elimination of methanethiol).
22 
 
Scheme 1-4. Pummerer Rearrangement of (Methylthio)Methyl Sulfoxides 
 
 
1.2.2.3 Divergent Reactivity of Ethyl Cyanoformate 
Nucleophilic addition to ethyl cyanoformate 1.16 typically occurs at the carbonyl site 
to give simple esters. However, Sakamoto has shown that zinc chloride activation of 1.16 
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results in addition to the nitrile with organocadmium reagents (prepared by transmetallation 
of Grignards with cadmium bromide), which upon hydrolysis affords the -keto ester 
(Scheme 1-5a).
23
 This difference in reactivity is explained in terms of hard and soft 
nucleophilicity. Organocadmium reagents are softer than Grignards, and in a screen with 
organomagnesium, –zinc, and –mercury reagents, organocadmium nucleophiles proved to be 
superior in all cases.
24
 Axiotis has prepared -keto esters in a similar manner from the 
addition of organolithium reagents to triethoxyacetonitrile 1.17 (Scheme 1-5b).
25 
 
Scheme 1-5. Nucleophilic Addition to Ethyl Cyanoformate
 
 
 
1.2.3 PEP Equivalents 
Due to the importance of PEP in biological systems, the development of chemical 
equivalents to transfer pyruvate units directly to electrophiles has been an active area of 
research. The one carbon homologation of aldehydes via Horner-Wadsworth-Emmons 
reaction with -hydroxy phosphonacetates 1.18, disclosed by Nakamura in 1981,26 is the 
most widely used method to prepare enol ether derivatives (Scheme 1-6). The -keto ester 
can be revealed upon treatment with acid or undergo silylation to remain protected as the 
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silyl enol ether. This strategy has been applied towards the synthesis of biologically active 
natural products. Doutheau used this method to directly introduce the -keto acid moiety in 
the total synthesis of deoxy-NeuAc 1.19.
27
 This approach has also been utilized by Overman 
in the assembly of the central cis-3-azobicyclo [3.3.0]octane core 1.20 of the structurally 
complex natural products palau’amine and styloguanidine.28 The key step involves an 
intramolecular cycloaddition with imine dipoles generated from the condensation of the -
keto ester and thiosemicarbazide.  
 
Scheme 1-6. PEP Homologs Derived from -Hydroxy Phosphonates 
 
 
Phosphoenolpyruvate homologs can be directly obtained by treating -chloro glycidic 
esters 1.22, readily available from the Darzens condensation of dichloroacetate 1.21, with 
trialkyl phosphites (Scheme 1-7).
29
 Nucleophilic opening of these intermediates typically 
gives -substituted -keto esters (Section 1.3.1). To account for this divergent reactivity, 
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Bodalski proposes that nucleophilic acttack of the phosphite on the chlorine, rather than the 
epoxide occurs. This opens the oxirane to form chlorophosphonium enolate 1.23 which gives 
PEP equivalent 1.24 upon dealkylation.   
 
Scheme 1-7. PEP Homologs Derived from -Chloro Glycidic Esters 
 
 
1.3 Synthetic Strategies for the Preparation of -Stereogenic -Keto Esters 
1.3.1 Racemic Methods 
The majority of the aforementioned methods for the preparation of -keto esters 
(acylations and nucleophilic additions) are not viable for the introduction of a -stereogenic 
center. The most direct approach to access this class of compounds is the addition of reagents 
that function as glyoxylate anion equivalents to -electrophiles. This strategy has been used 
in several methods for the preparation of -hydroxy -keto esters (Scheme 1-8). Takahashi 
has shown that 2-metallo-2-alkoxy-2-cyanoacetates 1.25 undergo a facile reaction with 
aldehydes,
30
 but significant functional group manipulation is required to reveal the -keto 
ester functionality: deprotection of the protected cyanohydrin to unmask the ketone first 
requires protection of the -hydroxyl group (Scheme 1-8a). Reetz has demonstrated that 
reacting 1,2-bis(trimethylsilyloxy)-1,2-diethoxyethene 1.26 with aldehydes and ketones 
under Lewis acidic conditions furnishes complimentary products (Scheme 1-8b).
31
 In 
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addition, 1.26 undergoes 1,4-conjugate addition to -unsaturated ketones to provide -
alkyl substrates. 
 
Scheme 1-8. Synthesis of -Hydroxy -Keto Esters Using Glyoxylate Anion Equivalents 
 
 
Another popular technique that indirectly affords -stereogenic -keto esters is the 
ozonolysis of -methylene esters (Scheme 1-9). Coelho has shown the oxidation of Morita-
Baylis-Hillman (MBH) adducts 1.27 provides access to both -silyloxy and -hydroxy 
substrates and displays a broader substrate scope than the abovementioned methods (Scheme 
1-9a).
32
 In studies directed toward developing new therapeutic glutamic acid analogs, 
Gefflaut developed a similar method in which enol acetates 1.28 derived from -substituted 
-keto esters are cleaved to provide -alkyl derivatives (Scheme 1-9b).33 Furthermore, 
Thompson disclosed that -aryl -keto esters can be accessed using this strategy via 
ozonolysis of substituted nitronates  1.29 (Scheme 1-9c).
34
 The -aryl nitro esters were 
prepared by conjugate addition of methyl nitroacetate to enones. Conversion of these 
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products to the -keto ester was initially attempted using the Nef reaction, but this proved 
unsuccessful; the desired products were obtained by deprotonation to generate the nitronate 
anions followed by in situ ozonolysis.  
 
Scheme 1-9. -Keto Ester Synthesis via Ozonolysis 
 
 
-Chloro glycidic esters are most commonly used for the preparation of -halo -
keto esters 1.30 by the addition of exogenous halide (Scheme 1-10a).
35 
These substrates are 
particularly useful intermediates as they are immediately amenable to secondary 
transformations via SN2 displacement. Additionally, in contrast to trialkyl phosphites, the 
addition of nitrogen
36
 and sulfur
37
 nucleophiles to 1.22 provides -amino and -sulfenyl -
keto esters respectively. -hydroxy -keto esters can also be obtained from -oxo glycidic 
esters 1.31 derived from 1.24 upon treatment with aqueous hydrofluoric acid in acetonitrile 
(Scheme 1-10b).
38 
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Scheme 1-10. -Hetero -Keto Esters From Nucleophilic Opening of Glycidic Esters 
 
1.3.2 Asymmetric Methods 
The preparation of enantioenriched -stereogenic -keto esters is inherently 
challenging due to their high CH acidity, which renders these products susceptible to 
racemization under both acidic and basic conditions. Additionally, the asymmetric methods 
that have been developed to access these products do not have widespread applicability due 
to case-dependent disadvantages and/or limitations. Of the known enantioselective 
procedures, only one allows for the direct incorporation of the glyoxylate unit and many 
require a chiral auxiliary to control the stereochemistry at the -stereocenter.  
1.3.2.1 Chiral Enolates 
The first enantioselective -keto ester synthesis was reported by Enders who utilized 
pyruvate derived RAMP/SAMP hydrazones (chiral PEP equivalents) 1.33 which undergo 
alkylation with a number of alkyl halides (Scheme 1-11).
39
 The -keto ester precursors 1.32 
were prepared by esterification of ethyl oxalyl chloride with the lithium salt of 2,6-di-tert-
butyl-4-methoxyphenol 1.34, followed by the chemoselective nucleophilic addition of ethyl 
Grignard to the unsymmetrical ethyl aryl oxalate 1.35. The presence of a sterically 
demanding aryl group on the ester was necessary due to the observed self-acylation of 
azaenolates derived from methyl and tert-butyl pyruvate homologs. Alkylation of metalated 
hydrazones derived from 1.33 proceeded with high diastereoselectivity (85 to >95% de) and 
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the resulting alkylated products 1.36 were converted to the corresponding -alkyl -keto 
esters by either oxidative cleavage with ozone or treatment with boron trifluoride-
ether/paraformaldehyde with no loss in optical purity. 
 
Scheme 1-11. Chiral -Keto Esters Using RAMP/SAMP Hydrazones 
 
 
Sodeoka recently reported a similar strategy in a catalytic enantio- and 
diastereoselective (up to 94% ee and >30:1 dr) conjugate addition of -keto esters to 
nitroalkenes (Scheme 1-12).
40
 The -keto ester precursors were prepared in one step from 
commercial di-tert-butyl oxalate and the corresponding alkyl Grignard according to the 
procedure developed by Weinstock
10
 (Section 1.2.1). Mild activation of the -keto ester was 
achieved with nickel(II) acetate-diamine complex 1.37 to effectively generate a chiral metal 
enolate 1.38 which reacts with nitroalkenes in a stereoselective manner. The reaction 
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proceeds using only 1 mol % of catalyst and 5 mol % triethylamine (to facilitate formation of 
the enolate) and displays broad generality with respect to the -keto ester and nitroalkene; 
however, the scope is also limited to alkyl substituents at the -stereocenter. The synthetic 
utility of the -disubstituted -keto esters was demonstrated in the asymmetric synthesis of 
the biologically interesting kainic acid analogue 1.39, a potent glutamate receptor agonist.  
 
Scheme 1-12. Chiral -Keto Esters via Asymmetric Conjugate Addition to Nitroalkenes 
 
 
The use of chiral dithianes to prepare enantioenriched -keto esters has been reported 
by Tyrell (Scheme 1-13).
41
 The -stereocenter was installed via alkylation of a chiral enolate 
using Evans’ auxiliary 1.40. Following cleavage of the auxiliary, primary alcohol 1.41 was 
obtained. Oxidation to the aldehyde with NaOCl-TEMPO and treatment with 1,3-
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propanedithiol afforded chiral dithiane 1.42 with no significant loss in enantiopurity. 
Acylation with methyl chloroformate followed by dethioacetalization provided the desired 
chiral -keto esters. This method has limited practicality due the redox manipulations 
required to unmask the -keto ester moiety (amide to alcohol to aldehyde to ketone).  
 
Scheme 1-13. Chiral -Keto Esters via Chiral Dithianes 
 
 
1.3.2.2 Asymmetric Claisen Rearrangement 
The first catalytic asymmetric synthesis of -alkyl -keto esters was reported by 
Hiersemann in a Cu(II)-bis(oxazoline) catalyzed enantioselective Claisen rearrangement of 
2-alkoxycarbonyl-substituted allyl vinyl ethers (Scheme 1-14a).
42-43
 The reactant substrates 
1.43 include two stereogenic double bonds which provides access to highly functionalized -
 substituted -keto esters 1.45 with high yield (>95%) and remarkable enantio- and 
diastereoselectivity (up to 99:1 er and 99:1 de). The synthetic utility of the -keto ester 
products is highlighted by the ability of 1.45 to undergo a diastereoselective reduction to the 
-hydroxy ester 1.46 and Wittig methylenation to provide highly functionalized ,-
unsaturated ester 1.47. While there is no argument against the usefulness of the title reaction, 
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it should be noted that five synthetic steps, each requiring purification (three steps overnight), 
are necessary for the preparation of the 2-alkoxycarbonyl-substituted allyl vinyl ethers.
44
 
Jacobsen later demonstrated that C2-symmetrical guanidinium catalyst 1.48 induced an 
asymmetric Claisen rearrangement (via hydrogen bonding) with similar substrates albeit with 
lower levels of enantioselectivity (Scheme 1-14b).
45
 Nevertheless, only three synthetic steps 
to access the starting materials employed are required.   
 
Scheme 1-14. Chiral -Keto Esters via an Asymmetric Clasien Rearrangement 
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1.3.2.3 Asymmetric Nucleophilic Glyoxylation 
The first formal asymmetric nucleophilic glyoxylation was accomplished by Enders 
utilizing the chiral metalated -aminonitrile 1.49 in addition reactions to nitroalkenes 
providing -nitro -alkyl -keto esters 1.50 (Scheme 1-15).46 The initial Michael addition 
proceeded with good diastereoselectivities (75-96% de crude, >98% after column 
chromatography), but cleavage of the aminonitrile to unmask the ketone proved difficult; 
subjection of the Michael adduct to a solution of 2.0 M silver nitrate for seven days was 
necessary to obtain reasonable conversions (89-94%) affording the -keto ester products in 
modest yields (59-74%). In addition this method displays a limited substrate scope (5 
examples), as only alkyl substituents at the -position are tolerated due the tendency of -
aryl products to readily eliminate nitrous acid on silica gel to form -unsaturated -keto 
esters (vide infra). 
 
Scheme 1-15. Chiral -Keto Esters Using Chiral Aminonitriles 
 
 
Enders took a similar approach by employing an achiral aminonitrile 1.51 in an 
organocatalytic nucleophilic glyoxation of -unsaturated aldehydes via iminium activation 
with trimethylsilyl protected diphenylprolinol (1.52, Scheme 1-16);
47
 however, cleavage of 
the aminonitrile 1.53 to the ketone with silver nitrate first required reduction of the aldehyde 
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with sodium borohydride followed by protection with tert-butyldimethylsilyl chloride. This 
requirement resulted in low isolated yields of the -alkoxy -keto ester products. Only alkyl 
-unsaturated aldehydes gave reasonable enantioselectivities as their aromatic counterparts 
were readily racemized under the reaction conditions.  
 
Scheme 1-16. Chiral -Keto Esters via Organocatalysis 
 
 
Commercial ethyl diazoacetate 1.54 has been utilized as a glyoxylate anion equivalent 
in an asymmetric direct aldol reaction with aldehydes providing access to enantioenriched -
hydroxy -keto ester derivatives following oxidation (Scheme 1.15a). This method was first 
disclosed by Wang
7
 who utilized Kobayashi’s zirconium-BINOL catalyst which facilitates 
the reaction by activating both the aldehyde and ethyl diazoacetate. A variety of aromatic and 
aliphatic aldehydes are viable reaction partners affording the corresponding -hydroxy -
diazo esters with modest enantioselectivity (53-87% ee). No loss in enantiopurity is observed 
upon oxidation of the diazo group with Oxone®. Higher enantioselectivities for the title 
reaction were later reported by Trost using a di-n-butylmagnesium/(S,S)-Prophenol catalyst 
system (Scheme 1.15b).
48
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Scheme 1-17. Ethyl Diazoacetate as a Glyoxylate Anion Equivalent 
 
The asymmetric intermolecular Stetter reaction with glyoxamides and alkylidene 
malonates developed by Rovis is the most direct method for the preparation of -stereogenic 
-keto acid derivatives, as the glyoxylate unit is directly incorporated into the product 
(Scheme 1-18).
49
 High enantioselectivities in the addition of morpholine-derived glyoxamide 
1.55 to a series of tert-butyl alkylidene malonates 1.57 were observed by using the chiral 
triazolium 1.56. To avoid racemization of the -keto amide products, it was necessary to 
conduct the reaction at low temperature and use a bulky base, diisopropylethylamine, to 
generate the active carbene; again, the scope is limited to -alkyl derivatives due to ready 
racemization of -aryl derivatives. This method was later extended to alkylidene 
ketoamides
50
 1.58 which incorporates four differentiated carbonyl groups in the -keto 
amide products 1.59. The asymmetric Stetter reaction proceeded with high enantioselectivity; 
the excellent level of diastereoselectivity observed is due to the highly diastereoselective 
protonation of the tertiary -ketoamide following 1,4-addition. The synthetic utility of the 
20 
 
products is highlighted by their ease of conversion to -hydroxy amides 1.60 with high 
diastereoselectivity and subsequent lactonization to trisubstituted -butyrolactones 1.61. 
 
Scheme 1-18. Enantioselective Glyoxylate Stetter with Alkylidene Malonates and 
Ketoamides 
 
 
1.4 Summary and Outlook 
The biological importance and synthetic utility of -keto acids and their derivatives 
has led to the development of various methods for their preparation. While there are a 
number of practical procedures in place for the synthesis of achiral -keto esters, a general 
synthetic method for the introduction of a stereocenter at the -position remains elusive. The 
current strategies that are available to access this important class of compounds, particularly 
asymmetric methods, suffer from several major drawbacks. With the exception of Wang and 
Trost, the reaction scopes are restricted to alkyl substituents at the -position due to the 
vulnerability of enolization at this site. From a practicality standpoint, in many cases, the -
keto ester moiety is not introduced in the key asymmetric CC bond forming step and 
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significant functional group manipulation to reveal the -keto ester is required, and/or the 
starting materials are not readily available. The methods described in the following chapters 
seek to address these deficiencies by introducing three simple reagents that function as 
glyoxylate anion equivalents to provide access to diverse classes of -stereogenic -keto 
esters. Additionally, the facile racemization of these substrates is capitalized on in the 
development of the first dynamic kinetic resolution of -keto esters. 
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CHAPTER TWO 
CATALYTIC NUCLEOPHILIC GLYOXYLATION OF ALDEHYDES 
 
 
2.1 Introduction 
 
2.1.1 Umpolung Reactivity 
 
The term umpolung is defined as “any process by which the normal alternating donor 
and acceptor reactivity pattern of a chain, which is due to the presence of O or N 
heteroatoms, is interchanged.”1 This concept was first introduced by Seebach to describe the 
latent electronic character at carbon in a heteroatom substituted framework, in which the 
inductive polarization of the more electronegative heteroatom (O, N, etc.) places a + on the 
ipso carbon and a - on the -position (Figure 2-1). 2 The incorporation of-bonds allows 
further delocalization of the partial charges via resonance to more remote sites. Based on this 
analysis, the normal polarity mode of carbonyls provides access to -hydroxy carbonyl (aldol 
reaction), -amino carbonyl (Mannich reaction), and 1,5-dicarbonyl (Michael reaction) 
motifs. However, access to the complementary class of products, -hydroxy carbonyl, -
amino carbonyl, and 1,4-dicarbonyls, requires an inversion of the standard polarity of 
carbonyl reagents (electrophilic to nucleophilic). As acyl anions and other umpolung reagents 
are often not stable or accessible (i.e. an acyl anion cannot be generated by deprotonation of 
an aldehyde), it is often necessary to mask umpoled functionality with a synthetically 
equivalent group.  
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Figure 2-1. Normal vs. Umpolung Reactivity 
 
The conversion of an aldehyde into an umpolung reagent is typically accomplished 
through dithiane
3
 and protected cyanohydrin
4
 derivatives (Scheme 2-1). The two anion-
stabilizing sulfur atoms of dithiane 2.1 and the electron-withdrawing properties of the nitrile 
in 2.2 allow these intermediates to be converted to the corresponding -carbanion (2.3 and 
2.4) with a strong base; this renders the electrophilic carbonyl carbon nucleophilic. The 
intermediate carbanion can then react with an electrophile and the deprotection of the 
dithiane or cyanohydrin regenerates the initially present carbonyl functionality in 2.5, 
yielding the formal acylation of an electrophile. While these tactics have proven to be useful 
in a number of circumstances, they lack the step economy and convenience of their enolate 
counterparts (generated from a normal polarity mode). 
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Scheme 2-1. Acylation of Electrophiles with Acyl Anion Equivalents 
 
 
2.1.2 Acyl Anion Catalysis 
The above shortcomings have been circumvented with the development of reaction 
manifolds that do not necessitate the stoichiometric generation of the acyl anion equivalent, 
viz., the benzoin reaction.
5
 This reaction is mediated by cyanide or heteroazolium carbenes 
and allows the direct coupling of two aldehydes to afford -hydroxy ketones.6 The 
mechanism for this reaction, proposed by Lapworth,
7
 is shown in Scheme 2-2. The 
conversion of the aldehyde 2.6 into the requisite nucleophilic reagent 2.8 involves 
nucleophilic addition of the Lewis basic catalyst (LB) to the carbonyl followed by migration 
of hydrogen from carbon to oxygen (2.7→2.8). The key productive bond construction is the 
interception of 2.8 with another aldehyde component. Catalysis is achieved via proton 
transfer to the terminus of the electrophile and collapse of the tetrahedral intermediate 2.9 to 
expel the catalyst and regenerate the carbonyl. 
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Scheme 2-2. General Mechanism for Acyl Anion Catalysis 
 
 
The utility of the traditional benzoin reaction is well documented, but its major 
limitation arises when coupling two different aldehydes (cross benzoin). The observed 
product distribution is thought to be determined by the relative stability of the four possible 
products, which typically results in product mixtures and/or inaccessibility to the higher 
energy regioisomer (Scheme 2-3). Our group has shown that the reaction can effectively be 
placed under kinetic control by generation of the acyl anion equivalent from acyl silanes
8
 
2.10 (aldehyde surrogate) in the cyanide-catalyzed cross silyl benzoin reaction.
9
 The addition 
of a nucleophilic catalyst (cyanide or metallophosphite) to 2.10 triggers a [1,2]-Brook 
rearrangement,
10
 the migration of silicon from carbon to oxygen (2.11→2.12), which 
generates (silyloxy)nitrile anion 2.12. The driving force for the Brook rearrangement is the 
formation of the stronger siliconoxygen bond at the expense of the weaker siliconcarbon 
bond,
11
 and is facilitated by electron-withdrawing groups  to the carbanion.  Addition of 
2.12 to aldehyde 2.13 followed by 1,4-silyl migration gives the alkoxide intermediate 2.14. 
Catalyst expulsion leads to the -silyloxy ketone product 2.15 to complete the catalytic 
cycle. The noteworthy features of this reaction are: 1) in situ protection of the secondary 
hydroxyl group, 2) no competing homobenzoin products are observed and 3) either 
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regioisomeric benzoin product can be accessed through the judicious choice of acyl silane 
and aldehyde.  
 
Scheme 2-3. Cross Silyl Benzoin Reaction Mechanism 
 
 
Additionally, we have identified TADDOL-based metallophosphites 2.16 as viable 
nucleophilic catalysts which led to the development of the first nonenzymatic 
enantioselective synthesis of unsymmetrical benzoins (Scheme 2-4).
12
 These catalysts are 
uniquely effective with acyl silanes, as they do not promote the benzoin reaction with other 
acyl donors (aldehydes, acyl phosphonates, and benzil). The acylsilane/metallophosphite 
system has since been extended to aza-benzoin
13
 and Stetter-type
14
 reactions using aryl 
nitrones and -unsaturated amides respectively. 
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Scheme 2-4. Metallophosphite-Catalyzed Cross Silyl Benzoin and Sila-Stetter Reactions 
 
   
While each of these reactions display a broad substrate scope, the acyl donors tend to 
be relatively simple and devoid of functionality for further derivatization. Therefore, the 
introduction of carboxyl functionality adjacent to the ketone would be highly desirable and 
significantly expand the product types delivered by this reaction class. This chapter 
delineates the development of a glyoxylate benzoin reaction utilizing silyl glyoxylates 2.18 
that provides facile access to a variety of -silyoxy -keto esters 2.17. 
 
Figure 2-2. Inspiration for the Development of Glyoxylate Benzoin 
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2.2 Background 
2.2.1 Development of Silyl Glyoxylates 
Acyl silanes provide a center of reactivity for both nucleophiles and electrophiles by 
way of the [1,2]-Brook rearrangement. The key (silyloxy)anion intermediate 2.19 in the 
above catalytic reactions is generated upon silyl migration and is facilitated by stabilization 
of the nascent carbanion by the nitrile or phosphonate groups, which are introduced into the 
molecule as the nucleophilic catalyst. It was speculated that silyl migration could also be 
promoted by incorporating an electron-withdrawing moiety directly into the acyl silane, 
thereby broadening the scope for the type of nucleophiles that can participate in this reaction 
manifold. Accordingly, silyl glyoxylates
15
 2.18 were identified as reagents that could fulfill 
this role. 
Scheme 2-5. Development of Silyl Glyoxylates 
 
 
The representative silyl glyoxylate 2.20,
16
 prepared in two steps from the 
corresponding diazoacetate (silylation followed by oxidation of the diazo group) has been 
shown to be a useful conjunctive reagent for one-pot geminal coupling of nucleophilic and 
electrophilic species to a glycolic acid junction (Scheme 2-6). These reactions proceed by 
nucleophilic addition which triggers a [1,2]-Brook rearrangement to generate glycolate 
enolate 2.21, followed by electrophilic trapping to yield fully substituted glycolic acid 
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derivatives 2.22. In most cases, the secondary electrophile and the silyl glyoxylate are present 
in the reaction simultaneously, exemplifying the unique reactivity of this -dicarbonyl. 
Highly reactive electrophiles such as aldehydes and nitroalkenes do not compete with 2.20 
for nucleophilic addition and the latent glycolate intermediate reacts with the desired 
secondary electrophile rather than another molecule of 2.20. Scheme 2-6 illustrates the 
diversity of complex building blocks that can arise from this multicomponent coupling 
strategy.
17 
 
Scheme 2-6. Synthetic Utility of Silyl Glyoxylates in Three-Component Couplings 
 
 
2.2.2 Origin of the Title Reaction 
All of the reported reactions involving silyl glyoxylates incorporate the nucleophile as 
a stoichiometric component.  It was postulated that divergent reactivity could be achieved in 
the presence of a nucleophilic catalyst and aldehyde to access -silyloxy -keto esters via a 
silyl benzoin reaction mechanism (Scheme 2-7a). In this context, silyl glyoxylates would 
function as a synthetic equivalent for the glyoxylate anion synthon. Alternate methods for the 
preparation of -hydroxy -keto acid derivatives were discussed in the previous chapter and 
are summarized again in Scheme 2-7b. In each case, the -keto ester is not directly 
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incorporated into the product so the implementation of this method would constitute the first 
catalytic, and hence most direct, method for the preparation of this class of -keto esters. 
 
Scheme 2-7. Silyl Glyoxylates as Glyoxylate Anion Equivalents 
 
 
2.3 Results and Discussion  
2.3.1 Identification of a Viable Nucleophilic Catalyst 
To assess the viability of the proposed reaction, various metal cyanides were 
evaluated as the nucleophilic catalyst with silyl glyoxylate 2.20 and benzaldehyde as the test 
substrate. Sodium cyanide, potassium cyanide, and potassium cyanide/18-crown-6 complex 
were initially screened. Under a variety of reaction conditions, the desired -keto ester 2.17 
was not obtained; instead, the reaction yielded -silyoxy -keto ester 2.23 (Table 2-1). This 
product is likely derived from isomerization of the initially formed -silyloxy -keto ester 
2.17 under the basic reaction conditions and occurs independent of solvent identity and 
temperature (entries 2, 3, and 5). To probe the propensity of this isomerization, several 
aldehyde substrates were examined, but the derived -keto ester was obtained in each case 
(entries 6-9). A less basic source of cyanide was desired that could potentially stop at the 
desired ketone product. 
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Table 2-1. Evaluation of Metal Cyanides 
 
entry R MCN solvent temp % yield (2.23) 
1 Ph NaCN DMF rt 53 
2 Ph NaCN DMF 0 ºC ND 
3 Ph NaCN DMF -78 ºC ND 
4  Ph KCN DMF rt ND 
5 Ph [18]crown6/KCN THF rt ND 
6 4Cl-Ph NaCN DMF rt 45 
7 2-furyl NaCN DMF rt 40 
8 2-thienyl NaCN DMF rt 42 
9 
i
Pr NaCN DMF rt 35 
 
Lanthanide isopropoxides have been reported as efficient catalysts in the 
transhydrocyanation from acetone cyanohydrin to aldehydes and ketones.
18
 Subjection of 
silyl glyoxylate and benzaldehyde to the reported reaction conditions, 10 mol % Yb(O
i
Pr)3 
and  one equivalent of acetone cyanohydrin in THF, resulted in a known Oppenauer 
oxidation/Brook rearrangement/aldolization sequence to give 2.24.
19
 A number of solvents 
were screened and DMF provided the desired reactivity, yielding the cyanohydrin adduct 
2.25 in a 1.2:1 dr. Although this product was not desired, it could potentially be useful as the 
nitrile offers a valuable functional handle, provided 2.25 could be obtained with higher levels 
of diastereoselectivity.  
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Scheme 2-8. Initial Studies with Ytterbium Isopropoxide/Acetone Cyanohydrin Catalyst 
System  
 
 
We initially screened all available lanthanide isopropoxides and the results are 
summarized in Table 2-2. With the exception of dysprosium (entry 7), all the lanthanides 
were efficient in promoting the reaction; however, the highest diastereomeric ratio observed 
was 1.4:1 (entries 8-9). Decreasing the temperature to 0 ºC had no effect (entry 9) and at -78 
ºC no reaction was observed (entry 10). Using catalytic quantities of Yb(O
i
Pr)3
 
(20 mol %) 
yielded a 5:1 mixture of the desired -keto ester 2.17a and the cyanohydrin, albeit in a 1.2:1 
dr. It was conjectured that cyanation and retrocyanation of the -keto ester were in rapid 
equilibrium which could deteriorate the diastereoselectivity. We then attempted to trap the 
alkoxide 2.26 formed following 1,4-silyl migration with acylating reagents. The introduction 
of methyl chloroformate to the reaction yielded a complex mixture of products, and in the 
presence of ethyl cyanoformate and quinuclidine, cyanation followed by acylation of 
benzaldehyde occurred. 
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Table 2-2. Evaluation of Lanthanide Isopropoxides 
 
entry Ln(O
i
Pr)3 temperature d.r. 
1 Yb(O
i
Pr)3 rt 1.2 : 1 
2 Y(O
i
Pr)3 rt 1 : 1 
3 Er(O
i
Pr)3 rt 1 : 1 
4 Gd(O
i
Pr)3 rt 1.4 : 1 
5 Nd(O
i
Pr)3 rt 1.2 : 1 
6 Sm(O
i
Pr)3 rt 1.4 : 1 
7 Dy(O
i
Pr)3 rt NR 
8 Pr(O
i
Pr)3 rt 1.4 : 1 
9 Pr(O
i
Pr)3 0 °C 1.4 : 1 
10 Pr(O
i
Pr)3 -78 °C NR 
 
 
Having determined a successful means of promoting the desired reactivity, conditions 
for retrocyanation to deliver the desired -silyoxy -keto ester 2.17a were explored. Initial 
efforts employed traditional methods by subjecting cyanohydrin 2.25 to basic conditions, but 
either starting material was recovered (entry 1) or decomposition occurred (entry 2). It is 
likely that cyanide expulsion occurs in the presence of potassium carbonate, but in the 
absence of a “cyanide sponge”, addition back into the ketone is inevitable. Several potential 
cyanide scavengers were evaluated (entries 3, 5-6) and the most promising results were 
observed with silver nitrate
20
 which produced the desired ketone product in a 2.5:1 ratio 
(entry 6). Most optimally, 2.17a was obtained directly from 2.20 using 20 mol % of 
Yb(O
i
Pr)3 by simply quenching the reaction with 1 mL of 2M aqueous silver nitrate. 
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Table 2-3. Retrocyanation Attempts 
 
entry base additive solvent observed product(s) 
1 K2CO3 none MeOH S.M. 
2 NEt3 none MeOH Decomposition 
3 none Ag2CO3 PhCH3 S.M. 
4 1% NaOH none THF Decomposition 
5 2,6-lutidine 
 
EtOH 2 : 1 (48 hrs) 
(S.M. : ketone) 
6 2,6-lutidine AgNO3 EtOH 2.5 : 1 (7 hrs) 
 
2.3.2 Reaction Scope 
With the optimal conditions in hand, 20 mol % acetone cyanohydrin, 5 mol% 
Yb(O
i
Pr)3 and two equivalents of aldehyde, the scope of the electrophiles amenable to the 
reaction was investigated (Scheme 2-7). Electron-rich, electron-poor, and heteroaromatic 
aldehydes all performed well with yields ranging from 80 to 92%. The reaction was also 
tolerant of aliphatic aldehydes (2.17k and 2.17l), but required Sm(O
i
Pr)3 as the catalyst to 
achieve full conversion. This method has steric limitations as pivaldehyde failed to provide 
any desired product. It is notable that all reactions were complete within twenty minutes, and 
in most cases the silyl glyoxylate was completely consumed upon addition of all reagents. 
Additionally, the products were obtained in analytically pure form after passing the crude 
reaction mixture through a short silica plug and removing the excess aldehyde under reduced 
pressure. Extension of this reaction to include ketones was unsuccessful which may be due to 
their lower reactivity and increased steric demand. 
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Scheme 2-9. Scope of Aldehyde Glyoxylation 
 
 
2.3.3 Efforts Toward an Enantioselective Catalytic Reaction 
The isomerization of 2.17 that was observed in the presence of metal cyanides 
indicates the lability of the newly formed stereocenter. To determine the stability of this 
center in the presence of Yb(O
i
Pr)3 and acetone cyanohydrin, deuterium labeling studies 
were performed (Scheme 2-8). Deuterated benzaldehyde 2.27 and isobutyraldehyde 2.28 
were prepared by reduction of the corresponding methyl esters with deuterated lithium 
aluminum hydride (LiAlD4), followed by a TEMPO oxidation (Scheme 2-8). When the 
reaction was run with these electrophiles, full deuterium incorporation at the methine was 
observed, suggesting that the product is stable toward enolization under the silyl benzoin 
conditions. This implicates the title reaction should be amenable to enantioselective catalysis.  
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Scheme 2-10. Deuterium Labeling Studies 
 
 
We presumed the enantiodetermining step to be the addition of the glycolate enolate 
to the aldehyde so the ideal chiral catalyst would need to both facilitate the 
transhydrocyanation and direct the facial selectivity in the subsequent aldol reaction. Our 
group had previously developed an enantioselective cyanation and acylation of acylsilanes 
using chiral (salen)metal,
21
 so this was our point of departure for this study (Scheme 2-9). 
We first evaluated the use of chiral complex 2.29, but racemic product was obtained as 
determined after conversion to diol 2.30. This result implies that either the catalyst is 
completely non-selective, or an achiral catalyst is generated by disproportionation of the 
(salen)-Yb complex to generate Yb(CN)3 as the active catalyst.  
 
Scheme 2-11. Asymmetric Attempts Using Yb(salen)-Complex 
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Chiral silyl glyoxylate 2.31 was employed as another potential option to introduce 
asymmetry; however, a 1:1 diastereoselectivity was observed. As a final attempt, chiral 
metallophosphites 2.16 were examined given their success in a number of asymmetric 
umpolung reactions (Scheme 2-4). Under a variety of reaction conditions, no desired product 
was observed.  
 
Scheme 2-12. Chiral Silyl Glyoxylates 
 
 
2.3.4 Subsequent Transformations of -Silyloxy -Keto Esters 
To highlight the synthetic utility of the products, several secondary derivatizations 
were examined. Reduction of the -keto ester 2.17a with sodium borohydride in methanol at 
-78 ºC provided orthogonally protected diol 2.32 in a 2.3:1 diastereomeric ratio. In an effort 
to increase the diastereoselectivity, other reducing reagents were evaluated, but no significant 
increase was observed (Table 2-4). The favored diastereomer was determined to be the anti-
isomer following deprotection of the tert-butyldimethyl silyl group with tetrabutylammonium 
fluoride to diol 2.30, whose spectral data was compared to that reported in the literature.
22
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Table 2-4. -Keto Ester Reduction Optimization 
 
entry reducing agent solvent d.r. 
1 NaBH4 MeOH 2.3:1 
2 NaBH4/CeCl3 MeOH 2:1 
3 L-selectride THF 2.5:1 
4 DIBAL-H PhCH3 no reaction 
5 Red-Al THF 1:1 
 
The -keto esters may also be converted to their derived -silyloxy -amino esters 
2.33 (Scheme 2-11). Under standard reductive amination conditions (p-methoxy aniline and 
sodium cyanoborohydride), competitive ketone reduction was observed.
23
 To obtain the 
desired product first required conversion of 2.17a to the derived oxime. This intermediate 
was then reduced with zinc and ammonium formate to give the -amino ester 2.34 in a 3:1 
dr, which was isolated following Boc protection in 72% yield over the three steps. Preference 
for the syn-diastereomer was observed.
24 
 
Scheme 2-13. Synthesis of -Silyloxy -Amino Esters 
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2.4 Conclusion 
We have demonstrated that silyl glyoxylates can function as glyoxylate anion equivalents in 
a silyl benzoin reaction with aldehydes to provide -silyloxy -keto esters. The reaction 
proceeds in excellent yield for both aryl and aliphatic aldehydes. Critical to our success was 
identifying Yb(O
i
Pr)3  and acetone cyanohydrin as a source of cyanide mild enough to 
prevent isomerization of the products to the corresponding -silyloxy -keto ester. The 
secondary transformations of the products add to the synthetic utility of this methodology. 
Deuterium labeling studies suggests an asymmetric variant is possible, but preliminary 
studies with chiral ytterbium complexes and chiral silyl glyoxylates displayed no selectivity. 
Of the methods available to prepare -hydroxy -keto acid derivatives, this method provides 
the most direct route and displays the broadest substrate scope. 
2.5 Experimental Details 
Methods. Infrared (IR) spectra were obtained using a Jasco 260 Plus Fourier transform 
infrared spectrometer. Proton and carbon magnetic resonance spectra (
1
H NMR and 
13
C 
NMR) were recorded on a Bruker model DRX 400 (
1
H NMR at 400 MHz and 
13
C NMR at 
100 MHz) spectrometer with solvent resonance as the internal standard (
1
H NMR: CDCl3 at 
7.26 ppm; 
13
C NMR: CDCl3 at 77.0 ppm). 
1
H NMR data are reported as follows: chemical 
shift, multiplicity (s = singlet, br s = broad singlet, d = doublet, br d = broad doublet, t = 
triplet, br t = broad triplet, q = quartet, sept = septuplet, oct = octuplet, m = multiplet), 
coupling constants (Hz), and integration. Analytical thin layer chromatography (TLC) was 
performed on Whatman 0.25 mm silica gel 60 plates. Visualization was accomplished with 
UV light and/or aqueous ceric ammonium molybdate solution followed by heating. 
Purification of the reaction products was carried out by using Siliaflash-P60 silica gel (40-
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63μm) purchased from Silicycle. Mass spectra were obtained using a Micromass Quattro II 
(triple quad) instrument with nanoelectrospray ionization (Note: All samples prepared in 
methanol). All reactions were carried out under an atmosphere of nitrogen in oven-dried 
glassware with magnetic stirring. Yield refers to isolated yield of analytically pure material 
unless otherwise noted. Yields and diastereomeric ratios (dr) are reported for a specific 
experiment and as a result may differ slightly from those found in the tables, which are 
averages of at least two experiments. Enantiomeric excesses were obtained using a 
Supercritical Fluid Chromatograph equipped with a UV-Vis detector using a Chiralcel 
Chiralpak AD HPLC column. Samples were eluted with SFC grade CO2 at the indicated 
percentage of MeOH. 
Materials: General. N,N-Dimethylformamide was distilled from P2O5 and stored under N2 
over 3Å molecular sieves. Benzaldehyde, p-anisaldehyde, 4-methylbenzaldehyde, and 2-
methylbenzaldehyde were purified by the following procedure: The neat aldehydes were 
washed sequentially with a 1 M sodium hydroxide solution and a saturated aqueous sodium 
bicarbonate solution, dried with magnesium sulfate, and distilled under reduced pressure. 4-
Chlorobenzaldehyde was sublimed under reduced pressure. Isobutyraldehyde and 
propionaldehyde were dried over CaSO4 and distilled under N2 prior to use. Silyl glyoxylate 
1 was prepared according to the published procedure. All other reagents were obtained from 
commercial sources and used without further purification unless otherwise noted. 
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General Procedure A for the Yb(O
i
Pr)3 catalyzed nucleophilic glyoxylation of aryl 
aldehydes to afford -siloxy--ketoesters 4a-j: 
 
 
 
 
In an inert atmosphere glovebox, a 10-mL round-bottomed flask containing a magnetic stir 
bar was charged with Yb(O
i
Pr)3 (0.05 equiv). The flask was sealed with a rubber septum and 
removed from the glovebox. To this flask was added DMF (1 mL), and this solution was 
allowed to stir until complete dissolution of the Yb(O
i
Pr)3 occurred. A shell vial containing 
silyl glyoxylate (1.0 equiv), aldehyde (2.0 equiv) and acetone cyanohydrin (0.20 equiv) in 
DMF ([2.20]0 = 0.20 M) was transferred to the round-bottomed flask via cannula. Upon the 
disappearance of the silyl glyoxylate (as indicated by TLC analysis: 10% EtOAc/hexanes), 
the reaction was quenched with 2 M aqueous silver nitrate (1 mL).
1
 The resultant silver salts 
were removed via filtration through a pad of silica gel with EtOAc (20 mL). The organic 
layer was washed with water (3x), brine, dried over Na2SO4 and concentrated in vacuo. The 
resulting -ketoesters were obtained in analytically pure form after the removal of the excess 
aldehyde as described below. 
 
tert-Butyl 3-(tert-butyldimethylsilyloxy)-2-oxo-3-phenylpropanoate (2.17a): 
The title compound was prepared according to General Procedure A using 
2.20 (1.00 g, 4.09 mmol, 1.0 equiv), benzaldehyde (0.868 g, 8.18 mmol, 
2.0 equiv), acetone cyanohydrin (0.070 g, 0.818 mmol, 0.20 equiv), Yb(O
i
Pr)3 (0.072 g, 
                                                 
1
 This was necessary to remove all trace amounts of the cyanohydrin product 3. 
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0.205 mmol, 0.05 equiv) and DMF (10 mL). The reaction was complete immediately upon 
the addition of all reagents as determined by TLC analysis. After workup and removal of the 
excess aldehyde in vacuo (<1 mm Hg), 2.17a (1.20 g, 3.57 mmol, 87% yield) was obtained 
as a clear yellow oil. Analytical data for 2.17a: IR (thin film, cm
-1
) 2956, 2931, 2857, 1748, 
1725, 1472, 1257, 1132, 872, 838, 426; 
1
H NMR (400 MHz, CDCl3)  7.30-7.42 (m, 5H), 
5.56 (s, 1H), 1.43 (s, 9H), 0.90 (s, 9H), 0.10 (s, 3H), -0.010 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3)  193.7, 162.2, 137.0, 128.5, 127.3, 84.2, 78.3, 27.9, 25.7, 18.3, -5.0; TLC (10% 
EtOAc/hexanes) Rf 0.46; LRMS (ESI) Calcd. For C19H30O4SiNa + CH3OH): 405.21. Found: 
405.20. 
 
tert-Butyl 3-(tert-butyldimethylsilyloxy)-3-(naphthalen-2-yl)-2-oxopropanoate (2.17b): 
The title compound was prepared according to General procedure A using 
2.20 (0.050 g, 0.205 mmol, 1.0 equiv), 2-napthaldehyde (0.064 g, 0.410 
mmol, 2.0 equiv), acetone cyanohydrin (0.0035 g, 0.041 mmol, 0.20 equiv), Yb(O
i
Pr)3 
(0.0035 g, 0.0102 mmol, 0.05 equiv) and DMF (2 mL).The reaction was complete 
immediately upon the addition of all reagents as determined by TLC analysis. After workup 
and purification by flash chromatography (10% EtOAC/hexanes), 2.17b (0.076 g, 0.188 
mmol, 92% yield) was obtained as a clear colorless oil. Analytical data for 2.17b: IR (thin 
film, cm
-1
) 2955, 2931, 2886, 2857, 1747, 1724, 1370, 1255, 1164, 1127, 839, 782; 
1
H NMR 
(400 MHz, CDCl3) 7.83-7.87 (m, 4H), 7.48-7.55 (m, 3H), 5.74 (s, 1H), 1.42 (s, 9H), 0.92 
(s, 9H), 0.14 (s, 3H), 0.007 (s, 3H); 
13
C NMR (100 MHz, CDCl3)  193.7, 162.3, 134.5, 
133.4, 133.2, 128.4, 128.1, 127.8, 126.8, 126.4, 126.3, 124.7, 84.3, 78.4, 27.9, 25.7, 18.4, -
46 
 
4.9; TLC (10% EtOAc/hexanes) Rf 0.42; LRMS (ESI) Calcd. For C23H32O4SiNa + CH3OH: 
455.22. Found: 455.21. 
 
tert-Butyl 3-(tert-butyldimethylsilyloxy)-2-oxo-3-p-tolylpropanoate (2.17c):  
The title compound was prepared according to General procedure A 
using 2.20 (0.050 g, 0.205 mmol, 1.0 equiv), p-tolualdehyde (0.049 g, 
0.410 mmol, 2.0 equiv), acetone cyanohydrin (0.0035 g,  0.041 mmol, 0.20 equiv), Yb(O
i
Pr)3 
(0.0035g, 0.0102 mmol, 0.05 equiv) and DMF (2 mL).The reaction was complete 
immediately upon the addition of all reagents as determined by TLC analysis. After workup 
and removal of the excess aldehyde in vacuo (<1 mm Hg), 2.17c (0.060 g, 0.164 mmol, 80% 
yield) was obtained as a clear colorless oil. Analytical data for 2.17c: IR (thin film, cm
-1
) 
2957, 2930, 2858, 1721, 1462, 1369, 1254, 1151, 1103, 838, 779; 
1
H NMR (400 MHz, 
CDCl3) d, J = 8 Hz, 2H), 7.15 (d, J = 8 Hz, 2H), 5.52 (s, 1H), 2.34 (s, 3H), 1.44 (s, 
9H), 0.90 (s, 9H), 0.095 (s, 3H), -0.018 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 193.8, 162.3, 
138.3, 134.0, 129.2, 127.3, 84.1, 78.2, 27.9, 25.7, 21.1, 18.3, -4.99; TLC (10% 
EtOAc/hexanes) Rf 0.49; LRMS (ESI) Calcd. For C20H32O4SiNa + CH3OH: 419.22 Found: 
419.22. 
 
tert-Butyl 3-(tert-butyldimethylsilyloxy)-2-oxo-3-o-tolylpropanoate (2.17d): 
 The title compound was prepared according to General procedure A 
using 2.20 (0.050 g, 0.205 mmol, 1.0 equiv), o-tolualdehyde (0.049 g, 
0.410 mmol, 2.0 equiv), acetone cyanohydrin (0.0035 g, 0.041 mmol, 0.20 equiv), Yb(O
i
Pr)3 
(0.0035g, 0.0102 mmol, 0.05 equiv) and DMF (2 mL).The reaction was complete 
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immediately upon the addition of all reagents as determined by TLC analysis. After workup 
and removal of the excess aldehyde in vacuo (<1 mm Hg), 2.17d (0.064 g, 0.176 mmol, 86% 
yield) was obtained as a clear colorless oil. Analytical data for 2.17d: IR (thin film, cm
-
1
)2955, 2931, 2858, 1747, 1725, 1462, 1370, 1257, 1132, 838, 780, 746; 
1
H NMR (400 
MHz, CDCl3) 7.35-7.37 (m, 1H), 7.14-7.22 (m, 3H), 5.69 (s, 1H), 2.36 (s, 3H), 1.39 (s 9H), 
0.89 (s, 9H), 0.11 (s, 3H), -0.048 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 194.0, 162.7, 
136.7, 135.1, 130.8, 129.1, 128.6, 126.0, 84.1, 77.3, 27.8, 25.7, 19.2, 18.2, -4.99, -5.03; TLC 
(10% EtOAc/hexanes) Rf 0.49; LRMS (ESI) Calcd. For C20H32O4SiNa + CH3OH: 419.22 
Found: 419.22. 
 
tert-Butyl 3-(tert-butyldimethylsilyloxy)-3-(4-chlorophenyl)-2-oxopropanoate (2.17e): 
 The title compound was prepared according to General procedure A 
using 2.20 (0.050 g, 0.205 mmol, 1.0 equiv), 4-chlorobenzaldehyde 
(0.058 g, 0.410 mmol, 2.0 equiv), acetone cyanohydrin (0.0035 g, 0.041 mmol, 0.20 equiv), 
Yb(O
i
Pr)3 (0.0035g, 0.0102 mmol, 0.05 equiv)and DMF (2 mL).The reaction was complete 
immediately upon the addition of all reagents as determined by TLC analysis. After workup 
and removal of the excess aldehyde in vacuo (<1 mm Hg), 2.17e (0.070 g, 0.182 mmol, 89% 
yield) was obtained as a clear colorless oil. Analytical data for 2.17e: IR (thin film, cm
-1
) 
2955, 2931, 2887, 2859, 1749, 1725, 1490, 1371, 1257, 1132, 1089, 869, 839; 
1
H NMR (400 
MHz, CDCl3) 7.36 (d, J = 8.4 Hz, 2H), 7.32 (d, J = 8.4 Hz, 2H), 5.51 (s, 1H), 1.46 (s, 9H), 
0.89 (s, 9H), 0.10 (s, 3H), -0.009 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 193.3, 162.0, 
135.7, 134.5, 128.7, 128.5, 84.5, 77.6, 27.9, 25.7, 18.3, -5.02; TLC (10% EtOAc/hexanes) Rf 
0.41; LRMS (ESI) Calcd. For C19H29ClO4SiNa + CH3OH: 439.17. Found: 439.15. 
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tert-Butyl 3-(tert-butyldimethylsilyloxy)-2-oxo-3-(4-(trifluoromethyl)phenyl)propanoate 
(2.17f): 
 The title compound was prepared according to General procedure A 
using 2.20 (0.050 g, 0.205 mmol, 1.0 equiv), 4-
(trifluoromethyl)benzaldehyde (0.071 g, 0.410 mmol, 2.0 equiv), acetone cyanohydrin 
(0.0035 g, 0.041 mmol, 0.20 equiv), Yb(O
i
Pr)3 (0.0035g, 0.0102 mmol, 0.05 equiv) and 
DMF (2 mL).The reaction was complete immediately upon the addition of all reagents as 
determined by TLC analysis. After workup and removal of the excess aldehyde in vacuo (<1 
mm Hg), 2.17f (0.077g, 0.185 mmol, 90% yield) was obtained as a clear colorless oil. 
Analytical data for 2.17f: IR (thin film, cm
-1
) 2956, 2933, 2889, 2860, 1750, 1726, 1326, 
1258, 1167, 1131, 1067, 870, 839, 782; 
1
H NMR (400 MHz, CDCl3) 7.62 (d, J = 8 Hz, 
2H), 7.56 (d, J = 8 Hz, 2H), 5.58 (s, 1H), 1.46 (s, 9H), 0.91 (s, 9H), 0.12 (s, 3H), 0.01 (s, 
3H); 
13
C NMR (100 MHz, CDCl3) 193.1, 161.9, 141.2, 127.4, 125.5, 84.7, 77.8, 27.9, 25.7, 
18.3, -5.00, -5.03; TLC (10% EtOAc/hexanes) Rf 0.43; LRMS (ESI) Calcd. For 
C20H29F3O4SiNa + CH3OH: 473.19. Found: 473.17. 
 
tert-Butyl 3-(tert-butyldimethylsilyloxy)-3-(4-cyanophenyl)-2-oxopropanoate (2.17g): 
The title compound was prepared according to General procedure A 
using 2.20 (0.050 g, 0.205 mmol, 1.0 equiv), 4-cyanobenzaldehyde 
(0.054 g, 0.410 mmol, 2.0 equiv), acetone cyanohydrin (0.0035 g, 0.041 mmol, 0.20 equiv), 
Yb(O
i
Pr)3 (0.0035g, 0.0102 mmol, 0.05 equiv) and DMF (2 mL).The reaction was complete 
immediately upon the addition of all reagents as determined by TLC analysis. After workup 
and purification by flash chromatography (10% EtOAC/hexanes), 2.17g (0.071 g, 0.189 
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mmol, 92% yield) was obtained as a clear colorless oil. Analytical data for 2.17g: IR (thin 
film, cm
-1
) 2955, 2931, 2859, 2230, 1750, 1730, 1502, 1394, 1257, 1133, 868, 840, 783; 
1
H 
NMR (400 MHz, CDCl3)  7.66 (d, J = 8 Hz, 2H), 7.56 (d J = 8 Hz, 2H), 5.55 (s, 1H), 1.46 
(s, 9H), 0.91 (s, 9H), 0.12 (s, 3H), 0.010 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 192.7, 
161.7, 142.5, 132.3, 127.6, 118.4, 112.5, 84.9, 77.7, 27.9, 25.6, 18.3, -5.01, -5.06; TLC (10% 
EtOAc/hexanes) Rf 0.25; LRMS (ESI) Calcd. For C20H29NO4SiNa + CH3OH: 430.20. 
Found: 430.18. 
 
tert-Butyl 3-(tert-butyldimethylsilyloxy)-3-(4-methoxyphenyl)-2-oxopropanoate (2.17h): 
The title compound was prepared according to General procedure A 
using 2.20 (0.050 g, 0.205 mmol, 1.0 equiv), p-anisaldehyde (0.056 g, 
0.410 mmol, 2.0 equiv), acetone cyanohydrin (0.0035 g, 0.041 mmol, 0.20 equiv), Yb(O
i
Pr)3 
(0.0035g, 0.0102 mmol, 0.05 equiv), 2,6-lutidine (0.022 g, 0.205 mmol, 1.0 equiv) and DMF 
(2 mL). After stirring 20 min, the reaction was complete as determined by TLC analysis. 
After workup and removal of the excess aldehyde in vacuo (<1 mm Hg), 2.17h (0.066 g, 
0.174 mmol, 85% yield) was obtained as a clear colorless oil. Analytical data for 2.17h: IR 
(thin film, cm
-1
) 2955, 2932, 2856, 1748, 1723, 1611, 1512, 1464, 1303, 1254, 1171, 1130, 
1033, 870, 838, 781; 
1
H NMR (400 MHz, CDCl3) 7.32 (d, J =8.4 Hz, 2H), 6.88 (d, J = 8.4 
Hz), 5.52 (s, 1H), 3.80 (s, 3H), 1.45 (s, 9H), 0.89 (s, 9H), 0.094 (s, 3H), -0.024 (s, 3H); 
13
C 
NMR (100 MHz, CDCl3) 193.7, 162.4, 159.9, 129.1, 128.8, 114.0, 84.1, 77.9, 55.3, 27.9, 
25.7, 18.3, -4.95; TLC (10% EtOAc/hexanes) Rf 0.35; LRMS (ESI) Calcd. For 
C20H32O5SiCs + CH3OH: 545.13. Found: 545.11. 
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tert-Butyl 3-(benzo[d][1,3]dioxol-5-yl)-3-(tert-butyldimethylsilyloxy)-2-oxopropanoate 
(2.17i):  
The title compound was prepared according to General procedure A 
using 2.20 (0.050 g, 0.205 mmol, 1.0 equiv), piperonal (0.062 g, 0.410 
mmol, 2.0 equiv), acetone cyanohydrin (0.0035 g, 0.041 mmol, 0.20 equiv), Yb(O
i
Pr)3 
(0.0035g, 0.0102 mmol, 0.05 equiv) and DMF (2 mL).The reaction was complete 
immediately upon the addition of all reagents as determined by TLC analysis. After workup 
and removal of the excess aldehyde in vacuo (<1 mm Hg), 2.17i (0.069 g, 0.176 mmol, 86% 
yield) was obtained as a clear colorless oil. Analytical data for 2.17i: IR (thin film, cm
-1
) 
2955, 2931, 2895, 2856, 1747, 1725, 1489, 1445, 1371, 1252, 1143, 1040, 873, 839, 782; 
1
H 
NMR (400 MHz, CDCl3) 6.90 (s, 1H), 6.86 (s, J = 8 Hz, 2H), 6.77 (d, J = 8 Hz, 2H), 5.96 
(s, 2H), 5.47 (s, 1H), 1.47 (s, 9H), 0.90 (s, 1H), 0.098 (s, 3H), -0.005 (s, 3H) ; 
13
C NMR (100 
MHz, CDCl3) 193.5, 162.3, 147.9, 131.0, 121.2, 108.2, 107.7, 101.2, 84.3, 77.9, 27.9, 25.7, 
18.3, -4.96, -4.99; TLC (10% EtOAc/hexanes) Rf 0.36; LRMS (ESI) Calcd. For 
C20H30O6SiNa + CH3OH: 449.20. Found: 449.15. 
 
tert-Butyl 3-(tert-butyldimethylsilyloxy)-3-(1H-indol-3-yl)-2-oxopropanoate (2.17j): 
The title compound was prepared according to General procedure A using 
2.20 (0.050 g, 0.205 mmol, 1.0 equiv), indole-3-carboxaldehyde (0.060 g, 
0.410 mmol, 2.0 equiv), acetone cyanohydrin (0.0035 g, 0.041 mmol, 0.20 equiv), Yb(O
i
Pr)3 
(0.0035g, 0.0102 mmol, 0.05 equiv) and DMF (2 mL).The reaction was complete 
immediately upon the addition of all reagents as determined by TLC analysis. After workup 
and removal of the excess aldehyde by treatment with hexanes and filtration, 2.17j (0.070 g, 
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0.180 mmol, 88% yield) was obtained as a light brown oil. Analytical data for 2.17j: IR (thin 
film, cm
-1
) 2955, 2931, 2857, 1755, 1668, 1537, 1461, 1395, 1370, 1255, 1149, 839, 783; 
1
H 
NMR (400 MHz, CDCl3) s, 1H), 8.30-8.33 (m, 1H), 7.96 (s, 1H), 7.47-7.49 (m, 1H), 
7.31-7.33 (m, 2H), 6.02 (s, 1H), 1.38 (s, 9H), 0.91 (s, 9H), 0.18 (s, 3H), -0.004 (s, 3H); 
13
C 
NMR (100 MHz, CDCl3) 185.0, 166.2, 136.2, 136.1, 125.5, 124.2, 123.3, 122.3, 119.4, 
110.8, 83.6, 79.2, 27.8, 25.4, 18.1, -5.26, -5.31; TLC (10% EtOAc/hexanes) Rf 0.14; LRMS 
(ESI) Calcd. For C21H31NO4SiNa: 412.19. Found: 412.18. 
 
General Procedure B for the Sm(O
i
Pr)3 catalyzed nucleophilic glyoxylation of aliphatic 
aldehydes to afford -siloxy--ketoesters 2.17k-l: 
 
 
 
These substrates were prepared in the same manner described in General Procedure A except 
10 mol % Sm(O
i
Pr)3 was substituted for Yb(O
i
Pr)3. 
 
tert-Butyl 3-(tert-butyldimethylsilyloxy)-2-oxopentanoate (2.17k): 
 The title compound was prepared according to General procedure B using 
2.20 (0.050 g, 0.205 mmol, 1.0 equiv), propionaldehyde (0.024 g, 0.410 mmol, 
2.0 equiv), acetone cyanohydrin (0.0035, g 0.041 mmol, 0.20 equiv), Sm(O
i
Pr)3 (0.0067 g, 
0.0205 mmol, 0.10 equiv) and DMF (2 mL).The reaction was complete immediately upon 
the addition of all reagents as determined by TLC analysis. After workup, 2.17k (0.060 g, 
0.197 mmol, 96% yield) was obtained as a clear colorless oil. Analytical data for 2.17k: IR 
(thin film, cm
-1
) 2958, 2932, 2885, 2859, 1746, 1722, 1472, 1463, 1371, 1256, 1147, 1111, 
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862, 839, 780; 
1
H NMR (400 MHz, CDCl3) 4.47 (t, J = 6.4 Hz, 1H), 1.71-1.86 (m, 2H), 
1.70 (s, 9H), 0.962 (t, J = 7.6 Hz, 3H), 0.91 (s, 9H), 0.081 (s, 3H), 0.066 (s, 3H) ; 
13
C NMR 
(100 MHz, CDCl3) 197.0, 162.8, 84.2, 77.32, 28.0, 27.3, 25.7, 18.3, 9.3, -4.81, -5.14; TLC 
(10% EtOAc/hexanes) Rf 0.48; LRMS (ESI) Calcd. For C15H30O4SiNa + CH3OH: 357.21. 
Found: 357.20. 
 
tert-Butyl 3-(tert-butyldimethylsilyloxy)-4-methyl-2-oxopentanoate (2.17l): 
The title compound was prepared according to General procedure B using 2.20 
(0.050 g, 0.205 mmol, 1.0 equiv), isobutyraldehyde (0.030 g, 0.410 mmol, 2.0 
equiv), acetone cyanohydrin (0.0035 g 0.041 mmol, 0.20 equiv), Sm(O
i
Pr)3 (0.0067 g, 
0.0205 mmol, 0.10 equiv) and DMF (2 mL).The reaction was complete immediately upon 
the addition of all reagents as determined by TLC analysis. After workup, 2.17l (0.055 g, 
0.174 mmol, 85% yield) was obtained as a clear colorless oil. Analytical data for 2.17l: IR 
(thin film, cm
-1
) 2960, 2932, 2859, 1745, 1722, 1472, 1371, 1255, 1147, 1073, 863, 839, 780; 
1
H NMR (400 MHz, CDCl3) 4.33 (d, J = 5.2 Hz, 1H), 2.11-2.17 (m, 1H), 1.54 (s, 9H), 0.98 
(d, J = 6.8 Hz, 3H), 0.91 (s, 9H), 0.89 (d, J = 6.8 Hz, 3H), 0.049 (s, 3H), 0.038 (s, 3H); 
13
C 
NMR (100 MHz, CDCl3) 196.9, 162.6, 84.1, 80.6, 31.8, 27.9, 25.8, 19.0, 18.3, 17.0, -4.74, 
-5.31; TLC (10% EtOAc/hexanes) Rf 0.50; LRMS (ESI) Calcd. For C16H32O4SiNa + 
CH3OH: 371.22. Found: 371.24. 
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Preparation of -Silyloxy -Hydroxy Ester 2.31 
 
 
 
Sodium borohydride (1.0 equiv) was added to a solution of -silyloxy -keto ester 2.17a (1.0 
equiv) in methanol (0.5 M concentration) at -78 ºC. When gas evolution ceased, 1 mL 
saturated ammonium chloride was added and the reaction was further diluted with diethyl 
ether and water. The organic layer was washed with brine and dried over sodium sulfate and 
concentrated in vacuo. Flash chromatography (10% EtOAc/hexanes) provided 2.31 as a clear 
colorless oil in a 2.5:1 dr, as determined by 
1
HNMR analysis. Analytical data for 2.31: IR 
(thin film, cm
-1
) 2958, 2930, 2857, 1726, 1368, 1252, 1161, 1119, 935, 837, 778, 700; 
1
H 
NMR (400 MHz, CDCl3) major: 7.24-7.36 (m, 5H), 5.05 (d, J = 2.4 Hz), 4.24 (dd, J = 2.8 
Hz, 8 Hz), 3.18 (d, J = 7.2 Hz), 1.46 (s, 9H), 0.93 (s, 9H), 0.11 (s, 3H), -0.045 (s, 3H) minor: 
7.24-7.36 (m, 5H), 4.95 (d, J = 2.4 Hz), 4.03 (dd, J = 2.8 Hz, 8 Hz), 2.99 (d, J = 8.8 Hz), 
1.58 (s, 9H), 0.89 (s, 9H), 0.043 (s, 3H), -0.22 (s, 3H);  13C NMR (100 MHz, CDCl3) major: 
 171.0, 140.4, 127.8, 127.2, 126.4, 77.3, 27.9, 25.9, 18.3, -4.8, -5.0 minor: 171.5, 141.0, 
128.0, 127.0, 82.3, 76.3, 28.1, 25.8, 18.1, -4.5, -5.1; TLC (10% EtOAc/hexanes) Rf major: 
0.43, minor: 0.38; LRMS (ESI) Calcd. For C19H32O4SiNa: 375.20. Found: 375.18. 
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Determination of Diastereomer Identity 
 
 
 
tert-Butyl 2,3-dihydroxy-3-phenylpropanoate (30): The title compound was prepared by 
dissolving 6 (0.040 g, 0.113 mmol, 1.0 equiv) in THF (2 mL) followed by addition of TBAF 
trihydrate (0.071 g, 0.226 mmol, 2.0 equiv). After stirring five minutes, TLC analysis (10% 
EtOAc/hexanes) showed that deprotection was complete (Rf(diol)  ≈ 0). The reaction mixture 
was passed through a plug of silica gel with EtOAc (30 mL) and filtrate was concentrated. 
The spectroscopic data matched that in the literature. 
 
 
Preparation of -silyoxy--aminoester 2.34 
 
 
tert-butyl 3-(tert-butyldimethylsilyloxy)-2-(hydroxyimino)-3-phenylpropanoate 
 
 Hydroxylamine hydrochloride (0.396 g, 5.70 mmol, 10.0 equiv) and sodium 
acetate (0.468 g, 5.70 mmol, 10.0 equiv) were dissolved separately in the 
minimum amount of water (~ 0.5 mL) and added sequentially to a solution of 2.17a (0.200 g, 
0.570 mmol, 1.0 equiv) in ethanol (5 mL). The reaction was allowed to stir overnight and 
diluted with EtOAc. The layers were separated and the organic layer was dried over Na2SO4 
and concentrated in vacuo. The crude product was passed through a plug of silica gel using 
20% EtOAc/hexanes to afford the oxime (0.194 g, 0.531 mmol, 93% yield) as a clear 
colorless oil (d.r. 5:1). Analytical data: IR (thin film, cm
-1
) 2955, 2930, 2887, 2858, 1736, 
1369, 1256, 1148, 869, 838, 780, 700; 
1
H NMR (400 MHz, CDCl3) major: (bs, 1H), 
tBuO
O
Ph
OTBS
N
HO
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7.24-7.50 (m, 5H), 5.54 (s, 1H), 1.33(s, 9H), 0.95 (s, 9H), 0.11 (s, 3H), 0.07 (s, 3H) minor  
7.24-7.50 (m, 5H), 6.30 (s, 1H), 1.42 (s, 9H), 0.94 (s, 9H), 0.109 (s, 3H), 0.07 (s, 3H); 13C 
NMR (100 MHz, CDCl3) major: 161.6, 152.2, 140.4, 127.9, 127.2, 126.0, 84.0, 74.0, 66.7, 
27.9, 25.8, 18.21, -4.8, -5.2; minor: 160.9, 154.7, 140.2, 127.4, 125.8, 82.6, 66.7, 29.7, 
27.9, 25.7, 18.2, -4.8, -5.2; TLC (10% EtOAc/hexanes) Rf major: 0.45, minor: 0.34; LRMS 
(ESI) Calcd. For C19H31NO4SiNa: 388.19. Found: 388.18. 
 
tert-Butyl 2-(tert-butoxycarbonylamino)-3-(tert-butyldimethylsilyloxy)-3-
phenylpropanoate (2.34):  
 
To a 10-mL round-bottomed flask was added zinc dust (0.173 g, 2.65 mmol, 
5.0 equiv) and ammonium formate (0.167 g, 2.65 mmol, 5.0 equiv). A solution 
of the oxime (0.194 g, 0.530 mmol, 1.0 equiv) in MeOH (5 mL) was added and the reaction 
was heated at reflux overnight. After cooling to room temperature, the reaction was filtered 
through a pad of celite. The pad was washed with MeOH (20 mL) and the filtrate was 
concentrated. The crude material was dissolved in EtOAc, washed with saturated NaHCO3, 
water, brine, dried over Na2SO4, and concentrated. The crude material was dissolved in THF 
(3 mL) and (
t
BuOC)2O (0.231 g, 1.06 mmol, 2.0 equiv) was added. Sodium hydroxide (0.042 
g, 1.06 mmol, 2.0 equiv) in water (2 mL) was added and the reaction was allowed to stir 
overnight. The reaction was diluted with water and the aqueous layer was extracted with 
EtOAc (3x). The combined organic extracts were washed with brine, dried over Na2SO4, and 
concentrated in vacuo. Purification by flash chromatography (eluting with 5% 
EtOAc/hexanes) afforded 7 (0.155 g, 0.410 mmol, 72% yield over three steps) as a clear 
colorless oil. The spectroscopic data matched that in the literature. 
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CHAPTER THREE 
ASYMMETRIC SYNTHESIS OF -KETO ESTERS VIA CU(II)-CATALYZED AEROBIC 
DEACYLATION OF ACETOACETATE ALKYLATION PRODUCTS 
3.1 Introduction 
The development of methods for the creation of carboncarbon bonds is essential for 
the construction of complex molecules and is exemplified by the continual efforts directed 
toward identifying novel and selective bond-forming reactions. However, the complementary 
process, carboncarbon bond cleavage, has received considerably less attention despite the 
tremendous potential it holds.
1
 These reactions are not always obvious retrosynthetic 
disconnections, but can efficiently provide useful synthetic intermediates as they often 
unmask latent functional groups (Figure 3-1). Important examples include oxidative cleavage 
of 1,2-diols
2
 and ozonolysis of alkenes
3
 to provide (di)carbonyl compounds, transition-metal 
catalyzed decarboxylations
4-8
 to generate reactive carbanionic species, and the Grob
9
 and 
Eschenmoser-Tanabe fragmentations
10
 to yield alkenyl and alkynyl ketones respectively. 
Moreover, the oxidative cleavage of enol acetates,
11
 nitronates,
12
 and MBH adducts
13
 via 
ozonolysis introduces the -keto ester functionality (Chapter 1). Introduced in this chapter is 
a copper(II)-catalyzed oxidative cleavage of substituted acetoacetates as a simple and 
efficient method for the preparation of diverse -stereogenic -keto esters, establishing 
synthetic equivalency between acetoacetate esters and the glyoxylate anion in the context of 
asymmetric synthesis.  
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Figure 3-1. CC Bond Cleavage Strategies in Organic Synthesis 
 
3.2 Background 
Formal nucleophilic glyoxylation of -functional groups through the application of 
glyoxylate anion equivalents in principle defines a direct entry into -keto esters. The 
existing reagents and strategies discussed in the previous chapters, which are highlighted in 
Figure 3-2, are not amenable to widespread adoption of the “glyoxylate anion” tactic in 
organic synthesis due to case-dependent disadvantages and/or limitations.  Application of 
these methods to access enantioenriched substrates is particularly challenging and the only 
two examples of direct asymmetric “glyoxylate anion” catalysis employ glyoxamides as the 
glyoxylate donor.
14-15
 Additionally, the substrate scopes of these methods and others (see 
Chapter 1) are confined to alkyl substituents at the -stereocenter (with the exception of 3.2), 
display limited functional group tolerance, and several require a chiral auxiliary to achieve 
acceptable levels of enantioselectivity. No single reagent has been developed to provide 
access to enantioenriched, structurally diverse -keto esters. Due to the importance of this 
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class of compounds and the lack of general methods for their preparation, we sought to 
identify a family of enantioselective reactions that would deliver products to serve as the -
keto ester progenitor.  
 
Figure 3-2. Notable Glyoxylate Anion Equivalents 
 
 
The conversion of -substituted -keto esters and malonates to the corresponding -
keto ester using oxygen and catalytic quantities of a Cu(II) or Fe(III) salt was disclosed in the 
patent literature by Clariant in 2000;
16
 this reaction is related to prior oxidative ring cleavage 
reactions of cycloalkanones disclosed by Cossy and co-workers
17
 (Scheme 3-1). Although 
the products reported by Clariant are achiral and unfunctionalized, the transformation is 
noteworthy for its simplicity, scalability, and use of cheap, unmodified catalysts.  
 
Scheme 3-1. Oxidative cleavage of -Keto Esters 
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The mechanism for this transformation has not been studied in detail but what has 
been proposed is shown in Scheme 3-2. Key to the success of this reaction is enolization of 
the -dicarbonyl 3.6 to generate copper enolate 3.7. The enolate is then oxidized via a one 
electron transfer yielding radical species 3.8. Reaction with dioxygen delivers hydroperoxide 
3.9 which undergoes cyclization to give dioxetane 3.10 that readily eliminates acetic acid as 
the only presumed byproduct to deliver the -keto ester product 3.11. 
 
Scheme 3-2. Proposed Mechanism for the Oxidative Cleavage of -Substituted -Keto 
Esters 
 
 
The appeal of using -substituted -dicarbonyls 3.14 as precursors to -keto esters 
3.15 stems from the range of chiral catalysts that are available to mediate enantioselective 
enolate-based carboncarbon bond constructions with-dicarbonyl nucleophiles 3.12 and -
electrophiles 3.13 (Scheme 3-3). These reactions offer significant practical advantages since 
the pronucleophiles are commercially available and inexpensive. Moreover, activation can be 
achieved under mild and convenient reaction conditions due to the low pKa of the carbon 
acid. Subjection of these chiral intermediates to a second-stage oxidative deacylation would 
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parlay the established advantages of enolate-based reactions into syntheses of many families 
of -keto esters that have not been previously prepared and would not be accessible via a 
glyoxylate anion catalysis manifold. 
 
Scheme 3-3. Proposed Strategy to Access Enantioenriched -Keto Esters 
 
 
3.3 Preliminary Studies 
For our preliminary studies we purposely chose a challenging substrate. The oxidative 
deacylation shown in Scheme 3-4 is an ideal inquiry into the efficiency, mildness and 
functional group compatibility of the title reaction. The proposed conversion of the Michael 
addition product 3.20 to the derived -keto ester 3.21 would give a product of formal alkene 
nucleophilic glyoxylation. The state of the art in this area comes from Enders
18
 which 
requires the synthesis of a noncommercial chiral auxiliary (3.16→3.17) and four overall steps 
to arrive at the glyoxylation products 3.18. Additionally, this method was found to be 
incompatible with nitrostyrenes due to their tendency to readily eliminate nitrous acid 
(HNO2) on silica gel to form the corresponding -unsaturated -keto ester 3.22. 
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Scheme 3-4. Formal Alkene Nucleophilic Glyoxylation: Nitrostyrenes  
 
 
The asymmetric addition of methyl acetoacetate 3.12 to nitrostyrene was 
accomplished using the chiral nickel diamine complex 3.19 developed by Evans, providing 
3.20 in >98:2 er.
19
 The oxidative deacylation was initially conducted under 1 atm of O2 using 
5 mol % Cu(NO3)2·3H2O, and after 48 h 60% conversion to the -keto ester was observed. 
Further optimization (Table 1) revealed that pressurized air (50 psig in a standard Fisher-
Porter bottle) and 20 mol % of Cu(NO3)2·3H2O provided the best results, affording 3.21 in 
83% yield and in >98:2 er; pretreating the silica gel with 5% acetic acid prevents elimination 
of HNO2 during purification. The fact that this elimination does not occur during the course 
of the reaction underscores the mildness of these oxidation conditions. Most importantly, 
despite the CH acidity of the product 3.2120 and the accompanying possibility of 
racemization, no loss in enantiopurity is observed allowing enantioenriched -aryl -keto 
esters to be prepared for the first time. 
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Table 3-1. Optimization of Oxidative Deacylation Reaction Conditions 
 
entry catalyst oxidant % 
conversion
a 
time (h) 
1 Cu(NO3)2·3H2O  (5 mol %) O2 60 48 
2 Cu(NO3)2·3H2O  (10 mol %) O2 63 23 
3 Cu(NO3)2·3H2O  (20 mol %) O2 56 18 
4 FeCl3 O2 43 24 
5 Cu(NO3)2·3H2O  (20 mol %) air (50 psig) 72 4 
6 Cu(NO3)2·3H2O  (20 mol %) air (50 psig) 100 24 
 a 
Determined by 
1
HNMR spectroscopy. 
Conjugate adduct 3.23 was not previously described using catalyst 3.19, but efficient 
enantioselective catalysis was observed and aerobic deacylation of the crude tautomeric and 
stereoisomeric mixture provided -keto ester 3.24 in good yield (80%) without measurable 
racemization (96:4 er) (Scheme 3-5). 
 
Scheme 3-5. Formal Alkene Nucleophilic Glyoxylation: Alkyl Nitroolefins 
 
 
 
3.4 Reaction Scope 
  With the goal of diversifying available product classes, attention was directed to 
finding other cases that might be amenable to aerobic deacylation.  Conjugate glyoxylation of 
cyclic enones has previously been described by Reetz using 1,2-bis(trimethylsilyloxy)-1,2-
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diethoxyethene,
21
 albeit in racemic form. Asymmetric addition of methyl acetoacetate to both 
2-cyclopenten-1-one
22
 and 2-cyclohexen-1-one
23
 were performed using the chiral catalysts 
developed by Ikariya (3.25) and Shibasaki (3.26), respectively. However, subjection of these 
substrates (3.27 and 3.28) directly to the optimized oxidation conditions afforded a complex 
mixture of products (Scheme 3-6). This observation was attributed to undesired reactivity in 
the presence of the ketone functionality; therefore, reaction conditions to allow a site-
selective ketalization were examined.  
 
Scheme 3-6. Initial Conjugate Glyoxylation Studies 
 
 
Initial attempts were made using one equivalent of ethylene glycol and catalytic 
quantities of p-TsOH (Scheme 3-7). For substrate 3.28, an inseparable mixture of the desired 
mono-protected and undesired di-protected ketone was obtained, and for 3.27, very low 
conversions were observed. This roadblock was overcome by performing the ketalization 
under the aprotic conditions developed by Noyori
24
 using two equivalents of 1,2-
bis(trimethylsiloxy)ethane and catalytic quantities of TMSOTf at -78 ºC. The aerobic 
66 
 
deacylation of the protected substrates 3.29 and 3.30 proceeded cleanly. Concomitant ketal 
deprotection was observed for 3.29 yielding dione 3.31 in 82% yield and 96:4 er. Conversely, 
the ketal remained intact for the cyclohexanone derivative 3.30, which afforded 3.32 (78%, 
er 96:4) with all three oxygenated functional groups differentiated.  
 
Scheme 3-7. Site Selective Ketalization/Deacylation of Cyclic Enones 
 
 
Extension of this method to achieve formal asymmetric glyoxylation of acyclic 
Michael acceptors was desired, but surprisingly enantioselective acetoacetate additions to 
acyclic -unsaturated carbonyls have yet to be developed. Kobayashi has reported the 
asymmetric conjugate addition of dimethyl malonate to chalcones using chiral strontium 
complex 3.33 (Scheme 3-8).
25
 The Clariant patent described the aerobic cleavage of simple 
linear malonates, but the oxidative cleavage of the branched and more highly functionalized 
malonate derivative 3.34 to the -keto ester 3.35 has to date been unsuccessful. 
Unfortunately, the use of catalyst 3.33 with methyl acetoacetate afforded racemic product 
3.36.  
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Scheme 3-8. Formal Asymmetric Conjugate Glyoxylation Attempts with Malonate 
Derivatives 
 
 
Nonetheless, conjugate adducts (±)-3.36
26
 and (±)-3.37
11
 are easily accessible and 
provide their derived -keto esters 3.39 and 3.40 in good yields in the presence of Cu(II)/air. 
This is a more practical method to prepare this class of -keto esters than those previously 
described which require conversion to either the nitronate or enol acetate followed by 
ozonolysis. 
 
Scheme 3-9. Formal Conjugate Glyoxylation of Acyclic Michael Acceptors 
 
 
Even more value-added products can be accessed by utilizing the second nucleophilic 
site on methyl acetoacetate. With an ambident electrophile such as 2-cyclo-hexen-1-one, 
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methyl acetoacetate undergoes a (3+3)-annulation providing bicyclo[3.3.1]nonanone 3.41.
27
 
Oxidative deacylation of (±)-3.41 led to a ring-cleavage reaction
17
 yielding cyclohexanol 
3.42 as single isomer with all four oxygenated functional groups differentiated. Notably, the 
product is the synthetic equivalent of two challenging reactions: enone conjugate 
glyoxylation and diastereoselective ketone acetate aldolization. The scalability of the aerobic 
cleavage was highlighted as this reaction was trivially performed on a 10 g scale without the 
need of chromatography; the product was isolated in pure form by precipitation from diethyl 
ether with hexanes as the antisolvent.  
 
Scheme 3-10. Formal Racemic Conjugate Glyoxylation/Ketone Acetate Adolization 
Sequence 
 
 
The acetoacetate/cyclohexanone (3+3)-annulation has only been reported in racemic 
form, but subjection the enantioenriched 1,4-conjugate adduct 3.28 to a second stage 
aldolization (NaOMe and MeOH) provided ()-3.41 in good yield. It was critical to run the 
aldol cyclization at room temperature to avoid loss in enantioputirty via a retro-
Michael/Michael sequence. Aerobic deacylation provided ()-3.42 with no loss in 
enantiopurity (95:5 er). 
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Scheme 3-11. Formal Asymmetric Conjugate Glyoxylation/Ketone Acetate Adolization 
Sequence 
 
 
Dual functionalization was also achieved with unsaturated -keto ester 3.43. The 
asymmetric allylic alkylation of cyclohexen-3-yl acetate has been reported with malonate 
esters, but the analogous asymmetric reaction with acetoacetate esters to the best our 
knowledge remained unknown. We have found that benzyl acetoacetate is a competent 
nucleophile for asymmetric allylic alkylations,
28
 affording -keto ester 3.43 in 95.5:4.5 er. 
Subjection of 3.43 to the standard oxidative conditions resulted in both aerobic deacylation 
and epoxidation of the alkene providing 3.44 with >95:5 diastereoselection. The syn-
stereochemical relationship strongly implicates participation of the -keto ester or a 
precursor thereto in the epoxidation.
29 
 
Scheme 3-12. Merged Aerobic Deacylation/Epoxidation 
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3.5 Stereochemical Analysis of 3.44 
  The syn-stereochemical relationship of the epoxide and -keto ester was based on the 
expectations of the vicinal coupling constant/diehedral angle relationship of HA and HC as 
described by Davies and Whitman for a closely related compound (Figure 3-3).
30
 COSY 
analysis allowed assignment of HC for which no interactions with the cyclohexane 
methylenes were observed. NOESY analysis allowed for the assignment of HA (nOE with HC 
but not with HB) and HB. If HA and HC were trans, the coupling constant would be expected 
to be ~0 Hz (90º dihedral angle) and HC would appear as a doublet; however, HC appears as a 
doublet of doublets which is consistent with a syn-relationship. 
 
 
HC  HB                    HA 
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3.6 Problematic Substrates 
While investigating the asymmetric addition of methyl acetoacetate to chalcone, it 
was observed if the reaction was allowed to run longer than one hour, a (3+3) annulation 
occurred, affording cyclohexanol 3.45 (Scheme 3-13a). Upon subjection of this substrate to 
the oxidative conditions, the ring cleavage product 3.46 was expected, however, a retro-aldol 
reaction was found to be operative and provided Michael adduct 3.39 (Scheme 3-13b). In an 
attempt to avoid this reactivity, the tertiary alcohol was protected as the trimethylsilyl ether 
3.47. However, decomposition of 3.47 occurred in the presence of Cu(II)/air, perhaps due to 
the formation of the benzylic carbocation 3.48 (Scheme 3-13c). Similar results were obtained 
with substrate 3.50, which was prepared by allylic alkylation of epoxide 3.49 (Scheme 3-
13d).
31
  Subjection of the free alcohol to the reaction conditions resulted in low conversion to 
the -keto ester and the allylic silyl ether derivative underwent decomposition, presumably 
through a similar pathway (formation of allylic carbocation 3.51). Addressing these 
limitations and extending the scope of the deacylation are current areas of interest.  
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Scheme 3-13. Problematic Substrates for the Aerobic Deacylation  
 
 
 
3.7 Conclusions 
A simple protocol for the preparation of -stereogenic -keto esters has been 
established through the aerobic deacylation of substituted acetoacetate derivatives. A 
heretofore underdeveloped relationship between chiral -keto esters and -keto esters has 
been realized that dramatically simplifies the glyoxylate anion problem. The strategy 
described herein captures many of the characteristics that are often described in “ideal” 
synthetic methods: aerobic deacylation is operationally simple and scalable, employs starting 
materials that are commercially available and cheap, generates an innocuous byproduct, 
provides product diversity, and is compatible with a number of useful functional groups. 
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3.8 Experimental Details 
Methods. Infrared (IR) spectra were obtained using a Jasco 260 Plus Fourier transform 
infrared spectrometer. Proton and carbon magnetic resonance spectra (
1
H NMR and 
13
C 
NMR) were recorded on a Bruker model DRX 400 or 600 (
1
H NMR at 400 MHz and 
13
C 
NMR at 100 MHz) spectrometer with solvent resonance as the internal standard (
1
H NMR: 
CDCl3 at 7.26 ppm and C6D6 at 7.15 ppm; 
13
C NMR: CDCl3 at 77.0 ppm). 
1
H NMR data are 
reported as follows: chemical shift, multiplicity (s = singlet, br s = broad singlet, d = doublet, 
br d = broad doublet, t = triplet, br t = broad triplet, q = quartet, sept = septuplet, oct = 
octuplet, m = multiplet), coupling constants (Hz), and integration. Supercritical fluid 
chromatography was performed on a Berger SFC system equipped with a Chiralcel WO 
column. Samples were eluted with SFC grade CO2 at the indicated percentage of MeOH. 
HPLC analysis was performed on an Agilent Technologies 1200 System equipped with 
Chiralpak IA, IB, and IC columns (constant flow at 1.00 mL/min). Optical rotations were 
measured using a 2 mL cell with a 1 dm path length on a Jasco DIP 1000 digital polarimeter. 
Mass spectra were obtained using a Micromass Quattro II (triple quad) instrument with 
nanoelectrospray ionization (Note: All samples prepared in methanol). Analytical thin layer 
chromatography (TLC) was performed on Whatman 0.25 mm silica gel 60 plates. 
Visualization was accomplished with UV light and/or aqueous ceric ammonium molybdate 
solution followed by heating. Purification of the reaction products was carried out by using 
Siliaflash-P60 silica gel (40-63μm) purchased from Silicycle All reactions were carried out 
under an atmosphere of nitrogen in oven-dried glassware with magnetic stirring. Yield refers 
to isolated yield of analytically pure material unless otherwise noted. Yields and 
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diastereomeric ratios (dr) are reported for a specific experiment and as a result may differ 
slightly from those found in the tables, which are averages of at least two experiments. 
Materials. Tetrahydrofuran and dichloromethane were dried by passage through a column of 
neutral alumina under nitrogen prior to use. 1,1-Dimethoxyethane was purchased from Sigma 
Aldrich and used without further purification. Copper(II) nitrate trihydrate, 1,2-
bis(trimethylsiloxy)ethane and acetonitrile were purchased from Fisher Scientific and used 
without further purification. The 3 oz. Fisher-Porter bottle was purchased from Andrew Glass 
Co. 
Preparation of Substrates 3.20 and 3.23 
 
 
(3S)-methyl 2-acetyl-4-nitro-3-phenylbutanoate (3.20): 
 The title compound was prepared on a 1 mmol scale according to the 
procedure described by Evans. Addition of hexanes to the crude reaction 
mixture afforded 3.20 as a white solid (95% yield) whose spectral properties matched those 
reported in the literature (dr ~1:1).
1
 SFC analysis: (Chiralcel, WO, 1.0% MeOH, 1.5 
mL/min, 150 bar, 210 nm) > 98:2 er, tR-major-1 8.8 min, tR-minor-1 9.5 min; tR-major-2 10.4 min, tR-
minor-2 10.6 min.  
 
 
 
75 
 
(3S)-Methyl 2-acetyl-4-methyl-3-(nitromethyl)pentanoate (3.23): 
The title compound was prepared on a 1 mmol scale according to the 
procedure described by Evans.
1
 The reaction afforded 3.23 as a tautomeric 
and diastereomeric mixture (94% yield). The enantiomeric excess was determined to be 97:3 
via conversion to 3.24. The crude material was used directly in the oxidative deacylation.  
 
Preparation of 3.27  
 
 
(S)-3-Oxo-2-(3-oxo-cyclopentyl)butyric acid methyl ester (3.27): 
The title compound was prepared according to the procedure described by 
Watanabe. Diketone 3.27 was obtained in 75% yield.  The spectral properties 
matched those reported in the literature. The enantiomeric excess was 
determined via conversion to (R)-3-(2-oxopropyl)cyclopentanone.
 
HPLC Analysis for that 
compound: (Chiralcel, IC, 15% 
i
PrOH/hexanes, constant flow at 1.00 mL/min, 210nm) 96:4 
er,  tR-major 28.6 min, tR-minor 27.1 min. 
 
Preparation of 3.28 
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(R)-3-Oxo-2-(3-oxo-cyclohexyl)butyric acid methyl ester (3.28): 
 
The title compound was prepared according to the procedure described by 
Shibasaki. Diketone 3.28 was obtained in 80% yield.  The spectral properties 
matched those reported in the literature.
3
 The enantiomeric excess was 
determined by conversion to (R)-1-(1,4-dioxaspiro[4.5]decan-7-yl)propan-2-one. GC 
Analysis for that compound: (Chiradex B-DM column, 80 kPa, 0.6 mL/min, 120 ºC) 96:4 er, 
tR-minor 77.9 min, tR-major 74.2 min. 
 
General Procedure for the Ketalization of Substrates 3.27 and 3.28 
 
 
 
An oven-dried flask was charged with the -ketoester (1 equiv), 1,2-
bis(trimethylsiloxy)ethane (2 equiv), and dichloromethane (0.20 M in the-ketoester) and 
cooled to -78 ºC. TMSOTf (0.10 equiv) was added and the reaction was allowed to stir at this 
temperature until the disappearance of starting material was confirmed by TLC analysis 
(30% EtOAc/hexanes as the mobile phase). The reaction was quenched with saturated 
sodium bicarbonate and diluted with ethyl acetate. The layers were separated and the organic 
was dried over Na2SO4. Concentration in vacuo afforded the ketals which were purified by 
flash chromatography using the indicated solvent system. 
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Methyl 3-oxo-2-((R)-1,4-dioxaspiro[4.5]nonan-7-yl)butyric acid methyl ester (3.29): 
 The title compound was prepared using (R)-3-oxo-2-(3-oxo-
cyclopentyl)butyric acid methyl ester (3.27, 142 mg, 0.717 mmol, 1.0 equiv), 
1,2-bis(trimethylsilyoxy)ethane (296 mg, 1.43 mmol, 2.0 equiv) and TMSOTf 
(16.0 mg, 0.0717 mmol, 0.1 equiv); reaction time = 4 h. Flash chromatography provided 3.29 
(145 mg, 0.598 mmol, 83% yield, dr 1:1) as a clear oil. Analytical data for 3.29: IR (thin film 
cm
-1
) 2954, 2881, 1743, 1714, 1434, 1357, 1210, 1145, 1025; 
1
H NMR (400 MHz, CDCl3) 
3.90-3.83 (m, 8H), 3.71 (s, 3H), 3.70 (s, 3H), 3.39 (d, J = 2.8 Hz, 1H), 3.37 (d, J = 2.8 Hz, 
1H), 2.75-2.63 (m, 2H), 2.21 (s, 3H), 2.20 (s, 3H), 2.09-1.94 (m, 2H), 1.91-1.75 (m, 6H), 
1.54-1.23 (m, 4H); 
13
C NMR (100 MHz, CDCl3) 202.0, 169.2, 169.2, 116.9, 116.7, 65.0, 
64.1, 64.1, 52.1, 40.5, 40.5, 36.4, 36.3, 35.4, 35.3, 29.0, 28.9, 28.1, 28.1; TLC (30% 
EtOAc/hexanes) Rf 0.32; LRMS (ESI) Calcd. for C12H18O5Na: 265.11, Found: 265.15. 
 
 
Methyl 3-oxo-2-((R)-1,4-dioxaspiro[4.5]decan-7-yl)butyric acid methyl ester (5b): 
 The title compound was prepared using (R)-3-oxo-2-(3-oxo-
cyclohexyl)butyric acid methyl ester (3.28, 104 mg, 0.490 mmol, 1.0 equiv), 
1,2-bis(trimethylsilyoxy)ethane (121 mg, 0.588 mmol, 1.2 equiv) and 
TMSOTf (11 mg, 0.0490 mmol, 0.10 equiv); reaction time = 1 h. Flash chromatography 
provided 3.30 (119 mg, 0.47 mmol, 95%, dr 1:1) as a clear oil. Analytical data for 3.30: IR 
(thin film cm
-1
) 2946, 1743, 1714, 1434, 1358, 1169, 1147, 1072, 1032, 924; 
1
H NMR (400 
MHz, CDCl3)  3.92 (brs, 8H), 3.71 (s, 6H), 3.34-3.29 (m, 2H), 2.47-2.41 (m, 2H), 2.21 (s, 
6H), 1.74-1.52 (m, 10H), 1.48-1.40 (m, 2H), 1.31-1.20 (m, 2H), 1.04-0.96 (m, 2H); 
13
C 
NMR (100 MHz, CDCl3)  202.3, 202.3, 169.1, 169.0, 108.3, 65.4, 65.3, 64.1, 52.0, 38.8, 
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38.5, 35.4, 35.4, 34.5, 29.2, 29.1, 29.0, 28.9, 22.5, 22.4; TLC (30% EtOAc/hexanes) Rf 0.26; 
LRMS (ESI) Calcd. for C12H20O5Na: 279.12, Found: 279.17. 
 
Preparation of Substrate 3.36 
 
 
 
 
Methyl 2-acetyl-5-oxo-3,5-diphenylpentanoate (3.36): 
 
The title compound was prepared according to the procedure described by 
Saidi. After 1 h, the reaction mix solidified and the resultant white solid 
was washed with hexanes affording 3.36 as a white solid (95% yield) 
whose spectral properties matched those reported in the literature. 
 
Preparation of Substrate 3.37 
 
 
 
Dimethyl 2-acetyl-3-methylpentanedioate (8b) 
An oven-dried 100-mL round-bottomed flask equipped with a magnetic 
stir bar was charged with sodium hydride (0.400 g, 10.0 mmol, 2.0 equiv) 
and THF (15 mL). The flask was fitted with a condenser and purged with 
nitrogen. Methyl acetoacetate (1.20 g, 10.0 mmol, 2.0 equiv) was added and the solution was 
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stirred for 15 minutes.  Methyl crotonate (0.500 g, 5.0 mmol, 1.0 equiv) was added and the 
reaction was heated at reflux for 48 h and then cooled to rt. The reaction was quenched with 
saturated ammonium chloride (5 mL) and diluted with water and ethyl acetate. The organic 
layer was washed with water and brine, dried over Na2SO4, and concentrated in vacuo.  Flash 
chromatography (30% EtOAc/hexanes) provided 3.36 (649 mg, 3.0 mmol, 60% yield, dr 1:1) 
as a clear oil whose spectral properties matched those reported in the literature. 
 
Preparation of Substrate ()-3.24 
 
 
 
 
(1R, 2S, 5R)-methyl 5-hydroxy-3-oxobicyclo[3.3.1]nonane-2-carboxylate ()-3.42: 
 
A flame-dried 1-dram vial equipped with a magnetic stir bar was charged with ()-3.28 (100 
mg, 0.471 mmol, 1 equiv), NaOMe (31 mg, 0.565 mmol, 1.2 equiv), and methanol (2 mL). 
The vial was sealed with a PTFE-lined screw cap and the reaction mixture was allowed to stir 
at rt. After 20 min, the reaction mixture turned brown; stirring was continued for 15 h. The 
reaction was quenched with water and neutralized with 1 M HCl. The aqueous layer was 
extracted with ethyl acetate three times and the combined organic extracts were washed with 
brine, dried over Na2SO4 and concentrated in vacuo. The resulting brown oil was purified by 
flash chromatography (30% EtOAc/hexanes, Rf 0.32) and ()-3.42 (94 mg, 0.442 mmol, 
94%) was obtained as a clear viscous oil whose spectral properties matched those reported in 
the literature. The enantiomeric ratio was determined to be 95:5 by  HPLC analysis 
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(Chiralpak, IB, 5% 
i
PrOH/hexanes, constant flow at 1.00 mL/min, 210 nm; tR-major 17.0 min, 
tR-minor 18.4 min); []D
26
 = -52.2. 
Scale-Up of (±)-3.42 
 
 
 
 
The title compound was prepared on a 55 mmol scale according to the procedure of Momose 
and Muraoka with the following modifications: 
1. Instead of refluxing for 36 h, TLC analysis (30% EtOAc/hexanes) showed the reaction 
was complete in 15 h. 
2. Instead of purification via distillation, the crude material was purified via flash 
chromatography (30% EtOAc/hexanes), affording the title compound (84% yield) as a 
clear viscous oil whose spectral properties matched those reported in the literature. 
 
Preparation of 3.43 
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Benzyl 2-((R)-cyclohex-2-en-1-yl)-3-oxobutanoate (3.43) 
 
An oven-dried 25-mL round bottomed flask equipped with a stir bar was 
charged with sodium hydride (0.124 g, 3.1 mmol, 3.1 equiv) and 
dichloromethane (15 mL). Benzyl acetoacetate (0.577 g, 3.0 mmol, 3 equiv) 
followed by tetrahexylammonium bromide (1.35 g, 3.1 mmol, 3.1 equiv) were added and 
stirred for 20 minutes. [Note: The reaction does not become homogeneous.] In an inert 
atmosphere glovebox, a 50-mL round bottomed flask equipped with a stir bar was charged 
with allylpalladium dimer (0.0091 g, 0.025 mmol, 0.025 equiv), N,N'-((1R,2R)-cyclohexane-
1,2-diyl)bis(2-(diphenylphosphino)benzamide (0.0518 g, 0.075 mmol, 0.075 equiv) and 
dichloromethane (2 mL). The flask was sealed with a septum, removed from the box and 
stirred under nitrogen. After 5 min, 2-cyclohexenyl acetate (0.140 g, 1.0 mmol, 1 equiv) was 
added. The solution of tetrahexylammonium benzyl acetoacetate was transferred via cannula 
into the reaction mix over 5 min. The reaction was allowed to stir for 15 h at rt and was 
quenched with saturated ammonium chloride and diluted with ethyl acetate and water. The 
aqueous layer was extracted with ethyl acetate (2x) and the combined organics were washed 
with brine, dried over sodium sulfate and concentrated in vacuo. Flash chromatography (10% 
EtOAc/hexanes) provided 3.43 (240 mg, 0.88 mmol, 88% yield, dr 1:1) as a clear oil. The 
enantiomeric ratio was determined to be 95.5:4.5 via conversion to 3.44. Analytical Data for 
3.43: IR (thin film, cm
-1
) 2360, 2341, 1743, 1715, 1135; 
1
H NMR (400 MHz, CDCl3) 
 (m, 10H), 5.76-5.75 (m, 2H), 5.49-5.44 (m, 2H), 3.44-3.40 (m, 2H), 2.97-2.95 
(m, 2H), 2.20 (s, 3H), 2.19 (s, 3H), 1.98-1.97 (m, 4H), 1.75-1.66 (m, 4H), 1.58-1.55 (m, 2H), 
1.30-1.27 (m, 2H); 
13
C NMR (125 MHz, CDCl3) 202.5, 202.4, 168.6, 168.5, 135.3, 129.8, 
129.5, 128.5, 128.4, 128.3, 128.3, 128.2, 127.4, 127.1, 67.0, 65.0, 35.1, 35.0, 29.8, 29.5, 26.6, 
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26.5, 24.9, 24.8, 20.8, 20.7; TLC (20% EtOAc/hexanes) Rf 0.48; LRMS (ESI) Calcd. for 
C17H20O3Na: 295.13, Found: 295.19. 
 
Preparation of (±)-3.43 
An oven-dried 25-mL round bottomed flask equipped with a stir bar was charged with 
sodium hydride (0.120 g, 3.0 mmol, 3 equiv) and THF (5 mL). Benzyl acetoacetate (0.577 g, 
3.0 mmol, 3 equiv) was added and the suspension was stirred for 10 minutes. A solution of 
palladium(II) acetate (0.0067 g, 0.030 mmol, 0.030 equiv) and triphenylphosphine (0.024 g, 
0.090 mmol, 0.090 equiv) in 2.5 mL THF was added via cannula followed by 2-cyclohexenyl 
acetate (0.140 g, 1.0 mmol, 1.0 equiv) in 2.5 mL THF. The reaction was heated at reflux for 
16 h and worked up and purified as above to provide (±)-3.43 (0.250 g, 0.92 mmol, 92% 
yield). 
 
General Procedure A: Aerobic Deacylation with Oxygen as the Oxidant 
 
A round-bottomed flask was charged with the -keto ester (1 equiv), copper(II) nitrate 
trihydrate (0.20 equiv), and acetonitrile (1 mL/100 mg -keto ester). Oxygen was bubbled 
through the reaction solution for 10 min. The reaction was stirred at rt under 1 atm of oxygen 
(balloon) for the indicated time and then diluted with ethyl acetate and water. The aqueous 
layer was extracted with ethyl acetate (2x) and the combined organic extracts were washed 
with brine and dried over Na2SO4. Concentration in vacuo afforded the -keto esters which 
were purified by flash chromatography using the indicated solvent systems.  
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General Procedure B: Aerobic Deacylation with Air as the Oxidant 
 
A 3 oz. Fisher-Porter bottle was charged with the -ketoester (1.0 equiv), copper(II) nitrate 
trihydrate (0.20 equiv) and acetonitrile (1 mL/100 mg of -ketoester). A pressure gauge was 
attached and the vessel pressurized with air (50 psig). The reaction was stirred at rt for 15-24 
h and diluted with ethyl acetate and water.The aqueous layer was extracted with ethyl acetate 
(2x) and the combined organic extracts were washed with brine and dried over Na2SO4. 
Concentration in vacuo afforded the -keto esters which were purified by flash 
chromatography using the indicated solvent systems. 
 
 (S)-methyl 4-nitro-2-oxo-3-phenylbutanoate (3.21): 
 The title compound was prepared according to General Procedure B using 
(3S)-methyl 2-acetyl-4-nitro-3-phenylbutanoate (3.20, 0.100 g, 0.377 
mmol, 1 equiv); reaction time = 24 h. Flash chromatography (97% (30% EtOAc/hexanes)/3 
% AcOH) provided 3.21 (0.076 g, 0.320 mmol, 85% yield) as a clear oil in >98:2 er as 
determined by SFC analysis (Chiralcel, WO, 1.0% MeOH, 1.5 mL/min, 150 bar, 210 nm; tR-
minor 8.4 min, tR-major 9.0 min). Analytical data for 3.21: IR (thin film, cm
-1
) 1731, 1553, 1377, 
1257, 1150, 1074, 700; 
1
H NMR (400 MHz, CDCl3)  7.42-7.39 (m, 3H), 7.29-7.27 (m, 2H), 
5.38 (dd, J = 10, 4.8 Hz, 1H), 5.20 ( dd, J = 14.8, 10 Hz, 1H), 4.64 (dd, J = 14.8, 4.8 Hz, 1H), 
3.84 (s, 1H); 
13
C NMR (100 MHz, CDCl3)  188.8, 160.0, 130.3, 129.7, 129.3, 129.0, 74.6, 
53.3, 50.8; TLC (30% EtOAc/hexanes) Rf 0.30; LRMS (ESI) Calcd. for C11H11NO5Na + 
CH3OH: 292.08, Found: 292.06; []D
25
 = -213.6 (c = 0.500, CHCl3). [Note: If AcOH is 
omitted during the chromatographic purification, elimination to enone 3.22 results.] 
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(S)-methyl 4-methyl-3-(nitromethyl)-2-oxopentanoate (3.24): 
 The title compound was prepared according to General Procedure B 
using (3S)-methyl 2-acetyl-4-methyl-3-(nitromethyl)pentanoate (3.23, 
0.100 g, 0.432 mmol, 1.0 equiv); reaction time = 16 h.  Flash 
chromatography (20% EtOAc/hexanes) provided 3b (0.070 g, 0.345 mmol, 80% yield) as a 
clear oil in 97:3 er as determined by HPLC analysis (Chiralpak, IA, 5% 
i
PrOH/hexanes, 
constant flow at 1.00 mL/min, 210 nm; tR-minor 15.2 min, tR-major 16.7 min). Analytical data for 
3.24: IR (thin film, cm
-1
) 1729, 1555, 1375, 1243, 1061; 
1
H NMR (400 MHz, CDCl3)  4.90 
(dd, J = 14.8, 10.8 Hz, 1H), 4.52 (dd, J = 14.8, 3.6 Hz, 1H), 4.07-4.02 (m, 1H), 3.93 (s, 3H). 
2.20-2.11 (m, 1H), 1.06 (d, J = 6.8 Hz, 1H), 0.92 (d, J = 6.8 Hz); 
13
C NMR (100 MHz, 
CDCl3)  193.0, 160.8, 72.8, 53.3, 49.8, 28.5, 20.4, 19.0; TLC (30% EtOAc/hexanes) Rf 
0.42; LRMS (ESI) Calcd. for C8H18NO5Na + CH3OH: 258.10, Found: 258.07; []D
25
 = -89.6 
(c = 0.700, CHCl3). 
 
(R)-Methyl 2-oxo-2-(3-oxocyclopentyl)acetate (3.31):  
The title compound was prepared according to General Procedure B using 
methyl 3-oxo-2-((R)-1,4-dioxaspiro[4.5]nonan-7-yl)butyric acid methyl ester 
(3.29, 0.077 g, 0.318 mmol, 1 equiv); reaction time =24 h. Flash 
chromatography (20% EtOAc/hexanes) provided 3.31 (0.044 g, 0.259 mmol, 81% yield) in 
96:4 er as determined by HPLC anlaysis (Chiralpak, IC, 15% 
i
PrOH/hexanes, constant flow 
at 1.00 mL/min, 210 nm; tR-minor 10.3 min, tR-major 11.7 min). Analytic data for 3.31: IR (thin 
film cm
-1
); 
1
H NMR (400 MHz, C6D6)  3.19 (s, 3H), 3.07-3.01 (m, 1H), 2.16-2.07 (m, 1 H), 
1.88-1.83 (m, 1H), 1.77-1.74 (m, 1H), 1.54-1.50 (m, 2H), 1.36-1.34 (m, 1H); 
13
C NMR (150 
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MHz)  215.3, 193.7, 161.0, 53.3, 44.2, 39.4, 37.3, 25.4; TLC (30% EtOAc/hexanes) Rf 0.28 
(20% EtOAc/hexanes); LRMS (ESI) Calcd. for C8H10O4Na + CH3OH: 225.07, Found: ; 
[]D
25
 = -9.00 (c = 0.75) . 
 
 
(R)-Methyl 2-oxo-2-(1,4-dioxaspiro[4.5]decan-7-yl)acetate (3.32):  
The title compound was prepared according to General Procedure B using 
methyl 3-oxo-2-((R)-1,4-dioxaspiro[4.5]decan-7-yl)butyric acid methyl 
ester (3.30, 0.0610 g, 0.238 mmol, 1.0 equiv); reaction time =  15 h. Flash 
chromatography (30% EtOAc/hexanes) provided 3.32 (0.0430 g, 0.188 mmol, 79% yield) in 
96:4 er as determined by HPLC analysis (Chiralpak, IC, 5% 
i
PrOH/hexanes, constant flow at 
1.00 mL/min, 210 nm; tR-minor 10.7 min, tR-major 11.4 min). Analytical data for 3.32: IR (thin 
film cm
-1
) 2950, 1731, 1454, 1250, 1164, 1073, 1020, 947; 
1
H NMR (400 MHz, CDCl3)  
3.95 (s, 4H), 3.87 (s, 3H), 3.37-3.31 (m, 1H), 1.95-1.82 (m, 3H), 1.75-1.62 (m, 3H), 1.57-
1.50 (m, 1H), 1.48-1.38 (m, 1H); 
13
C NMR (100 MHz)  195.9, 161.9, 108.3, 64.4, 52.7, 
44.7, 35.6, 34.6, 26.4, 22.5; TLC (30% EtOAc/hexanes) Rf 0.34; LRMS (ESI) Calcd. for 
C11H16O5Na + CH3OH: 283.12, Found: 283.17; []D
28
 = -20.1 (c = 0.850, CHCl3). 
 
Methyl 2,5-dioxo-3,5-diphenylpentanoate (3.39):  
The title compound was prepared according to General Procedure B using 
methyl 2-acetyl-5-oxo-3,5-diphenylpentanoate (3.36, 0.100 g, 0.206 mmol, 
1.0 equiv); reaction time = 20 h. Flash chromatography (30% 
EtOAc/hexanes) provided 3.39 as clear oil. Analytical data for 3.39: IR (thin film cm
-1
) 
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1730, 1679, 1449, 1261, 1037, 751, 699; 
1
H NMR (400 MHz, CDCl3)  (d, J = 8 Hz, 
2H), 7.57 (d, J = 7.2, 1H), 7.45 (t, J = 7.2 Hz, 2H), 7.36-7.30 (m, 5H), 5.16 (dd, J = 10.4, 2.8 
Hz 1H), 4.05 (dd, J = 18.4, 10.8 Hz, 1H), 3.85 (s, 3H), 3.46 (dd, J = 18.4, 2.8 Hz, 1H); 
13
C 
NMR (100 MHz, CDCl3)  197.3, 191.8, 160.8, 136.0, 135.3, 133.5, 129.2, 128.8, 128.6, 
128.2, 128.0, 52.9, 48.4, 43.3; TLC (30% EtOAc/hexanes) Rf 0.43; LRMS (ESI) Calcd. for 
C18H16O4Na: 319.09, Found: 319.07.  
 
Dimethyl 3-methyl-2-oxopentanedioate (3.40):  
The title compound was prepared according to General Procedure B using 
dimethyl 2-acetyl-3-methylpentanedioate (3.36, 0.336 g, 1.55 mmol, 1 
equiv); reaction time =  15 h. Concentration in vacuo provided 3.39 (0.283 
g, 1.50 mmol, 97% yield) as a clear oil. Analytical data for 3.39: IR (thin film cm
-1
) 2360, 
2337, 1732, 1261, 1172; 
1
H NMR (400 MHz, CDCl3)  3.89 (s. 3H), 3.73-3.69 (m, 1H), 3.66 
(s, 3H), 2.84 (dd, J = 16.8, 8.8 Hz, 1H), 2.51 (dd J = 16.8, 5.2 Hz, 1H) 1.21 (d, J = 7.2 Hz, 
3H); 
13
C NMR (150 MHz, CDCl3)  195.8, 172.1, 161.1, 52.9, 51.9, 38.2, 36.7, 15.8; TLC 
(30% EtOAc/hexanes) Rf 0.38; LRMS (ESI) Calcd. for C8H12O5Na: 211.06, Found: 211.04. 
 
2-((1R,3R)-1-hydroxy-3-(2-methoxy-2-oxoacetyl)cyclohexyl)acetic acid (3.42): 
 The title compound was prepared according to General Procedure B (3 oz. 
Fisher Porter bottle unable to accommodate this scale) using (1R, 2S, 5R)-
methyl 5-hydroxy-3-oxobicyclo[3.3.1]nonane-2-carboxylate (3.41, 0.106 g, 
0.500 mmol, 1.0 equiv); reaction time =  15 h. Flash chromatography (50% EtOAc/hexanes) 
provided 11 (0.115 g, 0.470 mmol, 94% yield) as a clear viscous oil in 95:5 er as determined 
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by HPLC analysis (Chiralpak, IC, 25% 
i
PrOH/hexanes, constant flow at 1.00 mL/min, 210 
nm; tR-minor 17.2 min, tR-major 19.4 min).  Analytical data for 3.42: IR (thin film, cm
-1
) 2942, 
1725, 1437, 1406, 1254, 968, 632; 
1
H NMR (400 MHz, CDCl3)  3.86 (s, 3H), 3.58-3.50 (m, 
1H), 2.55 (s, 2H), 2.04-2.00 (m, 2H), 1.98-1.86 (m, 2H), 1.83-1.79 (m, 1H), 1.70-1.67 (m, 
1H), 1.45-1.38 (m, 2H); 
13
C NMR (150 MHz, CDCl3)  196.9, 177.4, 161.7, 69.4, 52.9, 46.1, 
42.0, 37.1, 36.0, 27.2, 20.4; TLC (50% EtOAc/hexanes) Rf 0.28; LRMS (ESI) Calcd. for 
C11H16O6Na + CH3OH: 299.11, Found: 299.13. []D
26 
= -9.74.  (±)-11 was prepared 
according to General Procedure A using methyl 5-hydroxy-3-oxobicyclo[3.3.1]nonane-2-
carboxylate ((±)-3.41, 10.0 g, 47.1 mmol, 1.0 equiv)  in a 250-mL round bottomed flask; 
reaction time = 15 h. The material was dissolved in 50 mL diethyl ether and the product 
precipitated out upon the addition of 150 mL of hexanes. The off-white solid was collected 
by filtration to provide (±)-3.42 (10.0 g, 40.9 mmol, 87% yield, mp 85-87 °C). 
 
 
 Benzyl 2-((1R,2R,6S)-7-oxabicyclo[4.1.0]heptan-2-yl)-2-oxoacetate (3.44): 
 The title compound was prepared according to General Procedure B using 
benzyl 2-((R)-cyclohex-2-en-1-yl)-3-oxobutanoate (3.43, 0.100 g, 0.367 
mmol, 1.0 equiv); reaction time = 16 h. Flash chromatography (10% 
EtOAc/hexanes) provided 3.44 (0.064 g, 0.246 mmol, 67% yield) as a clear oil in 95.5: 4.5 er 
as determined by HPLC analysis (Chiralpak, IB, constant flow at 1.00 mL/min, 210 nm; tR-
major 12.7 min, tR-minor 15.3 min). Analytical data for 3.44: IR (thin film, cm
-1
) 2918, 1731, 
1456, 1246, 1065, 1032, 976, 753, 698; 
1
H NMR (400 MHz, CDCl3)  7.43-7.37 (m, 5H), 
5.33 (m, 2H), 3.59-3.58 (t, J = 4.0 Hz, 1H), 3.52-3.50 (dt, J = 9.6, 5.6 Hz 1H), 3.20-3.19 (dt, 
J = 4.0, 1.4 Hz, 1H), 1.99-1.88 (m, 1H), 1.86-1.80 (m, 2H), 1.51-1.49 (m, 1H), 1.40-1.32 (m, 
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2H); 
13
C NMR (150 MHz, CDCl3)  192.5, 161.2, 134.5, 128.7, 128.7, 128.5, 68.0, 51.8, 
51.0, 43.7, 23.5, 20.1, 17.3; TLC (20% EtOAc/hexanes) Rf 0.29; LRMS (ESI) Calcd. for 
C15H16O4Na + CH3OH: 315.12, Found: 315.12; []D
25
 = -38.3. 
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CHAPTER FOUR 
DYNAMIC KINETIC RESOLUTION OF -KETO ESTERS VIA ASYMMETRIC TRANSFER 
HYDROGENATION 
4.1 Introduction 
The preparation of enantioenriched organic molecules is an increasingly important 
objective in organic synthesis due to the growing need and interest in such compounds in the 
pharmaceutical and agrochemical industries.
1
 Many essential biomolecules exist in 
homochiral form. Examples include carbohydrates, which are involved in cell signaling and 
recognition processes, and amino acids, which are the primary constituents of structural 
proteins, enzymes, and receptors; as a result, biological activity is highly enantiomer 
dependent. This makes the advancement of drug candidates as racemates increasingly 
difficult to justify, as one enantiomeric form can be inactive and/or have adverse effects. 
Therefore, the development of methods to access enantiopure compounds is of considerable 
importance.  
The majority of methods used for the preparation of enantiomerically enriched 
compounds can be classified into three distinct strategies: the use of enantiopure compounds 
provided by Nature (chiral pool), enantioselective synthesis and the resolution of a pair of 
enantiomers. There are a number of instances where the chiral pool approach is unbeatable, 
but the range of compounds provided by Nature is limited in regards to structure and 
stereochemistry; for this reason asymmetric synthesis and the resolution of racemates are 
important strategies for accessing enantiopure substances.  
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 Significant advances have been made over the past several decades in asymmetric 
synthesis,
2-3
 particularly in the development of catalytic enantioselective reactions. The 
advantages associated with this approach are well-recognized and include: 1) access to either 
enantiomer of product based on which enantiomer of reagent/auxiliary/catalyst is employed; 
2) the use of readily available achiral starting materials; and 4) the minimization of waste 
typically associated with resolution processes (vide infra). Additionally, a number of factors 
influence the practicality of an asymmetric process and the characteristics that generally 
describe an ideal enantioselective transformation include, but are not limited to: 1) the 
products are obtained in near quantitative yield in high enantiomeric excess; 2) the chiral 
reagent or catalyst is inexpensive and does not contribute to the overall cost; 3) the reaction 
can be applied reliably and reproducibly on any scale; and 4) there is minimal generation of 
byproducts and waste. While there are a few asymmetric catalytic methodologies that make it 
as convenient to prepare highly enantioenriched materials as it is to prepare racemic mixtures 
(i.e. 1,2 diols, epoxy alcohols, and certain hydrogenation products), there are a far greater 
number of circumstances where it is much easier and cost effective to access racemates. As a 
result, resolution strategies are commonly evaluated against asymmetric methods.  
There are two commonly used resolution techniques, classical and kinetic. Classical 
resolutions involve the use of a stoichiometric amount of a chiral resolving reagent which 
associates to the substrate, either covalently or non-covalently, to generate a pair of 
diastereomers. The diastereomers are then separated, and through a separate chemical 
transformation, the substrate is released from the resolving reagent. This approach has proven 
to be especially useful for the resolution of amines and carboxylic acids through salt 
formation (Scheme 4-1a). Kinetic resolutions involve the use of a chiral catalyst or reagent to 
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promote the selective reaction of one enantiomer in a racemic substrate (S) over the other 
yielding a mixture of enantioenriched starting material and product (P), from which the 
desired component is then isolated (Scheme 4-1b). The relative rates of reaction for the 
substrate enantiomers, typically expressed as krel = kfast/kslow, are dictated by the magnitude of 
ΔΔG‡. This corresponds to the difference in energies between the diastereomeric transition 
states in the selectivity-determining step of the catalytic reaction (Scheme 4-1c). Although 
numerous methods exist which are highly efficient in terms of enantio-discrimination for 
each of the above resolutions, the maximum theoretical yield is only 50% for each 
enantiomer, which places a low ceiling on the productivity of such processes.  
 
Scheme 4-1. Classical and Kinetic Resolutions 
 
 
In some special circumstances, it is possible to induce substrate racemization under 
the conditions of a kinetic resolution, which allows the “undesired” resolution byproduct to 
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be converted back to the reactive enantiomer. It then becomes possible, in principle, to 
convert 100% of the racemate to the desired product (Scheme 4-2); this process is known as a 
dynamic kinetic resolution (DKR).
5
 While DKRs also rely on differential reactivity of 
substrate enantiomers (SR/SS), they are distinct from standard kinetic resolutions since the 
catalyst is always encountering a racemic, or nearly racemic substrate. As the faster acting 
enantiomer is depleted during the course of the reaction, the equilibrium of SR/SS is 
readjusted by racemization of the slower reacting counterpart SS. The kinetic balance of the 
two concurring reactions (racemization and product formation) is of crucial importance for 
the success of a DKR (Scheme 4-2).  The rate constants for racemization (krac) and the 
transformation of the more reactive enantiomer (kR) have to match each other, specifically, 
krac should be equal to or greater than kR. If krac is smaller than kR, krac needs to be much 
greater than the transformation of the less reactive enantiomer kS (kR>krac»kS). This system is 
an example of a reaction under Curtin-Hammett control in which the composition of the 
products is determined by the free energies of the transition states and not the composition of 
the starting materials.
6
  
 
Scheme 4-2. Kinetics of a Dynamic Kinetic Resolution 
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The simplest and hence most widely used method for in situ racemization involves 
acid/base-catalyzed enol(ate) formation.
7
 As such, a number of -substituted carbonyl 
compounds have successfully been dynamically resolved in this manner. The propensity of 
-stereogenic -keto esters to racemize under acidic and basic reaction conditions has been 
highlighted in previous chapters. While this process is undesired for enantioselective 
syntheses, it is favorable when considering opportunities for dynamic asymmetric reaction 
development. The work reported herein describes the development of the first highly 
selective dynamic kinetic resolution of several classes of -keto esters via asymmetric 
transfer hydrogenation. 
 
4.2 Background 
The enantioselective hydrogenation of configurationally labile -substituted--keto 
esters is the archetypal dynamic kinetic resolution which is used to create greater than 100 
tons of chiral material each year.
8
 The high impact of this transformation flows from (1) the 
ready availability of the starting materials, (2) the use of H2 as the stoichiometric reductant, 
and (3) the ability to simultaneously control two stereogenic centers in a useful product. As 
previously mentioned, the success of the reaction relies upon the acidity of the carbon acid 
that facilitates enantiomer interconversion via the achiral enol.  The first example of this 
dynamic process was described by Tai and co-workers in 1979 for the hydrogenation of 
methyl 2-ethyl-3-oxobutyrate 4.1 with a chiral nickel catalyst (Scheme 4-3).
9
 Addition of 
hydrogen from the catalyst surface in the preferentially bound 2S-4.1 complex furnished the 
2S,3R-4.2 syn-product in a 70:30 dr and 90:10 er. 
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Scheme 4-3. First Example of DKR of -Keto Esters 
 
 
Seminal work by Noyori using homogenous Ru(II) hydrogenation catalysts allows for 
high levels of enantio- and diastereocontrol to be achieved,  greatly extending the synthetic 
utility of this method.
10
 Notably, this dynamic kinetic resolution has been used on industrial 
scale for the synthesis of biologically important compounds including threonine,
11
 
phosphothreonine,
12
 and fosfomycin
13
 (Scheme 4-4). A variety of chiral variants have been 
developed and BINAP-based catalysts have particularly displayed excellent stereoinductive 
properties. However, no single catalyst can be universal due to the structurally diverse array 
of ketonic substrates. This hydrogenation system has the flexibility to cope with such diverse 
situations through modification of the catalyst structure and reaction conditions. A wide 
range of chiral ruthenium catalysts can be prepared by different combinations of chiral 
phosphane and diamine ligands.
14
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Scheme 4-4. Synthetic Applications of Ru(II) Catalyzed DKR of -Keto Esters 
 
 
Due to the air and moisture sensitivity of the above ruthenium(II) catalysts and the 
high pressures that are required for certain substrates, catalytic reductions that do not require 
molecular hydrogen have been developed. The (arene)RuCl(monosulfonamide) catalyst 
scaffold 4.3 developed by Noyori has proven to be highly efficient for the asymmetric 
transfer hydrogenation of simple ketones
15
 4.4 and the dynamic reduction of -substituted--
keto esters
16
 4.5 and amides
17
 4.6 (Scheme 4-5). This process has practical advantages due to 
its operational simplicity and use of either isopropanol or formic acid as the organic 
reductant.  
Scheme 4-5. (Dynamic) Asymmetric Transfer Hydrogenation of Ketones 
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While the dynamic kinetic resolution of -keto esters is well-established, the 
analogous reaction for -keto esters is an unknown process, despite its enormous potential 
synthetic utility and complementary nature of the derived products (Scheme 4-6). The CH 
acidity of -silyoxy -keto esters 4.7 was first realized when we observed isomerization of 
these products to the corresponding -silyloxy -keto ester under basic reaction conditions 
(Chapter 2). We sought to capitalize upon this reactivity in developing a dynamic kinetic 
resolution via asymmetric reduction to afford orthogonally protected 1,2-diols 4.8 (vide infra, 
Scheme 4-7), a common structural motif in many natural products. 
 
Scheme 4-6. Proposed Dynamic Kinetic Resolution of -Keto Esters 
 
 
4.3 Early Investigations 
Based on the observed isomerization, we recognized that two reaction pathways could 
be operative to arrive at the desired 1,2-diol (4.8, Scheme 4-7). Dynamic reduction of the -
keto ester would lead to regioisomer 4.8a; alternatively, the dynamic reduction of the -keto 
ester 4.9, which could potentially be formed under the basic reaction conditions, would lead 
to regioisomer 4.8b. While both isomers can be converted to the same 1,2-diol 4.10 upon 
silyl deprotection, the reduction would need to proceed with the same level of enantio- and 
diatereocontrol to be productive. Ideally, one reaction pathway would need to predominate. 
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Scheme 4-7. Competing Pathways for the DKR of -Silyoxy -Keto Esters 
 
We chose 4.11 as our test substrate and initially examined the use of the Ru(II)-
BINAP(diamine) complex 4.13, which has previously been shown to have success with -
alkoxy ketones,
18
 but only trace amounts of -alkoxy -keto ester 4.12 were observed and 
4.11 remained untouched. This lack of reactivity was attributed to the steric bulk of the TBS 
protected alcohol. Noyori developed hydrogenation catalyst 4.14 specifically for the 
reduction of sterically encumbered ketones,
19
 but the same results were obtained. All 
attempts to remove the silyl group led to decomposition, perhaps through retro-aldol reaction.  
Scheme 4-8. Attempted DKR of -Silyloxy -Keto Esters via Asymmetric Hydrogenation 
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Attention was then turned to developing a dynamic kinetic asymmetric transfer 
hydrogenation (DKR-ATH) with [RuCl2(p-cymene)]2 and L1 using triethylamine as the base 
and formic acid as the organic reductant (Table 4-1).
20
 Running the reaction in DMF at room 
temperature afforded the desired product 4.15, albeit with low enantioselectivity (67:33 er) 
and moderate anti-diastereoselectivity (5:1 dr) (entry 1). As anticipated, the basic reaction 
conditions also facilitated the formation of the isomerized product 4.12, and interestingly, 
this ketone is not reduced under the reaction conditions. Exclusive formation of regioisomer 
4.15 was confirmed by 
1
H NMR analysis. Increasing the equivalents of base led to higher 
enantioselectivities (entry 3), and this result can possibly be attributed to more rapid 
racemization of the starting material; however, this also led to an increased ratio of the 
isomerized product relative to the desired diol. It was speculated that fine-tuning the basicity 
of the reaction conditions could suppress silyl transfer, so a number of formate salts as well 
as other bases in combination with formic acid were screened (entries 4-12). The results in 
Table 4-1 reveal that the degree of isomerization is base-dependant and the most favorable 
outcome was observed with sodium formate at 40 ºC (entry 5). Unfortunately, these reaction 
conditions only afforded 4.15 in a 72:28 er and 3:1 dr. While these results indicate the 
potential of -keto esters to undergo a DKR-ATH, further optimization with a simpler 
system (i.e. non-base sensitive substrates) was desired. 
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Table 4-1. Dynamic Kinetic Resolution of -Silyoxyl -Keto Esters via Asymmetric 
Transfer Hydrogenation 
 
 
 
 
entry [H
-
]/base  
(equiv) 
conv (%)
a 
(4.15 : 4.12) 
er
b 
(anti) 
dr
c 
anti:syn 
1 HCOOH/NEt3 (3.2/4.4) 88 : 12 67 : 33 5 : 1 
2 HCOOH/NEt3 (12.5/5.0) 79 : 21 67 : 33 4 : 1 
3 HCOOH/NEt3 (3.2/10.0) 35 : 65 78 : 22 4 : 1 
4
d 
HCOONa (5.0) 97 : 0 67 : 33 3 : 1 
5
e 
HCOONa (5.0) 93 : 7 71 : 29 3 : 1 
6
 
HCOONa (5.0) 92 : 8 72 : 28 3 : 1 
7 HCOOH/DIEA (3.2/10.0) 67 : 33 75 : 25 2 : 1 
8 HCOOH/Cs2CO3 (3.2/10.0) 91 : 9 70 : 30 3 : 1 
9 HCOOH/Li2CO3 (3.2/10.0) 73 : 27 70 : 30 3 : 1 
10 HCOOH/BaCO3 (3.2/10.0) 46 : 2 70 : 30 3 : 1 
11 HCOOH/CdCO3 (3.2/10.0) 51 : 5 76 : 24 3 : 1 
12 HCOOCs (5.0) 89 : 6 70 : 30 3 : 1 
a
 Conversion determined by 
1
H NMR spectroscopy. 
b
Enantiomeric excess determined by 
SFC. 
c
 Diastereomeric excess determined by 
1
H NMR spectroscopy. 
d
 Reaction run at 0 °C. 
e
Reaction run at 40 °C 
 
4.4 Development of the Glyoxylate Stetter Reaction 
At the reaction design stage, we not only wanted to establish a convenient and 
scalable route to the -keto ester precursors, but also to strategically incorporate structural 
elements that would allow us to productively merge a dynamic process with downstream 
complexity-building events. With the functionality presented in -keto ester 4.16, we 
envisioned a diastereoselective dynamic reduction to create the - and -stereocenters; the 
incorporation of a diester at the -position was projected to facilitate substrate synthesis and 
allow a third stereocenter to be established by concomitant lactonization of the nascent 
hydroxyl group (Figure 4-1). Retrosynthetic analysis of 4.16 constitutes the addition of a 
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glyoxylate anion equivalent to readily available benzylidene malonate derivatives. While 
acetoacetate addition followed by oxidative deacylation would be a viable option (Chapter 
3),
21
 the most direct route to this class of -keto esters would be a catalytic Stetter reaction 
with ethyl glyoxylate. The implementation of this strategy would provide direct access to 
synthetically useful enantioenriched -butyrolactones 4.17, which notably would arise from 
four commercial reagents (aldehyde, dimethyl malonate, ethyl glyoxylate, and formic acid) 
and three catalytic steps (Knoevenagel, Stetter, DKR/lactonization). 
 
Figure 4-1. DKR-ATH of -Keto Esters—Modular, Green, de novo Approach to 
Enantioenriched -Butyrolactones 
 
 
 
The glyoxamide Stetter with alkylidene malonates has previously been reported by 
Rovis,
22
 but the analogous reaction with ethyl glyoxylate would be considerably more 
convenient, as it is commercially available, and obviate the need to manipulate an amide after 
the reaction of interest. As shown in Table 4-2, the glyoxylate Stetter catalyzed by triazolium 
carbene
23
 4.18 is efficient for a number of substrates and can be performed on a multigram 
scale (entry 7). The -aryl -keto esters 4.16a-k cannot be accessed in enantioenriched form 
using the method developed by Rovis due to the high configurational vulnerability of the -
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stereocenter.
22a
 This is a major problem associated with stereoselective umpolung catalysis, 
but is rendered moot here since the racemate is the desired product. 
Table 4-2. Scope of the Glyoxylate Stetter Reaction with Benzylidene Malonates
a 
 
Entry R Product % yield
b 
1 C6H5 4.16a 96 
2 4Cl-C6H5 4.16b 95 
3 4Me-C6H5 4.16c 92 
4 4MeO-C6H5 4.16d 93 
5 4NC-C6H5 4.16e 90 
6 2Me-C6H5 4.16f 78 
7
c 
piperonyl 4.16g 91 
8 2-furyl 4.16h 87 
9 3-N-TsIndole 4.16i 89 
10 3-N-BocIndole 4.16j 84 
11 CH2CHPh 4.16k 93 
a 
Conditions: Unless otherwise noted, all reactions were performed on a 2.0 mmol scale in PhCH3 (4 
mL) at ambient temperature for 16 h. 
b
 Isolated yield.
 c
 Reaction performed on a 10 mmol scale. 
 
4.5 Preliminary Studies on the DKR-ATH of -Aryl -Keto Esters 
Our point of departure with respect to catalyst development was Noyori’s 
(arene)RuCl(monosulfonamide) scaffold using HCOOH:NEt3 (5:2 azeotrope) as the organic 
reductant/base, and 4.16a as the test substrate (Table 4-3). Subjection of 4.16a to 2 mol % of 
[RuCl2(p-cymene)]2 and ligand L1 (Ru atom: L mole ratio 1:2) in DMF at room temperature 
afforded a mixture of the -hydroxy ester 4.19 and desired -butyrolactone 4.17a in a 1:2 
ratio, each as a single diastereomer. Heating the reaction to 70 ºC yielded 4.17a as the sole 
product in 70:30 er with complete diastereocontrol; this is the same level of enantiocontrol 
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observed with 4.11. Varying the arene ligand on ruthenium identified p-cymene to be optimal 
(entry 3). 
 
Table 4-3. Optimization of the DKR-ATH Reaction Conditions 
 
entry arene temperature ratio 4.19:4.17 er 
1 hexamethylbenzene rt 1:2 57:43 
2 hexamethylbenzene 70 ºC 0:100 62:38 
3 p-cymene 70 ºC 0:100 70:30 
4 benzene 70 ºC 0:100 71:29 
 
Having identified ideal reaction conditions to obtain -butryolactone 4.17, a number 
of chiral 1,2-diaminoethane monosulfonamide ligands were evaluated for selectivity (Table 
4-4). The ease of preparation and proven utility of these ligands in asymmetric reactions as 
diverse as cycloaddition,
24
 epoxidation,
25
 conjugate addition,
26
 carbonyl alkylation
27
 and 
others, allowed us to narrow our focus to ruthenium complexes derived from this class. 
While all the ligands catalyzed the title reaction to high conversion and diastereoselectivity, 
enantioselectivities were poor in all cases; the identity of the sulfonamide was shown to have 
a significant effect on the level of enatiocontrol (L1 vs L2). Employing 1,2-
diaminocyclohexane L5 and 1,2-aminoindaonol L6 to serve as the chiral backbone yielded 
comparable results. 
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Table 4-4. Evaluation of Chiral Diamine Ligands 
 
 
4.6 Further Ligand Development 
Based on these observations, it was clear that a new chiral ligand would need to be 
identified to achieve high levels of enantiocontrol. The development of the “mother 
diamine”/diazo-Cope approach to the synthesis of C2-symmetric 1,2-diamines allowed facile 
screening of several diamine backbones (Scheme 4-9).
29
 From this evaluation, we found the 
-naphthyl/triisopropylbenzenesulfonamide ligand L7 considerably increased the selectivity 
(88:12 er). To further optimize the ligand structure, pertubations of the sulfonamide were 
examined due to its apparent ability to directly impact the chiral environment. However, after 
screening a number of sulfonamide derivatives (L8-13) prepared from commercially 
available sulfonyl chlorides, no significant increase in enantioselectivity was observed. 
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Scheme 4-9. Evaluation of -Naphthyl Diamine Ligands 
 
 
We were able to access a number of diverse sulfonyl chlorides through a one-pot 
double alkylation/sulfonylation of 1,3-dichlorobenzene following a modified procedure 
developed by Hart (Scheme 4-10).
29
 The simplest m-terphenylsulfonamide variant L14, 
distinguished itself as being uniquely effective for providing high levels of enantioselectivity, 
providing 4.17a in 94:6 er. The -naphthyl backbone and m-terphenylsulfonamide operate 
synergistically; no improvement in enantiocontrol with DPEN/m-terphenylsulfonamide 
ligand L17 was observed. It is noteworthy that the -naphthyl ethylenediamine backbone has 
been used sporadically in asymmetric synthesis,
30
 and the current study is to the best of our 
knowledge the first use of the m-terphenylsulfonamide for enantioselective catalysis.
31 
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Scheme 4-10. Synthesis and Evaluation of m-Terphenyl Sulfonamide Ligands 
 
 
4.7 Reaction Scope 
As outlined in Table 4-5, this DKR-ATH was found to be broad in scope for a 
number of -aryl -keto esters. High yields and enantioselectivities (up to 94% yield and 
96.5:3.5 er) were obtained for substrates incorporating electron-rich, electron-poor, and 
heteroaryl substituents at the -position. -Keto ester 4.16k bearing an alkyl substituent was 
not a successful substrate as the derived -butyrolactone 4.17k was obtained in a 67:33 er and 
this is possibly due to insufficient racemization. The syn,anti-relationship of the trisubstituted 
-butyrolactone products 4.17a-k was determined by NOESY experiments, and the absolute 
configuration was established by single X-ray crystallographic analysis of 4.17b. 
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Table 4-5. DKR-ATH Substrate Scope
a 
 
a
Conditions: 4.16 (1.0 equiv), [RuCl2(p-cymene)]2 (0.02 equiv), L (0.08 equiv), 
[4.16]0 = 0.1 M in DMF, 70 ºC, 16 h 
 
Figure 4-2. Absolute Stereochemical Determination of -Butyrolactones 
through Single X-Ray Diffraction Analysis of 4.17b and Key nOe Interactions 
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4.8 Reaction Scalability and Catalyst Efficiency 
To demonstrate the synthetic utility and catalytic efficiency of this method, the 
reaction was performed on multigram scale (Scheme 4-11). Additional experimentation 
revealed that the catalyst loading could be lowered to 1 mol % with no loss in reaction 
efficiency. The reduction was trivially performed on a 10 g scale with 4.16g, yielding lactone 
4.17g in 95:5 er. The product lactones exhibit high incidence of crystallinity; recrystallization 
of 4.17g yielded enantiomerically pure lactone in 72% yield.  
 
Scheme 4-11. Catalyst Efficiency and Scalability 
 
 
4.9 Secondary Transformations 
The reduction products present functionality immediately amenable to further 
manipulation (Scheme 4-12). Lactone 4.17a undergoes facile diastereoselective alkylation 
upon treatment with allyl bromide and DBU, yielding tetrasubstitued lactone 4.20 bearing an 
all-carbon quaternary center (94% yield). Krapcho decarboxylation
32
 afforded -
unsubstituted lactone 4.21 (86% yield), which is primed to undergo further enolate-based 
bond constructions. Of particular importance, alkylation with dibromomethane followed by 
dehalodecarboxylation
33
 afforded -alkylidene -butyrolactone 4.22. This substructure is 
featured in 3% of all known natural products, and members of this subclass exhibit a wide 
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range of biological activity. Due to the versatility of the product classes obtainable, it is 
expected this method will be of significant value in the areas of both natural product and 
medicinal agent synthesis.  
 
Scheme 4-12. Synthetic Utility of Lactone Products 
 
Conditions: (a) allyl bromide (2 equiv), DBU (2 equiv), THF, rt, 2h, 94%. (b) LiCl, DMSO, 140 ºC, 
87%. (c) i) K2CO3, dibromomethane, 84%. ii) LiCl, DMSO, 140 ºC, 87%. 
 
4.10 Chemoselective DKR-ATH of -Diketo Esters 
4.10.1 Origin of the Title Reaction 
We next sought to extend this method to include -stereogenic ,-diketo esters 4.23. 
We and others have previously reported indirect methods to access this class of compounds, 
but we have found the Stetter reaction with ethyl glyoxylate and enones to be highly efficient 
for their preparation (Table 4-6). The glyoxylate Stetter is tolerant of a number of ketonic 
substrates and substituents at the -position. Notably, with the doubly activated enone, 
dibenzylideneacetone, exclusive mono-addition was observed (entry 5).  
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Table 4-6. Glyoxylate Stetter Scope with Enones
a
  
 
entry R
1
 R
2
 product yield
b 
1 C6H5 C6H5 4.23a 97 
2 C6H5 4I-C6H4 4.23b 95 
3 C6H5 4MeO-C6H4 4.23c 86 
4 C6H5 Me 4.23d 72 
5 C6H5  4.23e 91 
6  
C6H5  
4.23f 92 
7 4Cl-C6H5 C6H5 4.23g 94 
8 4MeO-C6H5 C6H5 4.23h 96 
9 2Me-C6H5 C6H5 4.23i 70 
10 3Me-C6H5 C6H5 4.23j 93 
11 4Me-C6H5 C6H5 4.23k 95 
12 CO2Et C6H5 4.23l 92 
13 
 
 
C6H5 
4.23m 94 
14 
 
 
C6H5 
 
4.23n 
70 
a
Conditions: Unless otherwise noted, all reactions were performed on a 2.0 mmol scale in PhCH3 (4 
mL) at ambient temperature. 
b
Isolated yield. 
 
With this substrate class we envisioned a dynamic diastereoselective reduction of the 
-keto ester to set the - and -stereocenters followed by a diastereoselective reduction of 
the -ketone to afford enantionriched 1,4 diols 4.24. We began this study by subjecting 4.23a 
to the standard reaction conditions and observed exclusive reduction of the -keto ester 
affording -hydroxy ester 4.25a as a single diastereomer in 96% yield and 91:9 er. This was 
an unexpected result as (arene)RuCl(sulfonamide) catalysts have been extensively used for 
the asymmetric transfer hydrogenation of ketones. We proceeded to capitalize upon this 
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unique reactivity and further optimized the reaction conditions (Table 4-7). A short screen of 
solvents and reaction temperatures revealed that high levels of selectivity (97:3 er) could be 
obtained by running the reaction in DMSO at room temperature (entry 6). 
 
Table 4-7. Optimization of the Reaction Conditions 
 
entry solvent temperature yield er 
1 DMF 70 ºC 94 91:9 
2 DMF rt 93 87:13 
3 2-MeTHF 70 ºC 90 65:35 
4 DCE 70 ºC 91 78:22 
5 DMSO 70 ºC 96 97:3 
6 DMSO rt 98 97:3 
 
4.10.2 Reaction Scope 
Next, we explored the generality of this chemoselective dynamic reduction. For all 
substrates examined, exclusive reduction of the -keto ester was observed, irrespective of the 
electronic characteristics of the -ketone (Table 4-8). High yields and enantioselectivites 
were obtained in each case (up to 98% yield and 99:1 er). The level of selectivity for 4.25l is 
noteworthy as this demonstrates that the scope is not limited to substrates that contain a -
aryl substituent. Additionally, the -unsaturated moiety in 4.25e remained intact, providing 
a useful functional handle for further derivatization.  
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Table 4-8. Chemoselective Dynamic Reduction Scope
a 
 
entry R
1
 R
2
 product yield
b 
er
c 
1 C6H5 C6H5 4.25a 98 97:3 
2 C6H5 4I-C6H4 4.25b 91 96.5:3.5 
3 C6H5 4MeO-C6H4 4.25c 94 96:4 
4 C6H5 Me 4.25d 85 93:7 
5 C6H5  4.25e 88 99:1 
6  
C6H5  
4.25f 98 99:1 
7 4Cl-C6H5 C6H5 4.25g 94 98:2 
8 4MeO-C6H5 C6H5 4.25h 98 96:4 
9 2Me-C6H5 C6H5 4.25i 87 83:17 
10 3Me-C6H5 C6H5 4.25j 98 98:2 
11 4Me-C6H5 C6H5 4.25k 97 98:2 
12 CO2Et C6H5 4.25l 93 91:9 
13 
 
 
C6H5 
4.25m 96 97:3 
14 
 
 
C6H5 
 
4.25n 
-- 98:2 
a
Conditions: 4.25 (1.0 equiv), [RuCl2(p-cymene)]2 (0.02 equiv), L (0.08 equiv), [4.25]0 = 0.1 M 
in DMSO, rt, 1-2 h. 
b
Isolated yield. 
c
Determined by SFC analysis. 
 
4.10.3 Stereochemical Analysis 
The absolute and relative stereochemistry of -hydroxy esters 4.19 were determined by 
converting 4.25c to 4.21 via a Bayer Villiger oxidation followed by in situ lactonization 
(Scheme 4-13). The spectral and optical rotation data were in agreement indicating the 
catalyst exhibits the same enantio- and diastereomeric preference for this substrate class.  
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Scheme 4-13. Stereochemical Analysis 
 
 
4.10.4 Origin of Selectivity 
To determine if the [RuCl2(p-cymene)]2/L14 catalyst system was uniquely effective 
for the reduction of -keto esters, the selectivity of transfer hydrogenation catalysts known to 
reduce simple ketones were evaluated with 4.23a (Scheme 4-14). Running the reaction with 
ligand L1, which is known to reduce acetophenone, also afforded 4.25a as the sole product, 
albeit with lower levels of enantioselectivity (69:31 er). This result suggested that the -
ketone could possibly be protected as the lactol 4.26 following the reduction of the -keto 
ester. To test this hypothesis, the reaction was monitored by 
1
H NMR in DMSO-d
6
 (using 
L14), but 4.26 was not detected. This implicates that the observed chemoselectivity may be 
substrate dependent. 
 
Scheme 4-14. Probing the Selectivity of L14 
 
 
The above results prompted us to examine the transfer hydrogenation of several other 
ketone substrates using the standard reaction conditions in outlined in Table 4-8 (Scheme 4-
14). Surprisingly, acetophenone 4.27, which is typically the test substrate for new transfer 
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hydrogenation catalysts, was not reduced with this catalyst system. However, aryl and alkyl 
glyoxylates 4.30 and 4.31 readily afforded the corresponding -hydroxy ester. This suggests 
the catalyst has a distinct preference for -keto esters. Furthermore, ethyl pyruvate 4.28 did 
not provide desired product which implies a branch point at the -position is also necessary 
for the reduction to proceed (4.29 vs 4.31). Further mechanistic studies to understand the 
origin of selectivity are ongoing.  
 
Scheme 4-15. Transfer Hydrogenation of Other Ketone Substrates Using L14 
 
 
4.11 Conclusions 
We have designed a new asymmetric transfer hydrogenation catalyst that has led to 
the successful development of the first dynamic kinetic resolution of -aryl -keto esters. For 
substrates 4.17a-4.17k, spontaneous lactonization of the -hydroxyl group onto the pendent 
ester occurs to provide trisubstituted -butyrolactones with complete diastereocontrol. With 
respect to the rubric of green chemistry, it is instructive to inventory the three steps that lead 
to the lactones 4.17: (i) the Knoevagel condensation is amine-catalyzed and generates water 
as the by-product; (ii) the glyoxylate Stetter addition is carbene-catalyzed and 100% atom 
economical, generating no stoichiometric byproducts; (iii) the DKR-ATH reaction uses a 
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chiral ruthenium catalyst and formic acid as the reductant and generates only CO2 and 
CH3OH as byproducts. Extension of this method to -stereogenic -diketo esters revealed 
that this catalyst system is selective for -keto esters exclusively providing -hydroxy esters 
4.25a-4.25n; other ketonic substrates are unreactive under the standard reaction conditions. 
Additional studies to understand the catalyst-substrate interactions to account for the high 
levels of selectivity for -keto esters as well as identification of other green, dynamic 
transformations of -stereogenic -keto esters are current areas of interest. 
 
4.12 Experimental Details 
Methods: Infrared (IR) spectra were obtained using a Jasco 260 Plus Fourier transform 
infrared spectrometer. Proton and carbon magnetic resonance spectra (
1
H NMR and 
13
C 
NMR) were recorded on a Bruker model DRX 400 or 600 (
1
H NMR at 400 MHz or 600 
MHz and 
13
C NMR at 100 MHz or 150 MHz) spectrometer with solvent resonance as the 
internal standard (
1
H NMR: CDCl3 at 7.26 ppm and 
13
C NMR: CDCl3 at 77.0 ppm). 
1
H NMR 
data are reported as follows: chemical shift, multiplicity (s = singlet, bs = broad singlet, d = 
doublet, dd = doublet of doublet, t = triplet, q = quartet, sept = septuplet, oct = octuplet, m = 
multiplet), coupling constants (Hz), and integration. Supercritical fluid chromatography was 
performed on a Berger SFC system equipped with a Chiralcel WO column. Samples were 
eluted with SFC grade CO2 at the indicated percentage of MeOH. HPLC analysis was 
performed on an Agilent Technologies 1200 System equipped with Chiralpak IA, IB, and IC 
columns (constant flow at 1.00 mL/min). Optical rotations were measured using a 2 mL cell 
with a 1 dm path length on a Jasco DIP 1000 digital polarimeter. Low resolution mass 
spectra were obtained using a Micromass Quattro II (triple quad) instrument with 
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nanoelectrospray ionization. (Note: All samples prepared in methanol). High resolution mass 
spectra were obtained using an Agilent Technologies 6520, Accurate—Mass QTOF LCMS, 
Series 1200 LC with dual spray electrospray ionization. Analytical thin layer 
chromatography (TLC) was performed on Whatman 0.25 mm silica gel 60 plates. 
Visualization was accomplished with UV light and/or aqueous ceric ammonium molybdate 
solution followed by heating. Purification of the reaction products was carried out by using 
Siliaflash-P60 silica gel (40-63μm) purchased from Silicycle. All reactions were carried out 
under an atmosphere of nitrogen in flame-dried glassware with magnetic stirring. Yield refers 
to isolated yield of analytically pure material unless otherwise noted. Yields and 
diastereomeric ratios (dr) are reported for a specific experiment and as a result may differ 
slightly from those found in the tables, which are averages of at least two experiments. 
Materials: Benzylidene malonates and -unsaturated ketones were prepared according to 
known procedures. Ethyl glyoxylate was purchased from Sigma Aldrich as a 40% solution in 
toluene and distilled under reduced pressure prior to use (the concentration after distillation 
was determined by 
1
H NMR). N,N-Dimethylformamide (DMF) was distilled from 
phosphorous pentoxide and stored under nitrogen over 3Å molecular sieves. Anhydrous 
DMSO was purchased from Sigma Aldrich and used as received. Triethylamine (NEt3) was 
freshly distilled from calcium hydride prior to use. Toluene (PhCH3) and tetrahdyrofuran 
(THF) were dried by passage through a column of neutral alumina under nitrogen prior to 
use. All other reagents were purchased from commercial sources and were used as received 
unless otherwise noted. 
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General Procedure A for the Preparation of -Substituted -Keto Esters 4.16a-4.16k 
 
 
 
To a flame-dried 10-mL round-bottomed flask equipped with a magnetic stir bar were added 
benzylidene malonate (2.0 mmol, 1.0 equiv), ethyl glyoxylate (4.0 mmol, 2.0 equiv) and 
triazolium salt (0.40 mmol, 0.20 equiv). The flask was sealed with a rubber septum and 
purged with nitrogen. Toluene (0.5 M concentration with respect to benzylidene malonate) 
followed by triethylamine (2.0 mmol, 1.0 equiv) were then added. The reaction was stirred at 
room temperature for 16 h and diluted with ethyl acetate and water. The organic layer was 
washed with brine and dried over sodium sulfate. Concentration in vacuo afforded the -
substituted -keto esters which were purified by flash chromatography using the indicated 
solvent systems. 
 
3-Ethyl 1,1-dimethyl 3-oxo-2-phenylpropane-1,1,3-tricarboxylate (4.16a):  
 
The title compound was prepared according to General Procedure A. 
Flash chromatography (20% EtOAc/hexanes) provided 4.16a (0.618 g, 
1.92 mmol, 96% yield) as a colorless oil. Analytical data for 4.16a: 
1
H 
NMR (600 MHz, CDCl3):  7.31-7.27 (m, 3H), 7.25-7.24 (m, 2H), 5.22 (d, J = 12 Hz, 1H), 
4.30 (d, J = 12 Hz, 1H), 4.26-4.19 (m, 2H), 3.74 (s, 3H), 3.46 (s, 3H), 1.26 (t, J = 7.2 Hz, 3 
H); 
13
C NMR (150 MHz, CDCl3):  190.2, 168.2, 167.4, 159.5, 131.4, 129.4, 129.1, 128.6, 
62.7, 54.5, 53.2, 52.7, 52.6, 13.8; IR (thin film cm
-1
): 2956, 1731, 1495, 1435, 1256, 1153, 
1103, 1052, 854, 753, 700; TLC (20% EtOAc/hexanes): Rf : 0.27; LRMS (ESI): Calculated 
for [M + H]
+ 
C16H18O7: 323.11, Found: 323.07. 
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3-Ethyl 1,1-dimethyl 2-(4-chlorophenyl)-3-oxopropane-1,1,3-tricarboxylate (4.16b):  
 
The title compound was prepared according to General Procedure A. 
Flash chromatography (20% EtOAc/hexanes) provided 4.16b (0.660 g, 
1.9 mmol, 95% yield) as a colorless oil. Analytical data for 4.16b: 
1
H 
NMR (600 MHz, CDCl3):  7.30 (d, J = 7.8 Hz, 2H), 7.21 (d, J = 8.4 Hz, 
2H), 5.22 (d, J = 12 Hz, 1H), 4.29 (d, J = 12 Hz, 1H), 4.28-4.22 (m, 2H), 3.75 (s, 3H), 3.51 
(s, 3H), 1.29 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  189.9, 168.0, 167.2, 159.4, 
134.8, 130.7, 130.1, 129.4,  62.9, 54.5, 53.3, 52.7, 51.8, 13.9; IR (thin film, cm
-1
): 3649, 
2956, 1732 1491, 1435, 1258, 1154, 1094, 1051, 936, 854, 717, 597; TLC (20% 
EtOAc/hexanes): Rf : 0.32; LRMS (ESI): Calculated for [M+H]
+
 C16H18ClO7: 357.07, 
Found: 357.02. 
3-Ethyl 1,1-dimethyl 3-oxo-2-(p-tolyl)propane-1,1,3-tricarboxylate (4.16c): 
 The title compound was prepared according to General Procedure A. 
Flash chromatography (20% EtOAc/hexanes) provided 4.16c (0.618 g, 
1.84 mmol, 92% yield) as a colorless oil. Analytical data for 4.16c: 
1
H 
NMR (600 MHz, CDCl3):  7.12 (m, 4H), 5.19 (d, J = 12 Hz, 1H), 4.29 
(d, J = 12 Hz, 1H), 4.27-4.18 (m, 2H), 3.75 (s, 3H), 3.49 (s, 3H), 2.30 (s, 3H), 1.28 (t, J = 7.2 
Hz, 3H);  
13
C NMR (150 MHz, CDCl3):  190.2, 168.3, 167.5, 159.6, 138.5, 129.9, 129.3, 
128.2, 62.7, 54.5, 53.1, 52.6, 52.3, 21.1, 13.9; IR (thin film, cm
-1
): 3649, 2956, 1731, 1513, 
1436, 1257, 1153, 1100, 1053, 854, 801, 718, 601; TLC (20% EtOAc/hexanes): Rf
 
: 0.32; 
LRMS (ESI): Calculated for [M+H]
+
 C17H21O7: 337.13, Found: 337.15. 
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3-Ethyl 1,1-dimethyl 2-(4-methoxyphenyl)-3-oxopropane-1,1,3-tricarboxylate (4.16d):  
The title compound was prepared according to General Procedure A. 
Flash chromatography (30% EtOAc/hexanes) provided 4.16d (0.655 g, 
1.86 mmol, 93% yield) as a colorless oil. Analytical data for 4.16d: 
1
H 
NMR (600 MHz, CDCl3):  7.16 (d, J = 9.0 Hz, 2H), 6.83 (d, J = 8.4 Hz, 
2H), 5.17 (d, J = 12 Hz, 1H), 4.27 (d, J = 12 Hz, 1H), 4.26-4.19 (m, 2H), 3.76 (s, 3H), 3.74 
(s, 3H), 3.49 (s, 3H), 1.27 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  190.0, 168.2, 
167.5, 159.7, 159.6, 130.6, 123.0, 114.6, 62.7, 55.2, 54.4, 53.1, 52.6, 51.8, 13.9; IR (thin 
film, cm
-1
): 2956, 1731, 1609, 1511, 1436, 1304, 1256, 1180, 1153, 1099, 1052, 1031, 832, 
741, 602; TLC (30% EtOAc/hexanes): Rf
 
: 0.34; LRMS (ESI): Calculated for [M+H]
+
 
C17H21O8: 353.12, Found: 353.17. 
 
3-Ethyl 1,1-dimethyl 2-(4-cyanophenyl)-3-oxopropane-1,1,3-tricarboxylate (4.16e):  
The title compound was prepared according to General Procedure A. 
Flash chromatography (30% EtOAc/hexanes) provided 4.16e (0.625 g, 
1.80 mmol, 90% yield) as a white solid. Analytical data for 4.16e: 
1
H 
NMR (600 MHz, CDCl3):  7.62 (d, J = 7.8 Hz, 2H), 7.42 (d, J = 7.8 Hz, 
2H), 5.29 (d, J = 12 Hz, 1 H), 4.32 (d, J = 12 Hz, 1H), 4.30-4.23 (m, 2H), 3.75 (s, 3H), 3.50 
(s, 3H), 1.30 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  189.5, 167.8, 166.9, 159.2, 
137.3, 132.7, 130.1, 118.0, 112.7, 63.1, 54.5, 53.4, 52.8, 52.2, 13.8; IR (thin film, cm
-1
): 
2957, 2230, 1732, 1506, 1436, 1259, 1156, 1097, 1051, 836; m.p. 71-73 ºC; TLC (30% 
EtOAc/hexanes): Rf
 
: 0.32; LRMS (ESI): Calculated for [M+H]
+
 C17H18NO7: 348.11, Found: 
348.14. 
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3-Ethyl 1,1-dimethyl 3-oxo-2-(o-tolyl)propane-1,1,3-tricarboxylate (4.16f): 
 The title compound was prepared according to General Procedure A. 
Flash chromatography (20% EtOAc/hexanes) provided 4.16f (0.524 g, 
1.56 mmol, 78% yield) as a colorless oil. Analytical data for 4.16f: 
1
H 
NMR (600 MHz, CDCl3):  7.18-7.12 (m, 3H), 7.11-7.01 (m, 2H), 5.47 (d, J = 11.6 Hz, 1H), 
4.29 (d, J = 11.6 Hz, 1H), 4.25-4.16 (m, 2H), 3.76 (s, 3H), 3.42 (s, 3H), 2.54 (s, 3H), 1.24 (t, 
J = 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  190.3, 168.3, 167.6, 159.8, 138.5, 131.4, 
129.7, 128.5, 128.2, 126.5, 62.7, 54.4, 53.1, 52.4, 48.3, 19.6, 13.8; IR (thin film, cm
-1
): 3578, 
2964, 1734, 1523, 1441, 1264, 1148, 1110, 1057, 852, 806, 714, 605; TLC (20% 
EtOAc/hexanes): Rf
 
: 0.33; LRMS (ESI): Calculated for [M+H]
+
 C17H21O7: 337.13, Found: 
337.14. 
 
3-Ethyl 1,1-dimethyl 2-(benzo[d][1,3]dioxol-5-yl)-3-oxopropane-1,1,3-tricarboxylate 
(4.16g):  
The title compound was prepared according to General Procedure A on a 
10 mmol scale. Flash chromatography (30% EtOAc/hexanes) provided 
4.16g (3.33 g, 9.10 mmol, 91% yield) as a viscous yellow oil. Analytical 
data for 4.16g: 
1
H NMR (600 MHz, CDCl3):  6.74-6.70 (m, 3H), 5.95 
(bs, 2H), 5.14 (d, J = 12 Hz, 1H), 4.24 (d, J = 12 Hz, 1H), 4.29-4.22 (m, 2H), 3.74 (s, 3H), 
3.54 (s, 3H), 1.29 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  189.9, 168.2, 167.4, 
159.6, 148.2, 147.9, 124.6, 123.2, 109.5, 108.8, 101.4, 62.8, 54.6, 53.2, 52.7, 52.0, 13.9; IR 
(thin film, cm
-1
): 2956, 2360, 1731, 1505, 1489, 1440, 1249, 1225, 1153, 1095, 1037, 932, 
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857, 812, 638; TLC (30% EtOAc/hexanes): Rf
 
: 0.35; LRMS (ESI): Calculated for [M+H]
+
 
C17H19O9: 367.10, Found: 367.01 
 
3-Ethyl 1,1-dimethyl 2-(furan-2-yl)-3-oxopropane-1,1,3-tricarboxylate (4.16h):  
The title compound was prepared according to General Procedure A. 
Flash chromatography (20% EtOAc/hexanes) provided 1h (0.543 g, 1.74 
mmol, 87% yield) as an orange oil. Analytical data for 1h: 
1
H NMR (600 
MHz, CDCl3):  7.37 (s, 1H), 6.32-6.30 (m, 2H), 5.40 (d, J = 12 Hz, 1H), 4.36 (d, J = 12 Hz, 
1H), 4.33-4.25 (m, 2H), 3.75 (s, 3H), 3.62 (s, 3H), 1.32 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 
MHz, CDCl3):  187.3, 167.9, 167.3, 159.5, 145.0, 143.9, 111.0, 110.7, 62.9, 53.2, 52.9, 
52.4, 46.5, 13.9; IR (thin film, cm
-1
): 2957, 1736, 1499, 1436, 1252, 1153, 1100, 1051, 1014, 
749, 599; TLC (20% EtOAc/hexanes): Rf
 
: 0.27; LRMS (ESI): Calculated for [M+H]
+
 
C14H17O8: 313.09, Found: 313.13. 
 
3-Ethyl 1,1-dimethyl 3-oxo-2-(1-tosyl-1H-indol-3-yl)propane-1,1,3-tricarboxylate 
(4.16i): 
 The title compound was prepared according to General Procedure A. 
Flash chromatography (30% EtOAc/hexanes) provided 4.16i (0.918 g, 
1.78 mmol, 89% yield) as a viscous yellow oil. Analytical data for 4.16i: 
1
H NMR (400 MHz, CDCl3):  7.94 (d, J = 8.4 Hz, 1H), 7.70 (d, J = 8.4 Hz, 2H), 7.67 (m, 
1H), 7.51 (s,1H), 7.33-7.30 (m, 2H), 7.23-7.21 (m, 2H), 5.48 (d, J = 11.6 Hz, 1H), 4.39 (d, J 
= 11.6 Hz, 1H), 4.21-4.12 (m, 2H), 3.77 (s, 3H), 3.25 (s, 3H), 2.33 (s, 3H), 1.15 (t, J = 7.2 
Hz, 3H); ); 
13
C NMR (100 MHz, CDCl3):  188.9, 168.0, 167.2, 159.5, 145.1, 135.1, 134.9, 
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129.9, 126.8, 126.4, 125.4, 123.7, 119.9, 113.6, 113.4, 62.8, 53.9, 53.2, 52.5, 43.5, 21.5, 
13.7; IR (thin film, cm
-1
): 2955, 1732, 1596, 1447, 1372, 1286, 1251, 1176, 1123, 1093, 
1050, 979, 814, 748, 704, 669, 573, 538; TLC (30% EtOAc/hexanes): Rf
 
: 0.25; LRMS 
(ESI): Calculated for [M+Na] C25H25NO9SNa + MeOH: 570.14, Found: 570.03. 
 
3-Ethyl 1,1-dimethyl 2-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)-3-oxopropane-1,1,3-
tricarboxylate (4.16j):  
The title compound was prepared according to General Procedure A. 
Flash chromatography (20% EtOAc/hexanes) provided 4.16j (0.775 g, 
1.68 mmol, 84% yield) as a pale yellow solid. Analytical data for 4.16j: 
1
H NMR (400 MHz, CDCl3):  8.12 (d, J = 8.0 Hz, 1H) 7.70-7.68 (m, 1H), 7.45 (s, 1H), 
7.35-7.27 (m, 2H), 5.53 (d, J = 11.6 Hz, 1H), 4.39 (d, J = 11.6 Hz, 1H), 4.25-4.15 (m, 2H), 
3.78 (s, 3H), 3.43 (s, 3H), 1.65 (s, 9H), 1.22 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, 
CDCl3):  188.9, 168.2, 167.2, 159.5, 149.1, 135.5, 128.7, 125.9, 125.0, 123.0, 119.3, 115.2, 
111.0, 84.3, 62.8, 54.0, 53.2, 52.7, 43.3, 28.1, 13.7; IR (thin film, cm
-1
): 2980, 1733, 1453, 
1367, 1257, 1154, 1083, 1051, 748; m.p. 96-97.5 ºC; TLC (20% EtOAc/hexanes) Rf
 
: 0.29; 
LRMS (ESI): Calculated for [M+Na] C23H17NO9Na + MeOH: 516.18, Found: 516.21. 
 
3-Ethyl 1,1-dimethyl 3-oxo-2-phenethylpropane-1,1,3-tricarboxylate (4.16k):  
The title compound was prepared according to General Procedure A. 
Flash chromatography (20% EtOAc/hexanes) provided 4.16k (0.775 g, 
1.86 mmol, 93% yield) as a colorless oil. Analytical data for 4.16k: 
1
H 
NMR (600 MHz, CDCl3):  7.29-7.26 (m, 2H), 7.21-7.18 (m, 1H), 7.12-7.11 (m, 2H), 4.41-
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4.33 (m, 2H), 4.13 (ddd, J = 10.8, 8.4, 4.2 Hz, 1H), 3.97 (d, J = 10.8 Hz, 1H), 3.98 (s, 3H), 
3.97 (s, 3H), 2.59-2.56 (m, 2H), 1.99-1.87 (m, 2H), 1.40 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 
MHz, CDCl3):  194.8, 168.6, 168.1, 140.6, 128.5, 128.3, 126.3, 62.7, 54.2, 53.1, 52.9, 45.2, 
32.4, 31.7, 14.0; IR (thin film, cm
-1
): 2955, 1797, 1730, 1603, 1496, 1455, 1436, 1257, 1155, 
1097, 1064, 752, 700; TLC (20% EtOAc/hexanes) Rf
 
: 0.29; LRMS (ESI): Calculated for 
[M+H]
+
 C18H23O7: 351.14, Found: 351.16. 
 
General Procedure B for the Preparation of -Aryl -Keto Esters 4.23a-4.23n 
 
 
 
To a flame-dried 10-mL round-bottomed flask equipped with a magnetic stir bar were added 
-unsaturated ketone (2.0 mmol, 1.0 equiv), ethyl glyoxylate (4.0 mmol, 2.0 equiv) and 
triazolium salt (0.20 mmol, 0.10 equiv). The flask was sealed with a rubber septum and 
purged with nitrogen. Toluene (0.5 M concentration with respect to-unsaturated ketone) 
followed by triethylamine (2.0 mmol, 1.0 equiv) were then added. The reaction was stirred at 
room temperature for 16 h and diluted with ethyl acetate and water. The organic layer was 
washed with brine and dried over sodium sulfate. Concentration in vacuo afforded the -
substituted -diketo esters which were purified by flash chromatography using the 
indicated solvent systems. 
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Ethyl 2,5-dioxo-3,5-diphenylpentanoate (4.23a): 
The title compound was prepared according to General Procedure B on a 
20 mmol scale. Flash chromatography (20% EtOAc/hexanes) provided 
4.23a (6.02 g, 19.4 mmol, 97% yield) as a white solid. Analytical data for 4.23a: 
1
H NMR 
(600 MHz, CDCl3):  7.96 (d, J = 7.2 Hz, 2H) 7.58-7.56 (m, 1H), 7.47-7.44 (m, 2H), 7.36-
7.35 (m, 4H), 7.31-7.29 (m, 1H), 5.16 (dd, J = 10.8 Hz, 3.6 Hz, 1H), 4.32-4.24 (m, 2H), 4.04 
(dd, J = 18 Hz, 10.8 Hz, 1H), 3.44 (dd, J = 18 Hz, 3.6 Hz, 1H), 1.31 (t, J = 7.2 Hz, 3H); 
13
C 
NMR (150 MHz, CDCl3):  197.4, 192.2, 160.3, 135.9, 135.3, 133.5, 129.1, 128.9, 128.6, 
128.2, 128.0, 62.5, 48.4, 43.2, 13.9; IR (thin film, cm
-1
): 1669, 1494, 1450, 1400, 1362, 
1277, 1207, 1098, 1036, 844, 751, 689, 563; m.p. ºC; TLC (20% EtOAc/hexanes) Rf
 
: 0.33; 
HRMS (ESI): Calculated for [M+H]
+
 C19H19O4: 311.1283, Found: 311.1281. 
 
Ethyl 5-(4-iodophenyl)-2,5-dioxo-3-phenylpentanoate (4.23b): 
The title compound was prepared according to General Procedure B. 
Flash chromatography (20% EtOAc/hexanes) provided 4.23b ().829 g, 
1.90 mmol, 95% yield) as a white solid. Analytical data for 4.23a: 
1
H NMR (600 MHz, 
CDCl3):  7.82 (d, J = 8.4 Hz, 2H), 7.65 (d, J = 8.4 Hz, 2H), 7.38-7.28 (m, 5H), 5.14 (dd, J = 
10.8 Hz, 4.0 Hz, 1H), 4.34-4.21 (m, 2H), 3.97 (dd, J = 10.8 Hz, 18.2 Hz, 1H), 3.36 (dd, J = 
18.2 Hz, 4.0 Hz, 1H), 1.30 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  196.7, 192.0, 
160.2, 138.0, 135.2, 135.1, 129.5, 129.2, 128.8, 128.0, 101.6, 62.6, 48.4, 42.9, 13.9; IR (thin 
film, cm
-1
): 1728, 1681, 1581, 1494, 1455, 1394, 1274, 1204, 1097, 1037, 1002, 818, 753, 
700, 560; m.p. ºC; TLC (20% EtOAc/hexanes) Rf
 
: 0.42; HRMS (ESI): Calculated for 
[M+H]
+
 C19H18IO4: 437.0250, Found: 437.0254. 
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Ethyl 5-(4-methoxyphenyl)-2,5-dioxo-3-phenylpentanoate (4.23c): 
The title compound was prepared according to General Procedure 
B. Flash chromatography (20% EtOAc/hexanes) provided 4.23c 
(0.585 g, 1.72 mmol, 97% yield) as a yellow solid. Analytical data for 4.23c: 
1
H NMR (600 
MHz, CDCl3):  7.93 (d, J = 9.0 Hz, 2H), 7.35-7.33 (m, 4H), 7.30-7.28 (m, 1H), 6.91 (d, J = 
8.4 Hz, 2H), 5.13 (dd, J = 10.8 Hz, 3.6 Hz, 1H), 4.33-4.24 (m, 2H), 3.99 (dd, J = 18.0 Hz, 
10.8 Hz, 1H), 3.86 (s, 3H), 3.40 (dd, J = 18.0 Hz, 3.6 Hz, 1H), 1.31 (t, J = 7.2 Hz, 3H); 
13
C 
NMR (150 MHz, CDCl3):  195.9, 192.3, 163.8, 160.4, 135.5, 130.5, 129.1, 129.0, 127.9, 
113.8, 62.5, 55.5, 48.4, 43.1, 13.9; IR (thin film, cm
-1
): 2360, 1726, 1669, 1600, 1509, 1454, 
1421, 1260, 1169, 1030, 833, 699; m.p. ºC; TLC (20% EtOAc/hexanes) Rf
 
: 0.26; HRMS 
(ESI): Calculated for [M+H]
+
 C20H21O5: 341.1389, Found: 341.1392. 
 
Ethyl 2,5-dioxo-3-phenylhexanoate (4.23d): 
The title compound was prepared according to General Procedure B. Flash 
chromatography (20% EtOAc/hexanes) provided 4.23d (0.357 g, 1.44 mmol, 
72% yield) as a clear oil. Analytical data for 4.23d: 
1
H NMR (600 MHz, CDCl3):  7.36-
7.26 (m, 5H), 4.96 (dd, J = 10.8 Hz, 4.2 Hz, 1H), 4.30-4.20 (m, 2H), 3.50 (dd, J = 18.0 Hz, 
10.8 Hz, 1H), 2.85 (dd, J = 18.0 Hz, 4.2 Hz, 1H) 2.20 (s, 3H), 1.29 (t, J = 7.2 Hz); 
13
C NMR 
(150 MHz, CDCl3):  205.9, 192.2, 160.3, 135.1, 129.1, 128.8, 127.9, 62.4, 48.5, 47.0, 29.5, 
13.8; IR (thin film, cm
-1
): 2984, 1729, 1455, 1363, 1271, 1165, 1098, 1027, 752, 700, 516; 
TLC (20% EtOAc/hexanes) Rf
 
: 0.28; HRMS (ESI): Calculated for [M+H]
+
 C14H17O4: 
249.1127, Found: 249.1121. 
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(E)-Ethyl 2,5-dioxo-3,7-diphenylhept-6-enoate (4.23e): 
The title compound was prepared according to General Procedure B. 
Flash chromatography (20% EtOAc/hexanes) provided 4.23e (0.612 g, 
1.82 mmol, 91% yield) as a clear oil. Analytical data for 4.23e: 
1
H NMR (600 MHz, CDCl3): 
 7.57 (d, J = 16.2 Hz, 1 H), 7.53-7.52 (m, 2H), 7.40-7.38 (m, 3H), 7.36-7.32 (m, 4H), 7.30-
7.28 (m, 1H), 6.72 (d, J = 16.2 Hz, 1H), 5.07 (dd, J = 10.2 Hz, 4.2 Hz, 1H), 4.32-4.22 (m, 
2H), 3.74 (dd, J = 18.0 Hz, 10.2 Hz, 1H), 3.14 (dd, J = 18.0 Hz, 4.2 Hz, 1H), 1.29 (t, J = 7.2 
Hz); 
13
C NMR (150 MHz, CDCl3):  197.2, 192.2, 160.4, 143.6, 135.4, 134.2, 130.7, 129.1, 
129.0, 128.8, 128.3, 127.9, 125.3, 62.4, 48.4, 44.6, 13.9; IR (thin film, cm
-1
): 2360, 1727, 
1655, 1610, 1494, 1451, 1337, 1274, 1176, 1070, 1035, 753, 699; TLC (20% 
EtOAc/hexanes) Rf
 
: 0.34; HRMS (ESI): Calculated for [M+H]
+
 C21H21O4: 337.1440, Found: 
337.1447. 
 
Ethyl 5-(benzo[d][1,3]dioxol-5-yl)-2,5-dioxo-3-phenylpentanoate (4.23f): 
The title compound was prepared according to General Procedure B. 
Flash chromatography (20% EtOAc/hexanes) provided 4.23f (0.652 
g, 1.84 mmol, 92% yield) as a clear oil. Analytical data for 4.23f: 
1
H NMR (600 MHz, 
CDCl3):  7.55 (d, J = 8.4 Hz, 1 H), 7.39 (s, 1H), 7.34-7.33 (m, 4H), 7.29-7.27 (m, 1H), 6.82 
(d, J = 8.4 Hz, 1H), 6.02 (s, 2H), 5.12 (dd, J = 10.8 Hz, 4.2 Hz, 1H), 4.32-4.22 (m, 2H), 3.95 
(dd, 18.0 Hz, 10.8 Hz, 1H), 3.35, (dd, J = 18.0 Hz, 3.6 Hz, 1H), 1.30 (t, J = 7.2 Hz, 3H); 
13
C 
NMR (150 MHz, CDCl3):  195.3, 192.2, 160.3, 152.0, 148.1, 135.3, 130.7, 129.0, 128.8, 
127.9, 124.5, 107.8, 107.8, 101,9, 62.4, 48.4, 43.0, 13.8; IR (thin film, cm
-1
): 1727, 1670, 
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1603, 1488, 1444, 1365, 1254, 1091, 1036, 932, 809, 753, 700; TLC (20% EtOAc/hexanes) 
Rf
 
: 0.29; HRMS (ESI): Calculated for [M+H]
+
 C20H19O6: 355.1182, Found: 355.1179. 
 
Ethyl 3-(4-chlorophenyl)-2,5-dioxo-5-phenylpentanoate (4.23g): 
The title compound was prepared according to General Procedure B. Flash 
chromatography (20% EtOAc/hexanes) provided 4.23g (0.648 g, 1.88 
mmol, 94% yield) as a clear oil. Analytical data for 4.23g: 
1
H NMR (600 
MHz, CDCl3):  7.94 (d, J = 8.0 Hz, 2H), 7.59-7.56 (m, 1H), 7.48-7.44 (m, 2H), 7.33 (d, J = 
8.4 Hz, 2H), 7.29 (d, J = 8.4 Hz, 2H), 5.13 (dd, J = 10.4 Hz, 4.0 Hz, 1H), 4.36-4.23 (m, 2H), 
3.99 (dd, J = 18.4 Hz, 10.4 Hz, 1H), 3.43 (dd, J = 18.4 Hz, 4.0 Hz, 1H), 1.33 (t, J = 7.2 Hz); 
13
C NMR (150 MHz, CDCl3):  197.1, 191.8, 160.2, 135.7, 134.0, 133.9, 133.6, 130.2, 
129.3, 128.7, 128.2, 62.7, 47.7, 43.1, 13.9; IR (thin film, cm
-1
): 2983, 1729, 1681, 1596, 
1490, 1449, 1273, 1207, 1092, 1037, 761, 688, 563;TLC (20% EtOAc/hexanes) Rf
 
: 0.38; 
HRMS (ESI): Calculated for [M+H]
+
 C19H18ClO4: 345.0894, Found: 345.0894. 
 
Ethyl 3-(4-methoxyphenyl)-2,5-dioxo-5-phenylpentanoate (4.23h): 
The title compound was prepared according to General Procedure B. Flash 
chromatography (20% EtOAc/hexanes) provided 4.23h (0.653 g, 1.92 
mmol, 96% yield) as a clear oil. Analytical data for 4.23h: 
1
H NMR (600 
MHz, CDCl3):  7.95 (d, J = 7.2 Hz, 2H), 7.58-7.55 (m, 1H), 7.47-7.43 (m, 2H), 7.26 (d, J = 
8.8 Hz, 2H), 6.88 (d, J = 8.8 Hz, 2H), 5.10 (dd, J = 10.4 Hz, 4.0 Hz, 1H), 4.34-4.21 (m, 2H), 
3.99 (dd, J = 18.4 Hz, 10,4 Hz, 1H), 3.79 (s, 3H), 3.40 (dd, 18.4 Hz, 4.0 Hz, 1H), 1.31 (t, J = 
7.2 Hz); 
13
C NMR (150 MHz, CDCl3):  197.5, 192.1, 160.4, 159.3, 136.0, 133.4, 130.0, 
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128.6, 128.1, 126.9, 114.5, 62.4, 55.2, 47.5, 42.9, 13.9; IR (thin film, cm
-1
): 2982, 2837, 
1728, 1681, 1609, 1511, 1449, 1361, 1255, 1180, 1095, 1036, 833, 796, 690, 552; TLC (20% 
EtOAc/hexanes) Rf
 
: 0.23; HRMS (ESI): Calculated for [M+H]
+
 C20H21O5: 341.1389, Found: 
341.1385. 
 
Ethyl 2,5-dioxo-5-phenyl-3-(o-tolyl)pentanoate (4.23i): 
The title compound was prepared according to General Procedure B. Flash 
chromatography (20% EtOAc/hexanes) provided 4.23i (0.454 g, 1.40 
mmol, 70% yield) as a clear oil. Analytical data for 4.23i: 
1
H NMR (600 
MHz, CDCl3):  7.95 (d, J = 7.2 Hz, 2H), 7.58-7.55 (m, 1H), 7.46-7.44 (m, 2H), 7.25-7.24 
(m, 1H), 7.21-7.15 (m, 2H), 7.07-7.06 (m, 1H), 5.38 (dd, J = 10.2 Hz, 3.6 Hz, 1H), 4.25-4.11 
(m, 2H), 3.93 (dd, J = 18.0 Hz, 10.2 Hz, 1H), 3.27 (dd, J = 18.0 Hz, 3.6 Hz, 1H), 2.54 (s, 
3H), 1.26 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  197.3, 192.3, 160.5, 137.1, 
136.0, 133.8, 133.4, 131.3, 128.6, 127.8, 127.5, 126.5, 62.4, 44.5, 42.2, 19.7, 13.8; IR (thin 
film, cm
-1
): 2982, 2359, 1727, 1683, 1596, 1490, 1448, 1359, 1240, 1094, 1038, 757, 689; 
TLC (20% EtOAc/hexanes) Rf
 
: 0.38; HRMS (ESI): Calculated for [M+H]
+
 C20H21O4: 
325.1440, Found: 325.1449. 
 
Ethyl 2,5-dioxo-5-phenyl-3-(m-tolyl)pentanoate (4.23j): 
The title compound was prepared according to General Procedure B. Flash 
chromatography (20% EtOAc/hexanes) provided 4.23j (0.603 g, 1.86 
mmol, 93% yield) as a clear oil. Analytical data for 4.23j: 
1
H NMR (600 
MHz, CDCl3):  7.96 (d, J = 7.2 Hz, 2H), 7.58-7.56 (m, 1H), 7.46-7.44 (m, 2H), 7.24-7.23 
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(m, 1H), 7.15-7.14 (m, 2H), 7.11-7.10 (m, 1H), 5.12 (dd, J = 10.8 Hz, 3.6 Hz, 1H), 4.34-4.24 
(m, 2H), 4.03 (dd, J = 18.6 Hz, 10.8 Hz, 1H), 3.41 (dd, J = 18.6 Hz, 3.6 Hz, 1H), 2.34 (s, 
3H), 1.31 (t, J = 6.6 Hz, 3H) ; 
13
C NMR (150 MHz, CDCl3):  197.4, 192.2, 160.3, 138.8, 
136.0, 135.2, 133.4, 129.4, 129.0, 128.7, 128.6, 128.1, 125.9, 62.4, 48.3, 43.1, 21.3, 13.9; IR 
(thin film, cm
-1
): 2982, 1730, 1681, 1596, 1491, 1449, 1358, 1240, 1095, 1038, 757, 689, 
560; TLC (20% EtOAc/hexanes) Rf
 
: 0.40; HRMS (ESI): Calculated for [M+H]
+
 C20H21O4: 
325.1440, Found: 325.1441. 
 
Ethyl 2,5-dioxo-5-phenyl-3-(p-tolyl)pentanoate (4.23k): 
The title compound was prepared according to General Procedure B. Flash 
chromatography (20% EtOAc/hexanes) provided 4.23k (0.615 g, 1.90 
mmol, 95% yield) as a clear oil. Analytical data for 4.23k: 
1
H NMR (600 
MHz, CDCl3):  7.95 (d, J = 7.8 Hz, 2H), 7.58-7.55 (m, 1H), 7.46-7.44 (m, 2H), 7.23 (d, J = 
8.4 Hz, 2H), 7.16 (d, J = 8.4 Hz, 2H), 5.12 (dd, J = 10.8 Hz, 3.6 Hz, 1H), 4.33-4.23 (m, 2H), 
4.01 (dd, J = 18.0 Hz, 10.8 Hz, 1H), 3.40 (dd, J = 18.0 Hz, 3.6 Hz, 1H), 2.33 (s, 3H), 1.31 (t, 
J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  197.4, 192.2, 160.4, 137.8, 136.0, 133.4, 
132.2, 129.8, 128.7, 128.6, 128.1, 62.4, 48.0, 43.0, 21.0, 13.9; IR (thin film, cm
-1
): 2983, 
1727, 1682, 1512, 1449, 1273, 1204, 1095, 1038, 764, 689, 544; TLC (20% EtOAc/hexanes) 
Rf
 
: 0.37; HRMS (ESI): Calculated for [M+H]
+
 C20H21O4: 325.1440, Found: 325.1440. 
 
Diethyl 2-oxo-3-(2-oxo-2-phenylethyl)succinate (4.23l): 
The title compound was prepared according to General Procedure B. Flash 
chromatography (20% EtOAc/hexanes) provided 4.23l (0.563 g, 1.84 
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mmol, 92% yield) as a clear oil. Analytical data for 4.23l: 
1
H NMR (400 MHz, CDCl3):  
12.89 (s, 1H), 7.96 (d, J = 8.0 Hz, 2H), 7.60-7.56 (m, 1H), 7.48-7.45 (m, 2H), 4.91 (dd, J = 
9.2 Hz, 4.4 Hz, 1H), 4.43-4.37 (m, 2H), 4.25-4.18 (m, 2H), 3.79 (dd, J = 18.0 Hz, 9.2 Hz, 
1H), 3.67 (dd, 18.0 Hz, 4.4 Hz, 1H), 1.40 (t, J = 8.0 Hz, 3H), 1.24 (t, J = 7.2 Hz, 3H); 
13
C 
NMR (100 MHz, CDCl3):  196.2, 188.5, 168.3, 160.2, 135.6, 133.7, 133.1, 128.7, 128.6, 
128.2, 128.0, 62.8, 62.1, 48.2, 37.6, 35.8, 14.0, 13.9; IR (thin film, cm
-1
): 2983, 2936, 1731, 
1683, 1597, 1449, 1368, 1256, 1097, 1042, 859, 760, 690; TLC (20% EtOAc/hexanes) Rf
 
: 
0.26; HRMS (ESI): Calculated for [M+H]
+
 C16H19O6: 307.1182, Found: 307.1190. 
 
Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-2,5-dioxo-5-phenylpentanoate (4.23m): 
The title compound was prepared according to General Procedure B. Flash 
chromatography (20% EtOAc/hexanes) provided 4.23m (0.665 g, 1.88 
mmol, 94% yield) as a clear oil. Analytical data for 4.23m: 
1
H NMR (600 
MHz, CDCl3):   7.95 (d, J = 7.8 Hz, 2H), 7.58-7.56 (m, 1H), 7.47-7.44 (m, 2H), 6.83 (s, 
1H), 6.80-6.76 (m, 2H), 5.95 (s, 2H), 5.06 (dd, J = 10.8 Hz, 3.6 Hz, 1H), 4.35-4.25 (m, 2H), 
3.96 (dd, J = 18.0 Hz, 10.8 Hz, 1H), 3.40 (dd, J = 18.0 Hz, 3.6 Hz, 1H), 1.33 (t, J = 7.2 Hz, 
3H); 
13
C NMR (150 MHz, CDCl3):  197.4, 191.9, 160.4 148.2, 147.4, 135.9, 133.5, 128.6, 
128.1, 122.4, 109.1, 108.8, 101.2, 62.5, 47.9, 43.0, 13.9; IR (thin film, cm
-1
): 2984, 2905, 
1727, 1681, 1596, 1504, 1486, 1447, 1361, 1247, 1232, 1095, 1037, 930, 859, 811, 765, 689; 
TLC (20% EtOAc/hexanes) Rf
 
: 0.28; HRMS (ESI): Calculated for [M+H]
+
 C20H19O6: 
355.1182, Found: 355.1185. 
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Tert-butyl 3-(1-ethoxy-1,2,5-trioxo-5-phenylpentan-3-yl)-1H-indole-1-carboxylate 
(4.23n): 
The title compound was prepared according to General Procedure B. Flash 
chromatography (20% EtOAc/hexanes) provided 4.23n (0.628 g, 1.40 
mmol, 70% yield) as a yellow solid. Analytical data for 4.23n: 
1
H NMR 
(400 MHz, CDCl3):   8.17 (d, J = 7.6 Hz, 1H), 7.96 (d, J = 7.6 Hz, 2H), 7.75-7.73 (m, 1H), 
7.59-7.55 (m, 1H), 7.52 (s, 1H), 7.47-7.7.43 (m, 2H), 7.38-7.34 (m, 1H), 7.31-7.27 (m, 1H), 
5.42 (dd, J = 10.8 Hz, 3.6 Hz, 1H), 4.30-4.26 (m, 2H), 4.11 (dd, J = 18.4 Hz, 10.8 Hz, 1H), 
3.54 (dd, J = 18.4 Hz, 3.6 Hz, 1H), 1.67 (s, 9H), 1.29 (t, J = 7.2 Hz, 3H); 
13
C NMR (100 
MHz, CDCl3):  197.4, 191.3, 160.4, 149.2, 135.7, 135.6, 133.5, 128.9, 128.6, 128.1, 124.9, 
124.6, 122.9, 119.3, 115.3, 114.6, 84.0, 62.6, 42.1, 39.0, 28.1, 13.8; IR (thin film, cm
-1
): 
2984, 2905, 1727, 1681, 1596, 1504, 1486, 1447, 1361, 1247, 1232, 1095, 1037, 930, 859, 
811, 765, 689; TLC (20% EtOAc/hexanes) Rf
 
: 0.37; HRMS (ESI): Calculated for [M+H]
+
 
C26H28NO6: 450.1916, Found: 450.1923. 
 
Preparation of m-Terphenyl Sulfonyl Chloride S1 
 
 
To a flame-dried 50-mL round-bottomed flask equipped with a magnetic stir bar and rubber 
septum were added 1,3-dichlorobenezne (1.47 g, 10.0 mmol, 1.0 equiv) and THF (25 mL). 
The solution was cooled to -78 ºC and nBuLi (1.6 M in hexanes, 11.0 mmol, 1.1 equiv) was 
added dropwise over 10 min. The resultant white slurry was stirred at -78 ºC for 1.5 hrs. 
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While being kept at -78 ºC, this reaction mixture was then added to a room temperature 
solution of phenylmagnesium bromide [prepared from bromobenzne (3.14 g, 20.0 mmol, 2.0 
equiv) and magnesium (578 mg, 24.0 mmol, 2.4 equiv)] in 30 mL of THF via cannula. The 
mixture was heated at reflux overnight, cooled to ambient temperature, and then to -78 ºC. 
Sulfuryl chloride (1 M in CH2Cl2, 20.0 mmol, 2.0 equiv) was added via syringe in a single 
portion and the reaction was warmed slowly to room temperature overnight. After being 
cooled to 0 ºC, the reaction mixture was diluted with 1 M HCl and extracted three times with 
diethyl ether. The combined organic extracts were washed with brine, dried over sodium 
sulfate and concentrated in vacuo. The crude brown solid was recrystallized from hexanes 
and CHCl3 to give the desired sulfonyl chloride (2.0 g, 6.1 mmol, 61% yield) whose spectral 
properties matched those reported in the literature.
34 
 
Preparation of L14 
 
A 10-mL round-bottomed flask equipped with a magnetic stir bar was charged with (1S,2S)-
1,2-di(1-naphthyl)-1,2-ethanediamine dihydrochloride (250 mg, 0.649 mmol, 1.0 equiv). 
Dichloromethane (3 mL) and 2 M NaOH (3 mL) were added sequentially and the biphashic 
mixture was cooled to 0 ºC. m-Terphenyl sulfonyl chloride S1 (213 mg, 0.649 mmol, 1.0 
equiv) was added and the reaction was warmed to room temperature and stirred for 3 h. The 
reaction mixture was diluted with ethyl acetate and water. The organic was washed with 
brine, dried over sodium sulfate and concentrated in vacuo. Flash chromatography (50% 
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EtOAc/hexanes) provided L14 (330 mg, 0.545 mmol, 84% yield) as a white solid. Analytical 
data for L14: 
1
H NMR (400 MHz, CDCl3):  8.07 (d, J = 8.0 Hz, 1H), 7.78 (d, J = 8.0 Hz, 
1H), 7.74 (d, J = 7.6 Hz, 1H), 7.72-7.67 (m, 2H), 7.66-7.02 (m, 20H), 6.97 (bs, 1H), 6.72 (bs, 
1H), 5.57 (d, J = 6.4 Hz, 1H), 4.95 (d, J = 7.6 Hz), 4.68 (bs, 1H), 1.75 (bs, 2H); 
13
C NMR 
(100 MHz, CDCl3):  141.9, 140.9, 139.7, 137.8, 135.3, 133.8, 133.6, 131.6, 131.0, 130.7, 
130.0, 129.2, 128.8, 128.6, 128.2, 127.9, 127.7, 127.7, 126.1, 126.0, 125.4, 125.3, 125.1, 
125.0, 124.3, 123.6, 122.9, 122.4; IR (thin film, cm
-1
): 2926, 2357, 1868, 1716, 1608, 1541, 
1507, 1456, 1338, 1158, 1028, 929, 778, 759, 700, 664, 592, 529; m.p. 158-160 ºC; TLC 
(50% EtOAc/hexanes) Rf
 
: 0.25; LRMS (ESI): Calculated for [M+H]
+
 C40H33N2O2S: 605.23, 
Found: 605.29; []D
25
 +170.6 (c = 1.30, CHCl3). 
 
General Procedure C for the Preparation of Racemic -Butyrolactones 4.16a-4.17k 
 
 
 
Sodium borohydride (1.0 equiv) was added to a solution of -aryl -keto ester (1.0 equiv) in 
methanol (0.5 M concentration) at room temperature. When gas evolution ceased, 1 mL 
saturated ammonium chloride was added. The reaction was further diluted with diethyl ether 
and water. The organic layer was washed with brine, dried over sodium sulfate and 
concentrated in vacuo to give a mixture of -hydroxy ester and -butyrolactone. The crude 
reaction mixture was dissolved in tetrahydrofuran (0.5 M concentration) and formic 
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acid:triethylamine 5:2 azeotrope (1.0 equiv) was added. The reaction heated at 70 ºC for 1 
hour, at which point the reaction mixture was allowed to cool to ambient temperature and 
diluted with diethyl ether and water. The organic layer was washed with brine and dried over 
sodium sulfate. Concentration in vacuo afforded the -butyrolatones which were purified by 
flash chromatography using the indicated solvent systems. 
 
General Procedure D for the ATH-DKR of -Aryl -Keto Esters 
 
 
 
To a flame-dried 1-dram vial equipped with a magnetic stir bar were added [RuCl2(p-
cymene)]2 (0.02 equiv) and ligand (0.08 equiv). The vial was sealed with a rubber septum 
and purged with nitrogen. DMF (0.5 mL) was added and the rubber septum was quickly 
replaced with a PTFE-lined screw cap. The mixture was heated at 70 ºC for 30 min and 
cooled to ambient temperature. A solution of -aryl -keto ester (1.0 equiv in 1.0 mL DMF) 
followed by formic acid:triethylamine 5:2 azeotrope (5.0 equiv) were added. The vial was 
purged with nitrogen and the reaction was heated at 70 ºC for 16 h, at which point the 
reaction mixture was allowed to cool to ambient temperature and diluted with ethyl acetate 
and water. The organic layer was washed with water (x2), brine, and dried over sodium 
sulfate. Concentration in vacuo afforded the -butyrolactones which were purified by flash 
chromatography using the indicated solvent systems. 
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 (2R,3R,4R)-2-ethyl 4-methyl 5-oxo-3-phenyltetrahydrofuran-2,4-dicarboxylate (4.17a): 
 The title compound was prepared according to General Procedure D using 
-aryl -keto ester 4.16a (50 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash 
chromatography (20% EtOAc/hexanes) provided -butyrolactone 4.17a (42.0 mg, 0.143 
mmol, 92% yield) as a white solid. Analytical data for 4.17a: 
1
H NMR (600 MHz, CDCl3):  
7.35-7.32 (m, 3H), 7.22-7.20 (m, 2H), 5.18 (d, J = 8.4 Hz, 1H),  4.52 (dd, J = 12, 8.4 Hz, 
1H), 4.25 (d, J = 12 Hz, 1H), 3.92-3.87 (m, 1H), 3.87 (s, 3H), 3.86-3.74 (m, 1H), 0.84 (t, J = 
7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  170.5, 167.7, 167.2, 132.6, 129.0, 128.7, 127.4, 
78.9, 61.7, 53.4, 48.7, 47.8, 13.5; IR (thin film, cm
-1
): 2963, 1797, 1742, 1455, 1437, 1382, 
1280, 1218, 1133, 1075, 994, 940, 751, 699; m.p. 100-102 ºC; TLC (20% EtOAc/hexanes) 
Rf
 
:0.26; LRMS (ESI): Calculated for [M+H]
+
 C15H17O6: 293.10, Found: 293.16  SFC 
Analysis: WO column, 2% MeOH, 1.5 mL/min, 150 bar, 210 nm; tminor = 12.5 min tmajor = 
14.5, 95:5 er; []D
25
 -150.9 (c = 1.70, CHCl3). 
 
(2R,3R,4R)-2-ethyl 4-methyl 3-(4-chlorophenyl)-5-oxotetrahydrofuran-2,4-
dicarboxylate (4.17b):  
The title compound was prepared according to General Procedure D using 
-aryl -keto ester 4.16b (55 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 
equiv). Flash chromatography provided -butyrolactone 4.17b (47.6 mg, 0.146 mmol, 94% 
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yield) as a white solid. Analytical data for 4.17b: 
1
H NMR (400 MHz, CDCl3):  7.34 (d, J = 
8.8 Hz, 2H), 7.16 (d, J = 8.8 Hz, 2H), 5.16 (d, J = 8.4 Hz, 1H), 4.48 (dd, J = 11.2, 8.4 Hz, 
1H), 4.18 (d, J = 11.2 Hz, 1H), 3.98-3.90 (m, 1H), 3.87-3.82 (m, 1H), 3.81 (s, 3H), 0.92 (t, J 
= 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  170.0, 167.6, 167.0, 134.8, 131.3, 129.6, 
129.2, 128.9, 128.5, 78.6, 61.9, 53.5, 48.9, 47.2, 13.6; IR (thin film, cm
-1
): 2957, 1796, 1741, 
1437, 1382, 1302, 1213, 1128, 1060, 840, 708, 564; m.p. 94-94 ºC; TLC (20% 
EtOAc/hexanes) Rf
 
: 0.31; LRMS (ESI): Calculated for [M+H]
+
 C15H16ClO6: 327.06, Found: 
327.10; SFC Analysis: WO column, 2% MeOH, 1.5 mL/min, 150 bar, 210 nm; tminor = 13.4 
min tmajor = 17.3, 96:4 er; []D
25
 -143.1 (c = 1.5, CHCl3). 
 
(2R,3R,4R)-2-ethyl 4-methyl 5-oxo-3-(p-tolyl)tetrahydrofuran-2,4-dicarboxylate (4.17c):  
The title compound was prepared according to General Procedure D using 
-aryl -keto ester 4.16c (52 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 
equiv). Flash chromatography provided -butyrolactone 4.17c (40 mg, 0.130 mmol, 84% 
yield) as a white solid. Analytical data for 4.17c:
 1
H NMR (400 MHz, CDCl3):  7.15 (d, J = 
8.0 Hz, 2H), 7.09 (d, J = 8.0 Hz, 2H), 5.15 (d, J = 8.8 Hz, 1H), 4.47 (dd, J = 11.2, 8 Hz, 1H), 
4.21 (d, J = 11.2 Hz, 1H), 3.93-3.89 (m, 1H), 3.82-3.78 (m, 1H), 3.79 (s, 3H), 0.88 (t, J = 7.2 
Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  170.5, 167.8, 167.3, 138.5, 129.6, 127.3, 79.0, 
61.7, 53.3, 49.0, 47.6, 21.0, 13.5; IR (thin film, cm
-1
): 2957, 1796, 1742, 1519, 1438, 1381, 
1306, 1213, 1131, 1058, 828, 517; m.p. 85-86 ºC; TLC (30% EtOAc/hexanes) Rf
 
: 0.38; 
LRMS (ESI): Calculated for [M+H]
+
 C16H19O6: 307.12, Found: 307.16; HPLC Analysis: 
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Chiralpak IB,10% 
i
PrOH/hexanes, constant flow at 1.00 mL/min, 210 nm; tminor = 12.5 min 
tmajor = 15.8 min, 95.5:4.5 er; []D
25
 -191.3 (c = 1.7, CHCl3). 
 
(2R,3R,4R)-2-ethyl 4-methyl 3-(4-methoxyphenyl)-5-oxotetrahydrofuran-2,4-
dicarboxylate (4.17d):  
The title compound was prepared according to General Procedure D using 
-aryl -keto ester 4.16d (55 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 
equiv). Flash chromatography provided -butyrolactone 4.17d (45 mg, 0.140 mmol, 90% 
yield) as a white solid. Analytical data for 2d: 
1
H NMR (600 MHz, CDCl3):  7.13 (d, J = 
9.0 Hz, 2H), 6.87 (d, J = 9.0 Hz, 2H), 5.14 (d, J = 8.4 Hz, 1H), 4.45 (dd, J = 11.4, 8.4 Hz, 
1H), 4.19 (d, J = 11.4 Hz, 1H), 3.95-3.80 (m, 1H), 3.84-3.8 (m, 1H), 3.79 (s, 3H), 3.78 (s, 
3H), 0.93 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  170.5, 167.8, 167.3, 159.8, 
128.6, 124.5, 114.3, 79.0, 61.7, 55.3, 53.4, 49.1, 47.2, 13.6; IR (thin film, cm
-1
): 2958, 1796, 
1742, 1613, 1518, 1440, 1382, 1256, 1218, 1182, 1132, 1096, 1058, 1030, 835, 750, 683; 
m.p. 106-107 ºC; TLC (30% EtOAc/hexanes) Rf
 
: 0.31; LRMS (ESI): Calculated for 
[M+Na] C16H18O7Na: 345.10, Found: 345.18; HPLC Analysis: Chiralpak IB,10% 
i
PrOH/hexanes, constant flow at 1.00 mL/min, 210 nm; tminor = 18.7 min tmajor = 23.6 min, 
95:5 er; []D
25
 -179.2 (c = 1.9, CHCl3).  
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(2R,3R,4R)-2-ethyl 4-methyl 3-(4-cyanophenyl)-5-oxotetrahydrofuran-2,4-dicarboxylate 
(4.17e): 
 The title compound was prepared according to General Procedure D using 
-aryl -keto ester 4.16e (54 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 
equiv). Flash chromatography provided -butyrolactone 4.17e (43 mg, 0.136 mmol, 88% 
yield) as a white solid. Analytical data for 4.17e: 
1
H NMR (400 MHz, CDCl3):  7.67 (d, J = 
8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 5.21 (d, J = 8.8 Hz, 1H), 4.56 (dd, J = 11.2, 8.8 Hz, 
1H), 4.21 (d, J = 11.2 Hz, 1H), 3.96-3.90 (m, 1H), 3.85-3.79 (m, 1H), 3.82 (s, 3H), 0.90 (t, J 
= 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  169.4, 167.3, 166.7, 138.2, 132.7, 128.4, 
117.9, 112.8, 78.1, 62.1, 53.6, 48.6, 47.6, 13.6; IR (thin film, cm
-1
): 2360, 2333, 1796, 1742, 
1312, 1271, 1134, 995, 836, 670; m.p. 104-107 ºC; TLC (30% EtOAc/hexanes) Rf
 
: 0.25; 
LRMS (ESI): Calculated for [M+Na] C16H15NO6Na: 340.08, Found: 340.18; HPLC 
Analysis: Chiralpak IB, 25% 
i
PrOH/hexanes, constant flow at 1.00 mL/min, 210 nm; tminor = 
18.6 min tmajor = 22.4 min, 95:5 er; []D
25
 -177.4 (c = 1.7, CHCl3). 
 
(2R,3R,4R)-2-ethyl 4-methyl 5-oxo-3-(o-tolyl)tetrahydrofuran-2,4-dicarboxylate (4.17f): 
 The title compound was prepared according to General Procedure D using 
-aryl -keto ester 4.16f (52 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash 
chromatography provided -butyrolactone 4.17d (39 mg, 0.127 mmol, 82% yield) as a white 
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solid. Analytical data for 4.17f:
 1
H NMR (400 MHz, CDCl3):  7.23-7.21 (m, 2H), 7.19-7.16 
(m, 1H), 7.09-7.07 (m, 1H), 5.24 (d, J = 8.8 Hz, 1H), 4.72 (dd, J = 12, 8.8 Hz, 1H), 4.34 (d, J 
= 12 Hz, 1H), 3.86-3.81 (m, 1H), 3.79 (s, 3H), 3.74-3.7 (m, 1H), 0.80 (t, J = 7.2 Hz, 3H); 
13
C 
NMR (100 MHz, CDCl3):  170.5, 167.7, 167.3, 137.4, 131.0, 130.7, 128.5, 126.5, 125.0, 
77.3, 61.6, 53.3, 48.3, 44.8, 19.6, 13.4; IR (thin film, cm
-1
): 2359, 2341, 1797, 1742, 1440, 
1381, 1317, 1212, 1135, 1021, 752, 538; m.p. 103-104 ºC; TLC (20% EtOAc/hexanes) Rf
 
: 
0.29; LRMS (ESI): Calculated for [M+H]
+
 C16H19O6: 307.12, Found: 307.16; HPLC 
Analysis: Chiralpak IB, 10% 
i
PrOH/hexanes, constant flow at 1.00 mL/min, 210 nm; tminor = 
12.1 min tmajor = 15.0 min, 89:11 er; []D
25
 -136.4 (c = 1.4, CHCl3).  
 
(2R,3R,4R)-2-ethyl 4-methyl 3-(benzo[d][1,3]dioxol-5-yl)-5-oxotetrahydrofuran-2,4-
dicarboxylate (4.17g):  
The title compound was prepared according to General Procedure D using 
-aryl -keto ester 4.16g (57 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 
equiv). Flash chromatography provided -butyrolactone 4.17d (43 mg, 0.129 mmol, 83% 
yield) as a white solid. Analytical data for 4.17g: 
1
H NMR (400 MHz, CDCl3):6.77 (d, J = 
8.4 Hz, 1H), 6.68-6.67 (m, 2H), 5.96 (s, 2H), 5.12 (d, J = 8.4 Hz, 1H), 4.41 (dd, J = 11.6, 8.4 
Hz, 1H), 4.14 (d, J = 11.6 Hz, 1H), 4.05-3.87 (m, 2H), 3.80 (s, 3H), 0.98 (t, J = 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  170.3, 167.7, 167.2, 148.2, 147.9, 126.2, 120.9, 108.6, 
107.8, 101.4, 78.9, 61.8, 53.3, 49.2, 47.7, 13.7; IR (thin film, cm
-1
): 2906, 2363, 2349, 1797, 
1740, 1506, 1494, 1446, 1304, 1256, 1237, 1142, 1093, 1037, 931, 801; m.p. 86-87 ºC; TLC 
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(30% EtOAc/hexanes) Rf
 
: 0.31; LRMS (ESI): Calculated for [M+H]
+
 C16H17O8: 337.09, 
Found: 337.09; HPLC Analysis: Chiralpak IB, 10% 
i
PrOH/hexanes, constant flow at 1.00 
mL/min, 210 nm; tminor = 21.8 min tmajor = 25.8 min, 96:4 er; []D
25
 -206.3 (c = 2.1, CHCl3). 
 
(2R,3S,4R)-2-ethyl 4-methyl 3-(furan-2-yl)-5-oxotetrahydrofuran-2,4-dicarboxylate 
(4.17h):  
The title compound was prepared according to General Procedure D using 
-aryl -keto ester 4.16h (48 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash 
-butyrolactone 4.17h (40 mg, 0.141 mmol, 91% yield) as a clear 
oil. Analytical data for 4.17h: 
1
H NMR (400 MHz, CDCl3):  7.38-7.37 (m, 1H), 6.34-6.33 
(m, 1H), 6.28-6.27 (m, 1H), 5.14 (d, J = 8.4 Hz, 1H), 4.56 (dd, J = 11.6, 8.4 Hz, 1H), 4.16 (d, 
J = 11.6, 1H), 4.10-4.04 (m, 1H), 3.99-3.92 (m, 1H), 3.82 (s, 3H), 1.09 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  169.6, 167.6, 166.8, 146.7, 143.2, 110.7, 109.0, 77.2, 62.2, 
53.5, 48.2, 41.9, 13.7; IR (thin film, cm
-1
): 2963, 1797, 1743, 1440, 1382, 1305, 1215, 1133, 
1061, 841, 708, 560; TLC (20% EtOAc/hexanes) Rf
 
: 0.21; LRMS (ESI): Calculated for 
[M+H]
+
 C13H15O7: 283.08, Found: 283.03; HPLC Analysis: Chiralpak IA, 10% 
i
PrOH/hexanes, constant flow at 1.00 mL/min, 210 nm; tminor = 11.4 min tmajor =  12.5 min, 
95:5 er; []D
25
 -52.3 (c = 1.2, CHCl3). 
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 (2R,3R,4R)-2-ethyl 4-methyl 5-oxo-3-(1-tosyl-1H-indol-3-yl)tetrahydrofuran-2,4-
dicarboxylate (4.17i):  
The title compound was prepared according to General Procedure D using 
-aryl -keto ester 4.16i (80 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash 
chromatography provided -butyrolactone 4.17i (68 mg, 0.141 mmol, 91% yield) as a white 
solid. Analytical data for 4.17i: 
1
H NMR (400 MHz, CDCl3):  7.99 (d, J = 8.4 Hz, 1H), 7.76 
(d, J = 8.4 Hz, 2H), 7.52 (d, J = 7.6 Hz, 1H), 7.42 (s, 1H), 7.37-7.35 (m, 1 H), 7.32-7.30 (m, 
1H), 7.54-7.23 (m, 1H), 5.30 (d, J = 8.4 Hz, 1H), 4.64 (dd, J =11.6, 8.4 Hz, 1H), 4.20 (d, J = 
11.6 Hz, 1H), 3.82 (s, 3H), 3.64-3.56 (m, 1H), 3.36-3.28 (m, 1H), 2.35 (s, 3H), 0.41 (t, J = 
6.8 Hz, 3H);  
13
C NMR (150 MHz, CDCl3):  169.8, 167.6, 167.0, 145.3, 135.0, 134.8, 
130.0, 129.2, 126.9, 125.6, 123.6, 123.4, 119.5, 115.5, 113.7, 77.6, 61.4, 53.5, 48.4, 39.9, 
30.2, 21.5, 12.9; IR (thin film, cm
-1
): 2978, 2348, 1800, 1742, 1595, 1449, 1373, 1290, 1215, 
1175, 1139, 1092, 1075, 1021, 974, 912, 816, 762, 747, 703, 680, 655; m.p. 99-100 ºC TLC 
(30% EtOAc/hexanes) Rf
 
: 0.28; LRMS (ESI): Calculated for [M+Na] C24H23NO8SNa: 
508.10, Found: 508.10; SFC Analysis: WO column, 10% MeOH, 1.5 mL/min, 150 bar 210 
nm; tminor = 16.5 min tmajor = 22.5 min, 96.5:3.5 er; []D
25
 -81.2 (c = 1.7, CHCl3). 
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(2R,3R,4R)-2-ethyl 4-methyl 3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)-5-
oxotetrahydrofuran-2,4-dicarboxylate (4.17j):  
The title compound was prepared according to General Procedure D using 
-aryl -keto ester 4.16j (71.5 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash 
chromatography provided -butyrolactone 4.17j (59 mg, 0.136 mmol, 88% yield) as a white 
solid. Analytical data for 4.17j: 
1
H NMR (400 MHz, CDCl3):  8.11 (d, J = 8.4 Hz, 1H), 
7.57-7.55 (m, 1H), 7.44 (s, 1H), 7.37-7.30 (m, 2H), 5.35 (d, J = 8.4 Hz, 1H), 4.70 (dd, J 
=11.6, 8.4 Hz, 1H), 4.24 (d, J = 11.6, 1H), 3.85-3.80 (m, 2H), 3.82 (s, 3H), 0.69 (t, J = 6.8 
Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  170.1, 167.9, 167.2, 149.2, 135.4, 129.0, 125.3, 
123.2, 123.0, 118.9, 115.4, 113.5, 84.5, 77.9, 61.7, 53.4, 48.8, 40.0, 28.1, 13.2; IR (thin film, 
cm
-1
): 2979, 1800, 1739, 1454, 1375, 1338, 1310, 1273, 1258, 1220, 1155, 1078, 1018, 857, 
840, 763, 748; m.p. 84-85 ºC; TLC (30% EtOAc/hexanes): Rf
 
: 0.4; LRMS (ESI): 
Calculated for [M+H]
+
 C22H26NO8: 432.17, Found: 432.18; HPLC Analysis: Chiralpak IB, 
10% 
i
PrOH/hexanes, constant flow at 1.0 mL/min, 210 nm; tminor = 11.7 min tmajor = 12.6 min, 
96:4 er; []D
25
 -75.7 (c =2.3, CHCl3). 
 
Large Scale Preparation of -Butyrolactone 4.17g 
To a flame-dried 250-mL round-bottomed flask were added [RuCl2(p-cymene)]2 (83.6 mg, 
0.137 mmol, 0.005 equiv), L14 (330 mg, 0.546 mmol, 0.020 equiv) and 50 mL of DMF. The 
mixture was heated at 70 ºC under nitrogen for 45 min and cooled to ambient temperature. A 
solution of -aryl -keto ester 4.16g (10.0 g, 27.3 mmol, 1.0 equiv) in 20 mL DMF was 
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added via syringe and the reaction mixture was further diluted with 66 mL DMF. Formic 
acid:triethylamine 5:2 azeotrope (11.8 g, 136.5 mmol, 5.0 equiv) was added in a single 
portion and the reaction was heated at 70 ºC for 16 h, at which point the reaction was cooled 
to ambient temperature and diluted with ethyl acetate and water. The aqueous layer was 
extracted with ethyl acetate (x2) and the combined organics were washed with water (x3) 
followed by brine (x1), dried over sodium sulfate and concentrated in vacuo. A 150-mL frit 
funnel (7 cm diameter) was charged with silica gel (4 cm in height). The crude reaction 
mixture was dissolved in the minimum amount of dichloromethane and passed through the 
pad of silica gel using 150 mL of 30% EtOAc/hexanes; the filtrate was concentrated in 
vacuo. The resultant residue was dissolved in the minimum amount of diethyl ether. Hexanes 
were added until the solution became cloudy. This solution was stored in the freezer 
overnight. The crystals were collected by filtration to yield enantiopure 4.17g (6.61 g, 19.6 
mmol, 72% yield). 
 
Preparation of -Butyrolactone 4.20 
 
 
 
 
 
To a 1-dram vial equipped with a magnetic stir bar were added 4.17a (29.2 mg, 0.100 mmol, 
1.0 equiv), allyl bromide (24.2 mg, 0.200 mmol, 2.0 equiv) and THF (1 mL). DBU (30.4 mg, 
0.200 mmol, 2.0 equiv) was added and the reaction was stirred at room temperature for 2 h 
and then diluted with water and ethyl acetate. The organic was washed with water followed 
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by brine, dried over sodium sulfate and concentrated in vacuo. Flash chromatography 
provided 4.20 (31.2 mg, 0.940 mmol, 94% yield) as a white solid. Analytical data for 3a: 
1
H 
NMR (600 MHz, CDCl3):  7.25-7.24 (m, 3H), 7.15-7.13 (m, 2H), 5.90-5.85 (m, 1H), 5.35-
5.30 (m, 2H), 5.22 (d, J = 7.2 Hz, 1H), 3.91-3.81 (m, 2H), 3.89 (d, J = 7.2 Hz, 1H), 3.22 (s, 
3H), 2.97 (dd, J = 14.1, 7.2 Hz, 1H), 2.85 (dd, J = 14.1, 7.2 Hz, 1H), 0.83 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  171.6, 167.6, 166.3, 134.8, 130.5, 128.6, 128.4, 128.2, 
121.5, 77.3, 61.6, 60.4, 53.6, 52.1, 40.1, 13.5; IR (thin film, cm
-1
): 2921, 2359, 1797, 1759, 
1740, 1436, 1221, 1168, 1125, 1087, 1028, 929, 705; m.p. 100-101.5 ºC; TLC (20% 
EtOAc/hexanes) Rf
 
: 0.22; LRMS (ESI): Calculated for [M+H]
+
 C18H21O6: 333.13, Found: 
333.16; []D
25
 -35.5 (c =6.5, CHCl3). 
 
Preparation of -Butyrolactone 4.21 
 
 
 
To a 1-dram vial equipped with a magnetic stir bar were added 4.17a (45.0 mg, 0.155 mmol, 
1.0 equiv), lithium chloride (71.0 mg, 0.310 mmol, 2.0 equiv), and DMSO (1 mL). The vial 
was fitted with a PTFE screw-cap and heated in an oil bath at 140 ºC for 16 h, at which point 
the reaction was cooled to ambient temperature and diluted with water and ethyl acetate. The 
organic layer was washed with water (x2) followed by brine (x1), dried over sodium sulfate 
and concentrated in vacuo. Flash chromatography (20% EtOAc/hexanes) provided 4.21 (31.2 
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mg, 0.133 mmol, 86% yield) as a colorless oil. Analytical data for 3b: : 
1
H NMR (400 MHz, 
CDCl3):  7.36-7.30 (m, 3H), 7.22-7.20 (m, 2H), 5.13 (d, J = 8.4 Hz, 1H), 4.13-4.06 (m, 1H), 
3.91-3.83 (m, 1H), 3.80-3.72 (m, 1H), 3.09 (dd, J = 17.2, 10 Hz, 1H), 2.84 (dd, J = 17.2, 8.8 
Hz, 1H), 0.86 (t, J = 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  175.2, 167. 9, 134.9, 
128.8, 128.3, 127.5, 80.1, 61.4, 44.1, 32.2, 13.5; IR (thin film, cm
-1
): 2985, 2359, 2342, 
1793, 1742, 1498, 1455, 1381, 1214, 1151, 1094, 1074, 1051, 700, 544; TLC (20% 
EtOAc/hexanes) Rf
 
: 0.19; LRMS (ESI): Calculated for [M+H]
+
 C13H15O4: 235.10, Found: 
235.08; []D
25
 -68.4 (c =1.6, CHCl3). 
 
Preparation of -methylene -Butyrolactone 4.22 
 
 
 
To a flame-dried 1-dram vial equipped with a magnetic stir bar were added 4.17a (29.2 mg, 
0.100 mmol, 1.0 equiv) and dibromomethane (0.125 mL). 18-crown-6 (1.30 mg, 0.005 
mmol, 0.05 equiv) and potassium carbonate (35 mg, 0.25 mmol, 2.5 equiv) were added 
sequentially and the reaction was stirred at ambient temperature for 36 h. The reaction was 
diluted with water and ethyl acetate and the organic was washed with water followed by 
brine, dried over sodium sulfate and concentrated in vacuo. Flash chromatography (30% 
EtOAc/hexeanes) provided S2 (32 mg, 0.084 mmol, 84% yield) as a white solid. Analytical 
data for S2: 
1
H NMR (400 MHz, CDCl3):  7.28-7.26 (m, 3H), 7.17-7.15 (m, 2H), 5.42 (d, J 
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= 8.4 Hz, 1H), 4.20 (d, J = 8.4 Hz, 1H), 4.01 (d, J = 10.8 Hz, 1H), 3.94 (d, J = 10.8 Hz, 1H), 
3.92-3.86 (m, 2H), 3.30 (s, 3H), 0.84 (t, J = 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  
170.3, 166.2, 134.2, 128.9, 128.7, 128.3, 78.2, 61.8, 61.6, 52.8, 52.7, 33.2, 13.5; IR (thin 
film, cm
-1
): 2360, 1795, 1751, 1736, 1232, 1146, 1086, 1041, 709; m.p. 161-162 ºC; TLC 
(30% EtOAc/hexanes) Rf
 
: 0.32; LRMS (ESI): Calculated for [M+Na] C16H17BrO6Na: 
407.01, Found: 407.01; []D
25
 = -37.3 (c =2.0, CHCl3). 
To a 1-dram vial equipped with a magnetic stir bar were added S2 (26 mg, 0.067 mmol, 1.0 
equiv), lithium chloride (6.0 mg, 0.134 mmol, 2.0 equiv) and DMSO (1 mL). The vial was 
fitted with a PTFE screw-cap and heated in an oil bath at 140 ºC for 16 h, at which point the 
reaction was cooled to ambient temperature and diluted with water and ethyl acetate. The 
organic was washed with water (x2) followed by brine (x1), dried over sodium sulfate and 
concentrated in vacuo. Flash chromatography (20% EtOAc/hexanes) provided 4.22 (14 mg, 
0.057 mmol, 85% yield) as a white solid. Analytical data for 3c: 
1
H NMR (600 MHz, 
CDCl3):  7.33-7.30 (m, 3H), 7.21-7.19 (m, 2H), 6.54 (d, J = 3 Hz, 1H), 5.63 (d, J = 3 Hz, 
1H), 5.18 (d, J = 9 Hz, 1H), 4.62-4.59 (dt, J = 9.6, 3 Hz 1H), 3.85-3.80 (m, 1H), 3.68-3.63 
(m, 1H), 0.84 (t, J = 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): 169.3, 167.7, 135.8, 135.3, 
129.0, 128.8, 128.4, 125.1, 78.4, 61.5, 48.6, 13.5; ; IR (thin film, cm
-1
): 2983, 2359, 1780, 
1747, 1402, 1188, 1095, 1067, 757, 702; m.p. 113-114 ºC; TLC (20% EtOAc/hexanes) Rf
 
: 
0.25; LRMS (ESI): Calculated for [M+H]
+
 C14H15O4: 247.10, Found: 247.12; []D
25
 -62.3 (c 
=2.2, CHCl3). 
 
 
 
148 
 
General Procedure E for the ATH-DKR of -Substituted -Diketo Esters 
 
 
To a flame-dried 1-dram vial equipped with a magnetic stir bar were added [RuCl2(p-
cymene)]2 (0.02 equiv) and ligand (0.08 equiv). The vial was sealed with a rubber septum 
and purged with nitrogen. DMSO (0.5 mL) was added and the rubber septum was quickly 
replaced with a PTFE-lined screw cap. The mixture was heated at 70 ºC for 30 min and 
cooled to ambient temperature. A solution of -substituted -diketo ester (1.0 equiv in 1.0 
mL DMF) followed by formic acid:triethylamine 5:2 azeotrope (5.0 equiv) were added. The 
vial was purged with nitrogen and the reaction was stirred at room temperature for 1-2 hours 
and diluted with ethyl acetate and water. The organic layer was washed with water (x2), 
brine, and dried over sodium sulfate. Concentration in vacuo afforded the -hydroxy esters 
which were purified by flash chromatography using the indicated solvent systems. 
 
(2R,3R)-Ethyl 2-hydroxy-5-oxo-3,5-diphenylpentanoate (4.25a): 
The title compound was prepared according to General Procedure E using 
-diketo ester 4.23a (48.0 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 0.08 equiv), and 
HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash chromatography (20% 
EtOAc/hexanes) provided -hydroxy ester 4.25a (47 mg, 0.152 mmol, 98% yield) as a white 
solid. Analytical data for 4.25a: 
1
H NMR (600 MHz, CDCl3): 8.03 (d, J = 7.2 Hz, 2H), 
7.60-7.57 (m, 1H), 7.50-7.47 (m, 2H), 7.35-7.33 (m, 2H), 7.31-7.29 (m, 2H), 7.27-7.24 (m, 
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1H), 4.66 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 4.18-4.11 (m, 2H), 3.97 (ddd, 8.4 Hz, 6.0 Hz, 3.0 Hz, 
1H), 3.80 (dd, J = 8.4 Hz, 18.0 Hz, 1H), 3.47 (dd, J = 18.0 Hz, 6.0 Hz, 1H), 2.92 (d, J = 6.0 
Hz, 1H), 1.26 (t, J =7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  198.3, 173.6, 139.0, 136.9, 
133.2, 128.6, 128.6, 128.3, 128.0, 127.3, 72.5, 61.7, 43.6, 40.4, 14.1; IR (thin film, cm
-1
): 
3503, 3029, 2981, 1733, 1684, 1597, 1579, 1495, 1449, 1369, 1267, 1212, 1103, 1022, 753, 
703, 691, 554; m.p.; TLC (30% EtOAc/hexanes): Rf
 
: 0.37; HRMS (ESI): Calculated for 
[M+Na]
 
C19H20NaO4: 335.1259, Found: 335.1259; SFC Analysis: WO column, 5% MeOH, 
1.5 mL/min, 150 bar, 210 nm; tminor = 9.3 min tmajor = 10.1 min, 97:3 er; []D
25
 +30.56 (c = 
5.6, CHCl3). 
 
(2R,3R)-Ethyl 2-hydroxy-5-(4-iodophenyl)-5-oxo-3-phenylpentanoate (4.25b): 
The title compound was prepared according to General Procedure E 
using -diketo ester 4.23b (68.0 mg, 0.155 mmol, 1.0 equiv), 
[RuCl2(p-cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 0.08 
equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash 
chromatography (20% EtOAc/hexanes) provided -hydroxy ester 4.25b (62 mg, 0.141 
mmol, 91% yield) as a white solid. Analytical data for 4.25b: 
1
H NMR (600 MHz, CDCl3):  
7.84 (d, J = 8.4 Hz, 2H), 7.72 (d, J = 8.4 Hz, 2H), 7.33-7.26 (m, 4H), 7.25-7.24 (m, 1H), 4.55 
(dd, J = 6.0 Hz, 3.6 Hz, 1H), 4.17-4.10 (m, 2H), 3.94 (ddd, J = 8.4 Hz, 6.0 Hz, 3.6 Hz, 1H), 
3.73 (dd, J = 18.0 Hz, 8.4 Hz, 1H), 3.40 (dd, J = 18.0 Hz, 6.0 Hz, 1H), 2.93 (d, J = 6.0 Hz, 
1H), 1.26 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  197.6, 173.5, 138.7, 137.9, 
136.2, 129.4, 128.6, 128.3, 127.4, 101.2, 72.4, 61.8, 43.5, 40.3, 14.1; IR (thin film, cm
-1
): 
3503, 3029, 2980, 2360, 1732, 1685, 1580, 1455, 1393, 1266, 1211, 1102, 1058, 990, 813, 
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755, 702, 555; m.p.; TLC (30% EtOAc/hexanes): Rf
 
: 0.42; HRMS (ESI): Calculated for 
[M+Na]
 
C19H19INaO4: 461.0226, Found: 461.0220; SFC Analysis: WO column, 5% MeOH, 
1.5 mL/min, 150 bar, 210 nm; tminor = 9.3 min tmajor = 10.1 min, 96.5:3.5 er; []D
25
 +34.32 (c 
= 12.5, CHCl3). 
 
(2R,3R)-Ethyl 2-hydroxy-5-(4-methoxyphenyl)-5-oxo-3-phenylpentanoate (4.25c): 
The title compound was prepared according to General Procedure E 
using -diketo ester 4.23c (53.0 mg, 0.155 mmol, 1.0 equiv), 
[RuCl2(p-cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 0.08 
equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash 
chromatography (20% EtOAc/hexanes) provided -hydroxy ester 4.25c (49.8 mg, 0.152 
mmol, 94% yield) as a clear oil. Analytical data for 4.25c: 
1
H NMR (600 MHz, CDCl3):  
8.01 (d, J = 8.4 Hz, 2H), 7.34-7.24 (m, 5H), 6.95 (d, J = 8.4 Hz, 2H), 4.59 (dd, J = 6.0 Hz, 
3.0 Hz, 1H), 4.19-4.11 (m, 2H), 3.96 (ddd, J = 8.4 Hz, 6.0 Hz, 3.0 Hz, 1H), 3.89 (s, 3H), 3.74 
(dd, J = 18.0 Hz, 8.4 Hz, 1H), 3.40 (dd, J = 18.0 Hz, 6.0 Hz, 1H), 2.91 (d, J =6.0 Hz, 1H), 
1.26 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  196.8, 173.7, 163.5, 139.0, 130.4, 
130.0, 128.6, 128.3, 127.3, 113.7, 72.5, 61.8, 55.4, 43.7, 39.9, 14.1; IR (thin film, cm
-1
): 
3503, 2980, 2935, 2360, 1732, 1675, 1600, 1575, 1510, 1455, 1419, 1369, 1259, 1214, 1171, 
1103, 1025, 991, 832, 703, 554; TLC (30% EtOAc/hexanes): Rf
 
: 0.30; HRMS (ESI): 
Calculated for [M+Na]
 
C20H22NaO5: 365.1365, Found: 365.1364; SFC Analysis: WO 
column, 5% MeOH, 1.5 mL/min, 150 bar, 210 nm; tminor = 9.3 min tmajor = 10.1 min, 96:4 er; 
[]D
25
 +47.15 (c = 2.7, CHCl3). 
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(2R,3R)-Ethyl 2-hydroxy-5-oxo-3-phenylhexanoate (4.25d): 
The title compound was prepared according to General Procedure E using 
-diketo ester 4.23d (38.0 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 0.08 equiv), and 
HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash chromatography (20% 
EtOAc/hexanes) provided -hydroxy ester 4.25d (33.0 mg, 0.132 mmol, 85% yield) as a 
clear oil. Analytical data for 4.25d: 
1
H NMR (600 MHz, CDCl3): m, 2H), 7.24-
7.23 (m, 3H), 4.48 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 4.14-4.07 (m, 2H), 3.72 (ddd, J = 8.4 Hz, 6.0 
Hz, 3.0 Hz, 1H), 3.12 (dd, J = 17.7 Hz, 7.8 Hz, 1H), 2.92 (dd, J = 17.7 Hz, 6.0 Hz, 1H), 2.83 
(d, J = 6.0 Hz, 1H), 2.16 (s, 3H), 1.24 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3): 
; IR (thin film, 
cm
-1
): 3502, 2983, 2937, 1731, 1717, 1494, 1455, 1366, 1213, 1165, 1106, 1025, 864, 758, 
703, 542; TLC (30% EtOAc/hexanes): Rf
 
: 0.22; HRMS (ESI): Calculated for [M+Na]
 
C14H18NaO4: 273.1103, Found: 273.1107; SFC Analysis: AS column, 7% MeOH, 1.5 
mL/min, 150 bar, 210 nm; tminor = 6.4 min tmajor = 9.2 min, 93:7 er; []D
25
 +47.15 (c = 2.7, 
CHCl3). 
 
(2R,3R,E)-Ethyl 2-hydroxy-5-oxo-3,7-diphenylhept-6-enoate (4.25e): 
The title compound was prepared according to General Procedure E 
using -diketo ester 4.23e (52.1 mg, 0.155 mmol, 1.0 equiv), 
[RuCl2(p-cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 0.08 
equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash 
chromatography (20% EtOAc/hexanes) provided -hydroxy ester 4.25e (46.0 mg, 0.136 
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mmol, 88% yield) as a white solid. Analytical data for 4.25e: 
1
H NMR (600 MHz, CDCl3): 
d, J = 16.2 Hz, 1H), 7.57-7.55 (m, 2H), 7.43-7.41 (m, 3H), 7.33-7.29 (m, 4H), 7.27-
7.24 (m, 1H), 6.76 (d, J = 16.2 Hz, 1H), 4.56 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 4.19-4.11 (m, 2H), 
3.88 (ddd, J = 8.4 Hz, 6.0 Hz, 3.0 Hz, 1H), 3.47 (dd, J = 17.4 Hz, 8.4 Hz, 1H), 3.19 (dd, J = 
17.4 Hz, 6.0 Hz, 1H), 2.94 (d, J = 6.0 Hz, 1H), 1.26 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, 
CDCl3): 198.3, 173.6, 143.0, 138.8, 134.4, 130.5, 128.9, 128.6, 128.3, 128.3, 127.3, 126.4, 
72.5, 61.8, 43.7, 42.5, 14.1; IR (thin film, cm
-1
): 3503, 1733, 1684, 1655, 1610, 1576, 1495, 
1450, 1259, 1210, 1176, 1096, 1024, 976, 749, 703, 554; TLC (30% EtOAc/hexanes): Rf
 
: 
0.33; HRMS (ESI): Calculated for [M+Na]
 
C21H22NaO4: 361.1416, Found: 361.1416; SFC 
Analysis: WO column, 5% MeOH, 1.5 mL/min, 150 bar, 210 nm; tminor = 15.0 min tmajor = 
16.1 min, 99:1 er; []D
25
 +47.32 (c = 5.3, CHCl3). 
 
(2R,3R)-Ethyl 5-(benzo[d][1,3]dioxol-5-yl)-2-hydroxy-5-oxo-3-phenylpentanoate (4.25f): 
The title compound was prepared according to General Procedure E 
using -diketo ester 4.23f (55.0 mg, 0.155 mmol, 1.0 equiv), 
[RuCl2(p-cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 0.08 
equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash 
chromatography (20% EtOAc/hexanes) provided -hydroxy ester 4.25f (54.0 mg, 0.152 
mmol, 98% yield) as a clear oil. Analytical data for 4.25f: 
1
H NMR (600 MHz, 
CDCl3):7.65 (dd, J = 8.4 Hz, 1.8 Hz, 1H), 7.48 (d, J = 1.8 Hz, 1H), 7.33-7.28 (m, 4H), 
7.25-7.24 (m, 1H), 6.87 (d, J =8.4 Hz, 1H), 6.06 (s, 2H), 4.58 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 
4.26-4.05 (m, 2H), 3.94 (ddd, J = 8.4 Hz, 6.0 Hz, 3.0 Hz, 1H), 3.71 (dd, J = 18.0 Hz, 8.4 Hz, 
1H), 3.37 (dd, J = 18.0 Hz, 6.0 Hz, 1H), 2.89 (d, J = 6.0 Hz, 1H) 1.26 (t, J = 7.2 Hz, 3H); 
13
C 
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NMR (150 MHz, CDCl3):  196.3, 173.7, 151.8, 148.2, 139.0, 131.9, 128.6, 128.3, 127.3, 
124.4, 107.9, 107.8, 101.8, 72.5, 61.8, 43.8, 40.1, 14.1; IR (thin film, cm
-1
): 3503, 2980, 
1731, 1684, 1597, 1492, 1448, 1413, 1365, 1266, 1212, 1095, 1015, 785, 690, 546; TLC 
(30% EtOAc/hexanes): Rf
 
: 0.28; HRMS (ESI): Calculated for [M+Na]
 
C20H20NaO6: 
379.1158, Found: 379.1161; SFC Analysis: WO column, 5% MeOH, 1.5 mL/min, 150 bar, 
210 nm; tminor = 15.2 min tmajor = 16.3 min, 99:1 er; []D
25
 +32.94 (c = 10.0, CHCl3). 
 
(2R,3R)-Ethyl 3-(4-chlorophenyl)-2-hydroxy-5-oxo-5-phenylpentanoate (4.25g): 
The title compound was prepared according to General Procedure E using 
-diketo ester 4.23g (53.0 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 
equiv). Flash chromatography (20% EtOAc/hexanes) provided -hydroxy ester 4.25g (50.0 
mg, 0.146 mmol, 94% yield) as a clear oil. Analytical data for 4.25g: 
1
H NMR (600 MHz, 
CDCl3): 7.98 (d,  J = 7.2 Hz, 2H), 7.58-7.55 (m, 1H), 7.47-7.44 (m, 2H), 7.26 (d, J = 8.4 
Hz, 2H), 7.24 (d, J = 8.4 Hz, 2H), 4.55 (dd, J = 5.4 Hz, 3.0 Hz, 1H), 4.17-4.10 (m, 2H), 3.93 
(ddd, J = 7.8 Hz, 6.6 Hz, 3.0 Hz, 1H), 3.70 (dd, J = 18.0 Hz, 7.8 Hz, 1H), 3.43 (dd, J = 18.0 
Hz, 6.6 Hz, 1H), 2.91 (d, J = 5.4 Hz, 1H), 1.24 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, 
CDCl3):  197.3, 173.5, 137.5, 136.8, 133.3, 133.2, 130.0, 128.6, 128.4, 128.0, 72.4, 62.0, 
43.0, 40.5, 14.2; IR (thin film, cm
-1
): 3503, 2982, 2905, 1733, 1676, 1603, 1504, 1489, 1443, 
1367, 1256, 1097, 1037, 933, 808, 757, 703, 556; TLC (30% EtOAc/hexanes): Rf
 
: 0.38; 
HRMS (ESI): Calculated for [M+Na]
 
C19H19ClNaO6: 369.0870, Found: 369.0873; SFC 
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Analysis: OD column, 10% MeOH, 1.5 mL/min, 150 bar, 210 nm; tminor = 8.8 min tmajor = 9.8 
min, 98:2 er; []D
25
 +48.4 (c = 4.2, CHCl3). 
 
(2R,3R)-Ethyl 2-hydroxy-3-(4-methoxyphenyl)-5-oxo-5-phenylpentanoate (4.25h): 
The title compound was prepared according to General Procedure E using 
-diketo ester 4.23h (53.0 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 
equiv). Flash chromatography (20% EtOAc/hexanes) provided -hydroxy ester 4.25h (52.0 
mg, 0.152 mmol, 98% yield) as a clear oil. Analytical data for 4.25h: 
1
H NMR (600 MHz, 
CDCl3): 7.99 (d, J = 7.2 Hz, 2H), 7.57-7.54 (m, 1H), 7.46-7.44 (m, 2H), 7.22 (d, J = 8.4 
Hz, 2H), 6.80 (d, J = 8.4 Hz, 2H), 4.54 (dd,  J = 6.0 Hz, 3.0 Hz, 1H), 4.17-4.09 (m, 2H), 3.90 
(ddd, J = 8.4 Hz, 6.0 Hz, 3.0 Hz, 1H), 3.76 (s, 3H), 3.71 (dd, J = 18.0 Hz, 8.4 Hz, 1H), 3.41 
(dd, J = 18.0 Hz, 6.0 Hz, 1H), 2.86 (d, J = 6.0 Hz, 1H), 1.25 (t, J = 7.2 Hz, 3H); 
13
C NMR 
(150 MHz, CDCl3):  198.4, 173.7, 158.7, 137.0, 133.1, 130.9, 128.6, 128.1, 113.7, 72.7, 
61.8, 55.1, 42.8, 40.6, 14.2; IR (thin film, cm
-1
): 3502, 2935, 1731, 1683, 1612, 1597, 1580, 
1514, 1448, 1366, 1251, 1180, 1100, 1032, 837, 757, 691; TLC (30% EtOAc/hexanes): Rf
 
: 
0.33; HRMS (ESI): Calculated for [M+Na]
 
C20H22NaO5: 365.1365, Found: 365.1366; SFC 
Analysis: AD column, 10% MeOH, 1.5 mL/min, 150 bar, 210 nm; tminor = 13.2 min tmajor = 
16.8 min, 96:4 er; []D
25
 +34.6 (c = 6.3, CHCl3). 
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(2R,3R)-Ethyl 2-hydroxy-5-oxo-5-phenyl-3-(o-tolyl)pentanoate (4.25i): 
The title compound was prepared according to General Procedure E using 
-diketo ester 4.23i (50.0 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 
(1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 0.08 equiv), 
and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash chromatography 
(20% EtOAc/hexanes) provided -hydroxy ester 4.25i (44.0 mg, 0.135 mmol, 87% yield) as 
a clear oil. Analytical data for 4.25i: 
1
H NMR (600 MHz, CDCl3): 7.97 (d, J = 6.6 Hz, 2H), 
7.56-7.51 (m, 2H), 7.46-7.43 (m, 2H), 7.15-7.08 (m, 3H), 4.63 (d, J = 4.2 Hz, 1H), 4.24 (ddd, 
J = 7.8 Hz, 6.0 Hz, 4.2 Hz, 1H), 4.14-4.08 (m, 1H), 4.01-3.95 (m, 1H), 3.72 (dd, J = 18.0 Hz, 
7.8 Hz, 1H), 3.36 (dd, J = 18.0 Hz, 6.0 Hz, 1H), 3.03 (bs, 1H), 2.41 (s, 3H), 1.12 (t, J = 7.2 
Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  198.5, 173.9, 138.2, 136.8, 136.2, 133.2, 130.4, 
128.6, 128.1, 127.5, 126.9, 126.0, 72.4, 61.8, 41.3, 40.9, 37.7, 19.8, 13.8; IR (thin film, cm
-
1
): 3495, 2980, 1732, 1624, 1597, 1490, 1448, 1365, 1259, 1216, 1115, 1094, 1022, 754, 730, 
690; TLC (30% EtOAc/hexanes): Rf
 
: 0.40; HRMS (ESI): Calculated for [M+Na]
 
C20H22NaO4: 349.1416, Found: 349.1422; SFC Analysis: AD column, 10% MeOH, 1.5 
mL/min, 150 bar, 210 nm; tminor = 14.6 min tmajor = 11.6 min, 83:17 er; []D
25
 +1.9 (c = 2.7, 
CHCl3). 
 
(2R,3R)-Ethyl 2-hydroxy-5-oxo-5-phenyl-3-(m-tolyl)pentanoate (4.25j): 
The title compound was prepared according to General Procedure E using 
-diketo ester 4.23j (50.0 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash 
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chromatography (20% EtOAc/hexanes) provided -hydroxy ester 4.25j (49.0 mg, 0.152 
mmol, 98% yield) as a clear oil. Analytical data for 4.25j: 
1
H NMR (600 MHz, CDCl3): 
8.00 (d, J = 8.4 Hz, 2H), 7.57-7.55 (m, 1H), 7.47-7.44 (m, 2H), 7.17-7.15 (m, 1H), 7.11-7.08 
(m, 1H), 7.04-7.03 (m, 1H), 4.56 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 4.15-4.11 (m, 2H), 3.91 (ddd, 
J = 8.4 Hz, 5.4 Hz, 3.0 Hz, 1H), 3.76 (dd, J = 18.0 Hz, 8.4 Hz, 1H), 3.42 (dd, J = 18.0 Hz, 
5.4 Hz, 1H), 2.85 (d, J = 6 Hz, 1H), 2.31 (s, 3H), 1.24 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 
MHz, CDCl3):  198.3, 173.7, 138.8, 137.8, 137.0, 133.1, 129.4, 128.6, 128.2, 128.1, 128.1, 
125.6, 72.5, 61.7, 43.6, 40.3, 21.4, 14.1; IR (thin film, cm
-1
): 3505, 2980, 2922, 1733, 1685, 
1597, 1448, 1365, 1265, 1207, 1104, 1023, 1001, 757, 709, 691; TLC (30% 
EtOAc/hexanes): Rf
 
: 0.43; HRMS (ESI): Calculated for [M+Na]
 
C20H22NaO4: 349.1416, 
Found: 349.1419; SFC Analysis: AD column, 10% MeOH, 1.5 mL/min, 150 bar, 210 nm; 
tminor = 9.6 min tmajor = 7.9 min, 98:2 er; []D
25
 +22.6 (c = 9.0, CHCl3). 
 
(2R,3R)-Ethyl 2-hydroxy-5-oxo-5-phenyl-3-(p-tolyl)pentanoate (4.25k): 
The title compound was prepared according to General Procedure E using 
-diketo ester 4.23k (50.0 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 
equiv). Flash chromatography (20% EtOAc/hexanes) provided -hydroxy ester 4.25k (48.0 
mg, 0.151 mmol, 97% yield) as a clear oil. Analytical data for 4.25k: 
1
H NMR (600 MHz, 
CDCl3): 7.99 (d, J = 7.8 Hz, 2H), 7.57-7.54 (m, 1H), 7.47-7.44 (m, 2H), 7.19 (d, J = 7.8 
Hz, 2H), 7.08 (d, J = 7.8 Hz, 2H), 4.55 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 4.17-4.09 (m, 2H), 3.91 
(ddd, J = 8.4 Hz, 6.0 Hz, 3.0 Hz, 1H), 3.74 (dd, J = 18.0 Hz, 8.4 Hz, 1H), 3.42 (dd, J = 18.0 
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Hz, 6.0 Hz, 1H), 2.85 (d, J = 6.0 Hz, 1H), 2.29 (s, 3H), 1.25 (t, J = 7.2 Hz, 3H); 
13
C NMR 
(150 MHz, CDCl3):  198.3, 173.7, 137.0, 136.8, 135.8, 133.1, 129.0, 128.5, 128.4, 128.1, 
72.6, 61.7, 43.2, 40.4, 21.0, 14.1; IR (thin film, cm
-1
): 3509, 2981, 2923, 1731, 1684, 1597, 
1515, 1448, 1336, 1265, 1210, 1100, 1022, 757, 691, 550; TLC (30% EtOAc/hexanes): Rf
 
: 
0.43; HRMS (ESI): Calculated for [M+Na]
 
C20H22NaO4: 349.1416, Found: 349.1422; SFC 
Analysis: AD column, 10% MeOH, 1.5 mL/min, 150 bar, 210 nm; tminor = 12.8 min tmajor = 
10.6 min, 98:2 er; []D
25
 +32.1 (c = 8.0, CHCl3). 
 
(2R,3S)-Diethyl 2-hydroxy-3-(2-oxo-2-phenylethyl)succinate (4.25l): 
The title compound was prepared according to General Procedure E using 
-diketo ester 4.23l (47.0 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash 
chromatography (20% EtOAc/hexanes) provided -hydroxy ester 4.25l (44.0 mg, 0.144 
mmol, 93% yield) as a clear oil. Analytical data for 4.25l: 
1
H NMR (600 MHz, 
CDCl3):d,  J = 7.2 Hz, 2H), 7.60-7.56 (m, 1H), 7.49-7.46 (m, 2H), 4.37 (d, J = 2.8 
Hz, 1H), 4.33-4.28 (m, 2H), 4.21-4.11 (m, 2H), 3.79 (ddd, J = 8.4 Hz, 5.6 Hz, 8.4 Hz, 1H), 
3.71 (dd, J = 18.0 Hz, 8.4 Hz, 1H), 3.25 (dd, J = 18.0 Hz, 5.6 Hz, 1H), 3.19 (bs 1H), 1.34 (t, 
J = 7.2 Hz, 3H), 1.21 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  197.7, 173.3, 
171.2, 136.6, 133.4, 128.6, 128.1, 70.9, 62.2, 61.2, 44.1, 36.7, 14.1, 14.0; IR (thin film, cm
-
1
): 3487, 2982, 1734, 1685, 1449, 1366, 1226, 1180, 1111, 1032, 861, 759, 691; TLC (30% 
EtOAc/hexanes): Rf
 
: 0.23; HRMS (ESI): Calculated for [M+Na]
 
C16H20NaO6: 331.1158, 
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Found: 338.1165; SFC Analysis: AD column, 10% MeOH, 1.5 mL/min, 150 bar, 210 nm; 
tminor = 7.3 min tmajor = 6.5 min, 91:9 er; []D
25
 +27.5 (c = 4.2, CHCl3). 
 
(2R,3R)-Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-2-hydroxy-5-oxo-5-phenylpentanoate 
(4.25m): 
The title compound was prepared according to General Procedure E using 
-diketo ester 4.23m (55.0 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 
equiv). Flash chromatography (20% EtOAc/hexanes) provided -hydroxy ester 4.25m (53.0 
mg, 0.149 mmol, 96% yield) as a clear oil. Analytical data for 4.25m: 
1
H NMR (600 MHz, 
CDCl3):d, J = 7.2 Hz, 2H), 7.57-7.55 (m, 1H), 7.47-7.44 (m, 2H), 6.84 (s, 1H), 6.74-
6.73 (m, 1H), 6.70-6.69 (m, 1H), 5.91 (s, 2H), 4.52 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 4.21-4.10 
(m, 2H), 3.87 (ddd, J = 8.4 Hz, 6.0 Hz, 3.0 Hz, 1H), 3.67 (dd, J = 18.0 Hz, 8.4 Hz, 1H), 3.41 
(dd, J = 18.0 Hz, 6.0 Hz, 1H), 2.89 (d, J = 6.0 Hz, 1H), 1.26 (t, J = 7.2 Hz, 3H); 
13
C NMR 
(150 MHz, CDCl3): 198.2, 173.7, 147.5, 146.7, 136.9, 133.2, 132.6, 128.6, 128.1, 121.9, 
109.0, 108.0, 100.9, 72.6, 61.8, 43.2, 40.6, 14.2; IR (thin film, cm
-1
): 3503, 2982, 2902, 
1733, 1684, 1504, 1487, 1446, 1239, 1098, 1038, 933, 811, 759, 690; TLC (30% 
EtOAc/hexanes): Rf
 
: 0.28; HRMS (ESI): Calculated for [M+Na]
 
C20H20NaO6: 379.1158, 
Found: 379.1162; SFC Analysis: AD column, 10% MeOH, 1.5 mL/min, 150 bar, 210 nm; 
tminor = 16.5 min tmajor = 12.8 min, 98:2 er; []D
25
 +30.8 (c = 7.0, CHCl3). 
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Tert-butyl 3-((2R,3R)-1-ethoxy-2-hydroxy-1,5-dioxo-5-phenylpentan-3-yl)-1H-indole-1-
carboxylate (4.25n): 
The title compound was prepared according to General Procedure E using 
-diketo ester 4.23n (70.0 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-
cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), L14 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash 
chromatography (20% EtOAc/hexanes) provided -hydroxy ester 4.25n (60.0 mg, 0.133 
mmol, 86% yield) as a clear oil. Analytical data for 4.25n: 
1
H NMR (400 MHz, CDCl3)  
8.09-8.07 (m, 1H), 8.00-7.98 (m, 2H), 7.68-7.66 (m, 1H), 7.58-7.54 (m, 2H), 7.47-7.44 (m, 
2H), 7.31-7.26 (m, 1H), 7.25-7.21 (m, 1H), 4.62 (dd, J = 6.0 Hz, 2.8 Hz, 1H), 4.32 (ddd, J = 
8.4 Hz, 6.0 Hz, 2.8 Hz, 1H), 4.09-4.01 (m, 2H), 3.81 (dd, J = 18.0 Hz, 8.4 Hz, 1H), 3.42 (dd, 
J = 18.0 Hz, 6.0 Hz, 1H), 3.09 (d,  J = 6.0 Hz, 1H), 1.67 (s, 9H), 1.15 (t, J = 7.2 Hz, 3H); 
13
C 
NMR (100 MHz, CDCl3):  198.2, 173.4, 136.8, 133.2, 130.0, 128.6, 128.1, 124.4, 124.0, 
122.3, 119.3, 118.2, 115.2, 83.7, 71.7, 61.9, 41.0, 34.5, 28.2, 13.9; IR (thin film, cm
-1
): 3502, 
2979, 2932, 1732, 1685, 1452, 1375, 1309, 1256, 1217, 1157, 1107, 1090, 1020, 856, 765, 
749, 690; TLC (30% EtOAc/hexanes): Rf
 
: 0.40; HRMS (ESI): Calculated for [M+Na]
 
C26H29NNaO6: 474.1893, Found: 474.1899; SFC Analysis: AD column, 10% MeOH, 1.5 
mL/min, 150 bar, 210 nm; tminor = 29.4 min tmajor = 23.5 min, 98:2 er; []D
25
 +21.5 (c = 8.7, 
CHCl3). 
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Bayer Villiger Oxidation of 4.25c 
 
 
To a 1-dram vial equipped with a magnetic stir bar were added 4.25c (34.2 mg, 0.100 mmol, 
1.0 equiv), m-CPBA (86.3 mg, 0.500 mmol, 5.0 equiv), TFA (11.4 mg, 0.100 mmol, 1.0 
equiv) and CH2Cl2 (1 mL). The reaction was stirred at room temperature overnight and then 
diluted with water and ethyl acetate. The organic was washed with water followed by brine, 
dried over sodium sulfate and concentrated in vacuo. Flash chromatography provided 4.21 
(17.0 mg, 0.072 mmol, 72% yield) as a white solid whose spectral data were in agreement 
with the cis-lactone. 
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